Partners HealthCare System, Inc. and Affiliates · Partners HealthCare System, Inc. and Affiliates Report on Federal Awards in Accordance with OMB Uniform Guidance Index September

Partners HealthCare System, Inc. and Affiliates Report on Federal Awards in Accordance with the OMB Uniform Guidance September 30, 2016 EIN 04-3230035

Partners HealthCare System, Inc. and Affiliates Report on Federal Awards in Accordance with OMB Uniform Guidance Index September 30, 2016

Page(s)

Part I - Financial Statements

Report of Independent Auditors ............................................................................................................... 1–2

Consolidated Financial Statements and Notes to Consolidated Financial Statements ......................... 3–47

Schedule of Expenditures of Federal Awards and Notes to Schedule of Expenditures of Federal Awards .......................................................................................................... 48–95

Part II - Reports on Compliance and Internal Controls

Report of Independent Auditors on Internal Control Over Financial Reporting and on Compliance and Other Matters Based on an Audit of Financial Statements Performed in Accordance with Government Auditing Standards .......................................................................... 96–97

Report of Independent Auditors on Compliance with Requirements That Could Have a Direct and Material Effect on Each Major Program and on Internal Control Over Compliance in Accordance with the OMB Uniform Guidance ........................... 98–99

Part III - Federal Award Findings and Questioned Costs

Schedule of Findings and Questioned Costs ................................................................................... 100–101

Summary of Status of Prior Year Findings ............................................................................................... 102

Management’s Views and Corrective Action Plan ................................................................................... 103

Part I Financial Statements

Report of Independent Auditors

To the Board of Directors of

Partners HealthCare System, Inc. and Affiliates

Report on the Consolidated Financial Statements

We have audited the accompanying consolidated financial statements of Partners HealthCare

System, Inc. and Affiliates (Partners HealthCare), which comprise the consolidated balance sheets as of

September 30, 2016 and 2015, and the related consolidated statements of operations, changes in net

assets and of cash flows for the years then ended, and the related notes to the consolidated financial

statements.

Management’s Responsibility for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial

statements in accordance with accounting principles generally accepted in the United States of America;

this includes the design, implementation, and maintenance of internal control relevant to the preparation

and fair presentation of consolidated financial statements that are free from material misstatement,

whether due to fraud or error.

Auditor’s Responsibility

Our responsibility is to express an opinion on the consolidated financial statements based on our audits.

We conducted our audits in accordance with auditing standards generally accepted in the United States of

America and the standards applicable to financial audits contained in Government Auditing Standards,

issued by the Comptroller General of the United States. Those standards require that we plan and

perform the audit to obtain reasonable assurance about whether the consolidated financial statements are

free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in

the consolidated financial statements. The procedures selected depend on our judgment, including the

assessment of the risks of material misstatement of the consolidated financial statements, whether due to

fraud or error. In making those risk assessments, we consider internal control relevant to the entity’s

preparation and fair presentation of the consolidated financial statements in order to design audit

procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on

the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also

includes evaluating the appropriateness of accounting policies used and the reasonableness of significant

accounting estimates made by management, as well as evaluating the overall presentation of the

consolidated financial statements. We believe that the audit evidence we have obtained is sufficient and

appropriate to provide a basis for our audit opinion.

PricewaterhouseCoopers LLP, 101 Seaport Blvd., Boston, MA 02210 T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us

2

Opinion

In our opinion, the consolidated financial statements referred to above present fairly, in all material

respects, the consolidated financial position of Partners HealthCare as of September 30, 2016 and 2015,

and the results of their operations, their changes in their net assets and their cash flows for the years then

ended in accordance with accounting principles generally accepted in the United States of America.

Other Matters

Other Information

Our audit was conducted for the purpose of forming an opinion on the consolidated financial statements as a whole. The accompanying schedule of expenditures of federal awards is presented for purposes of additional analysis as required by Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards

(Uniform Guidance) and is not a required part of the consolidated financial statements. Such information

is the responsibility of management and was derived from and relates directly to the underlying accounting

and other records used to prepare the consolidated financial statements. The information has been

subjected to the auditing procedures applied in the audit of the consolidated financial statements and

certain additional procedures, including comparing and reconciling such information directly to the

underlying accounting and other records used to prepare the consolidated financial statements or to the

consolidated financial statements themselves, and other additional procedures in accordance with

auditing standards generally accepted in the United States of America. In our opinion, the schedule of

expenditures of federal awards is fairly stated, in all material respects, in relation to the consolidated

financial statements as a whole.

Other Reporting Required by Government Auditing Standards

In accordance with Government Auditing Standards, we have also issued our report dated December 9,

2016 on our consideration of Partners HealthCare’s internal control over financial reporting and on our

tests of its compliance with certain provisions of laws, regulations, contracts and grant agreements and

other matters. The purpose of that report is to describe the scope of our testing of internal control over

financial reporting and compliance and the results of that testing and not to provide an opinion on internal

control over financial reporting or on compliance. That report is an integral part of an audit performed in

accordance with Government Auditing Standards in considering Partners HealthCare’s internal control

over financial reporting and compliance.

December 9, 2016

Partners HealthCare System, Inc. and AffiliatesConsolidated Balance SheetsSeptember 30, 2016 and 2015

The accompanying notes are an integral part of these consolidated financial statements.

3

(in thousands of dollars) 2016 2015

AssetsCurrent assets

Cash and equivalents 827,683$ 621,568$

Investments 1,069,006 1,354,636Current portion of investments limited as to use 1,588,787 1,590,203

Patient accounts receivable, net of allowance for bad debts

(2016 - $121,652; 2015 - $112,630) 881,993 878,033Research grants receivable 129,243 121,775

Other current assets 449,440 447,188

Receivable for settlements with third-party payers 55,238 60,374

Total current assets 5,001,390 5,073,777

Investments limited as to use, less current portion 3,069,175 2,832,744

Long-term investments 1,136,528 1,061,176Pledges receivable, net and contributions receivable from trusts,

less current portion 194,684 209,064

Property and equipment, net 5,881,927 5,328,782Other assets 629,168 572,150

Total assets 15,912,872$ 15,077,693$

Liabilities and Net Assets

Current liabilities

Current portion of long-term obligations 441,018$ 398,990$Accounts payable and accrued expenses 732,187 646,355

Accrued medical claims and related expenses 289,866 232,268

Accrued compensation and benefits 731,674 710,929Current portion of accrual for settlements with third-party payers 63,195 53,066

Unexpended funds on research grants 247,423 202,137

Total current liabilities 2,505,363 2,243,745

Accrual for settlements with third-party payers, less current portion 7,443 41,977

Accrued professional liability 487,705 482,640

Accrued employee benefits 2,163,540 1,705,287Interest rate swaps liability 510,172 404,062

Accrued other 156,178 153,146

Long-term obligations, less current portion 4,608,114 3,994,034

Total liabilities 10,438,515 9,024,891

Commitments and contingencies

Net assets

Unrestricted 4,060,285 4,707,662Temporarily restricted 790,886 765,562

Permanently restricted 623,186 579,578

Total net assets 5,474,357 6,052,802

Total liabilities and net assets 15,912,872$ 15,077,693$

Partners HealthCare System, Inc. and AffiliatesConsolidated Statements of OperationsYears Ended September 30, 2016 and 2015


4

(in thousands of dollars) 2016 2015

Operating revenue

Net patient service revenue, net of provision for

bad debts (2016 - $127,798; 2015 - $129,051) 7,571,548$ 7,317,918$

Premium revenue 2,508,924 2,034,420

Direct academic and research revenue 1,363,580 1,316,283

Indirect academic and research revenue 368,192 354,942

Other revenue 647,887 642,082

Total operating revenue 12,460,131 11,665,645

Operating expenses

Employee compensation and benefit expenses 5,987,168 5,655,073

Supplies and other expenses 2,508,630 2,325,085

Medical claims and related expenses 2,017,773 1,652,538

Direct academic and research expenses 1,363,580 1,316,283

Depreciation and amortization expenses 557,542 493,505

Interest expense 133,317 116,703

Total operating expenses 12,568,010 11,559,187

(Loss) income from operations (107,879) 106,458

Nonoperating gains (expenses)

Income (loss) from investments 61,102 (37,258)

Change in fair value of interest rate swaps (106,110) (110,315)

Gifts and other, net of fundraising and other expenses (37,293) (39,468)

Academic and research gifts, net of expenses (58,831) (11,406)

Total nonoperating gains (expenses), net (141,132) (198,447)

Deficit of revenues over expenses (249,011) (91,989)

Other changes in net assets

Change in net unrealized appreciation on marketable investments 200,042 (224,616)

Funds utilized for property and equipment 49,162 38,288

Change in funded status of defined benefit plans (647,180) (639,167)

Other (390) 1,387

Decrease in unrestricted net assets (647,377)$ (916,097)$

Partners HealthCare System, Inc. and AffiliatesConsolidated Statements of Changes in Net AssetsYears Ended September 30, 2016 and 2015


5

Temporarily Permanently

(in thousands of dollars) Unrestricted Restricted Restricted Total

Net assets at October 1, 2014 5,623,759$ 855,954$ 463,774$ 6,943,487$

Increases (decreases)

Income from operations 106,458 - - 106,458

(Loss) income from investments (37,258) (46,460) 55 (83,663)

Gifts and other (39,468) 8,029 116,449 85,010

Academic and research gifts, net of expenses (11,406) - - (11,406)

Change in net unrealized appreciation on

marketable investments (224,616) (36,351) (2,313) (263,280)

Change in fair value of interest rate swaps (110,315) - - (110,315)Funds utilized for property and equipment 38,288 (17,151) - 21,137

Change in funded status of defined benefit plans (639,167) - - (639,167)

Other 1,387 1,541 1,613 4,541

Change in net assets (916,097) (90,392) 115,804 (890,685)

Net assets at September 30, 2015 4,707,662 765,562 579,578 6,052,802

Increases (decreases)

Loss from operations (107,879) - - (107,879)

Income (loss) from investments 61,102 (21,616) 37 39,523

Gifts and other (37,293) 39,875 44,093 46,675Academic and research gifts, net of expenses (58,831) - - (58,831)

Change in net unrealized appreciation on

marketable investments 200,042 30,170 (340) 229,872

Change in fair value of interest rate swaps (106,110) - - (106,110)

Funds utilized for property and equipment 49,162 (23,105) - 26,057

Change in funded status of defined benefit plans (647,180) - - (647,180)

Other (390) - (182) (572)

Change in net assets (647,377) 25,324 43,608 (578,445)

Net assets at September 30, 2016 4,060,285$ 790,886$ 623,186$ 5,474,357$

Partners HealthCare System, Inc. and AffiliatesConsolidated Statements of Cash FlowsYears Ended September 30, 2016 and 2015

6


Partners HealthCare System, Inc. and AffiliatesNotes to Consolidated Financial StatementsSeptember 30, 2016 and 2015

(in thousands of dollars)

7

1. Organization and Community Benefit Commitments

Partners HealthCare System, Inc. (PHS) is the sole member of The Massachusetts General

(NSMC), Newton-Wellesley Health Care System, Inc. (NWHCS), Partners Continuing Care, Inc.(PCC), Partners HealthCare International, LLC (PHI) and Neighborhood Health Plan, Incorporated(NHP). The two physicians who serve as the President and Chief Executive Officer of PHS (PHSCEO) and the Chief Clinical Officer of PHS are the members of Partners Community PhysiciansOrganization, Inc. (PCPO). The individual serving as the PHS CEO is the sole member of PartnersMedical International, Inc. (PMI). P

The Boards of MGH, Wentworth-Douglass Health System and Wentworth-Douglass Hospital(WDH) have entered into a definitive agreement pursuant to which MGH will become the parentorganization of WDH and its affiliates. The parties have completed due diligence and expect tocomplete the regulatory approval process in the near future. The transaction is expected to closein fiscal 2017.

Partners HealthCare currently operates two tertiary and seven community acute care hospitals inMassachusetts, one facility providing inpatient and outpatient mental health services and threefacilities providing inpatient and outpatient services in rehabilitation medicine and long-term care.Partners HealthCare also operates physician organizations and practices, a home health agency,nursing homes and a graduate level program for health professions. Partners HealthCare providesservices to patients primarily from the Greater Boston area as well as New England and beyond.In addition, Partners HealthCare is a nonuniversity-based non-profit private medical researchenterprise and is a principal teaching affiliate of the medical and dental schools of HarvardUniversity. Partners HealthCare also operates a licensed, not-for-profit managed care organizationthat provides health insurance products to the Massachusetts Medicaid program (MassHealth),ConnectorCare (a state subsidized program for adults who meet income and immigrationguidelines) and commercial populations.

PHS and substantially all of its affiliates are tax-exempt organizations under Section 501(c)(3) ofthe Internal Revenue Code (IRC). NHP is a tax-exempt organization under Section 501(c)(4) of theIRC. Accordingly, no provision for income taxes related to these tax-exempt entities has beenmade. The Internal Revenue Service approved PCPO a tax-exemptorganization under Section 501(c)(3) of the IRC effective October 1, 2015. Harbor MedicalAssociates (Harbor), a subsidiary of BWHC, applied to become a tax-exempt organization underSection 501(c)(3) of the IRC effective October 1, 2016. In 2016, Harbor recognized income taxexpense of $2,700 within supplies and other expenses.

Community Benefit

number of public health issues including racial disparities, alcohol and substance abuse amongyoung people, infant mortality, domestic violence and cancer. Partners HealthCare provideseconomic opportunity for low income Boston residents by helping people advance into nursing andother healthcare careers through its public school partnerships and workforce developmentprograms. In addition, twenty community health centers are licensed by or affiliated with PartnersHealthCare entities and provide high quality, culturally competent primary care and access to

. P



8

infrastructure, programming and operation and also helps with relocation, renovation and othercapital requirements.

efits Guidelines direct non-profit acute carehospitals and health maintenance organizations to prepare annual reports documenting the statusand level of their community benefit programs and initiatives. These annual reports serve theimportant purpose of providing the public with access to useful information about these programsand initiatives. Partners HealthCare files its report annually with the Massachusetts AttorneyGeneral. The report summarizes community benefit activities on a system-wide basis. In addition,each of the acute care hospitals within Partners HealthCare has a community benefit planning andservice delivery structure and files separate community benefit reports. NHP also files acommunity benefit report annually.

Uncompensated CarePartners HealthCare provides care to all patients regardless of their ability to pay. The cost ofproviding that care is reflected in the statements of operations. The cost related to those patientsfor which Partners HealthCare receives either partial or no reimbursement for healthcare servicesprovided is summarized as follows:

State ProgramsCharity care services are partially reimbursed to acute care hospitals through the statewide HealthSafety Net Trust Fund (HSN) established by the Massachusetts Health Care Reform Law (Chapter58 of the Acts of 2006 or Chapter 58). A portion of the funding for the HSN is paid by hospitalsthrough a statewide acute care hospital assessment that has been set by the MassachusettsLegislature, beginning in 2014, at $160,000 plus 50% of the estimated cost of administering theHSN and related assessments, as determined by the Massachusetts Secretary of Administrationand Finance. All acute care hospitals in the state are assessed their share of this total statewidehospital assessment amount ($165,200 in 2016 and $165,000 in 2015charges for private sector payers. P acute care hospitals report thisassessment as a deduction from net patient service revenue.

Acute care hospitals are reimbursed for charity care based on claims for eligible patients andeligible services that are submitted to and adjudicated by the HSN. Rates of payment are basedon Medicare rates and payment policies. The HSN was under-funded by approximately $110,627and $41,327 in 2016 and 2015, respectively. This shortfall is allocated to hospitals based on theirshare of total statewide patient care costs with approximately $39,571 and $10,881 in 2016 and2015, respectively, allocated to Partners Health . Eof the overall state shortfall cannot exceed its total charity care reimbursement. Hospitals with ahigh proportion of charity care and government funding receive more favorable reimbursement,including limiting their shortfall allocation to no more than 15% of their payments for charity care. In

covering 38% and 68% of the estimated cost of charity care provided in 2016 and 2015,respectively, excluding the assessment.



9

MedicaidMedicaid is a health insurance program jointly funded by the states and the federal government.Each state administers its own program and sets rules for eligibility, benefits and providerpayments within broad federal guidelines and in some cases, including Massachusetts, within aWaiver Agreement between the state and the federal government. The program provides healthcare coverage to low-income adults and children. Eligibility is determined by a variety of factors,which may include income relative to the federal poverty line, age, immigrant status and assets.

Medicaid payments to Partners HealthCare providers do not cover the full cost of servicesprovided. In aggregate, reimbursement from Medicaid covered 60% and 62% of the estimated costof services provided in 2016 and 2015, respectively. In addition, Medicaid premium revenue paidto NHP for the care of Medicaid patients enrolled in NHP did not cover the medical expense andadministrative costs of care for these enrollees. In aggregate, the premium revenue paid to NHPby Medicaid, excluding the impact of premium deficiency reserves, was $72,542, or 3.9%, less thanthe cost of care in 2016, and $72,549, or 4.6%, less than the cost of care in 2015.

Federal ProgramMedicareMedicare is a federally sponsored health insurance program for people age 65 or older, under age65 with certain disabilities and any age with End-Stage Renal Disease. For many years, Medicarepayments have not kept pace with increases in the cost of care provided at many hospitals.Additionally, payments to physicians have seen little or no increases over the past several years.Compounding this shortfall in payments is the continued shift of care from higher paying inpatientservices to lower paying outpatient services.

Consequently, Medicare payments to Partners HealthCare providers do not cover the full cost ofservices provided. In aggregate, reimbursement from Medicare covered approximately 73% of theestimated cost of services provided in 2016 and 2015.



10

SummaryFor charity care, Medicaid and Medicare, the estimated cost of services provided is either obtaineddirectly from a costing system or based on an entity specific ratio of cost to gross charges. In thelatter case, cost is derived by applying this ratio to gross charges associated with providing care tocharity care, Medicaid and Medicare patients. The following summarizes, by program, the cost ofservices provided, net reimbursement and cost of services in excess of reimbursement for eachyear:

2016 2015

Cost of services providedCharity care, including assessment payments to HSN of

$57,458 and $56,716 in 2016 and 2015, respectively 138,680$ 136,276$Medicaid 1,077,629 1,008,882

Medicare 2,982,128 2,824,890

4,198,437$ 3,970,048$

Net reimbursementCharity care 23,293$ 40,906$

Medicaid 651,022 625,761Medicare 2,168,664 2,073,591

2,842,979$ 2,740,258$

Cost of services in excess of reimbursement

Charity care 115,387$ 95,370$Medicaid 426,607 383,121

Medicare 813,464 751,299

1,355,458$ 1,229,790$

Years Ended September 30,

Bad DebtsIn addition to charity care and inadequate funding from the Medicaid and Medicare programs, thereare significant losses related to self-pay patients who fail to make payment for services rendered orinsured patients who fail to remit co-payments and deductibles as required under the applicablehealth insurance arrangement. The provision for bad debts represents charges for servicesprovided that are deemed to be uncollectible and was $127,798 and $129,051 in 2016 and 2015,respectively. The estimated cost of providing these services was approximately $44,959 and$48,347 for 2016 and 2015, respectively.

2. Summary of Significant Accounting Policies

Basis of AccountingThe accompanying consolidated financial statements have been prepared on the accrual basis ofaccounting and include the accounts of PHS and its affiliates. Significant interaffiliate accounts andtransactions have been eliminated.



11

Use of EstimatesThe preparation of financial statements in conformity with accounting principles generally acceptedin the United States of America requires management to make estimates and assumptions thataffect the reported amounts of assets and liabilities and disclosure of contingent assets andliabilities at the date of the financial statements and the reported amounts of revenues andexpenses during the reporting period. Actual results could differ from those estimates. Significantestimates are made in the areas of patient accounts receivable, research grants receivable,investments, receivables and accruals for settlements with third-party payers, accrued medicalclaims and related expenses, accrued professional liability, accrued compensation and employeebenefits, interest rate swaps and accrued other.

Fair Value of Financial InstrumentsThe fair value of financial instruments approximates the carrying amount reported in theconsolidated balance sheets for cash and equivalents, certain investments and investments limitedas to use, patient accounts receivable, research grants receivable, accounts payable and accruedexpenses and interest rate swaps. More information can be found in Note 6, Fair ValueMeasurements.

Cash and EquivalentsCash and equivalents represent cash, registered money market funds and highly liquid debtinstruments with a maturity at the date of purchase of three months or less. Partners HealthCare sbanking cash and equivalents are maintained with several national banks and from time to timecash deposits exceed federal insurance limits. It is Partners HealthCare s policy to monitor thesebanks financial strength on an ongoing basis and no losses have been experienced to date.

InvestmentsInvestments in equity securities with readily determinable fair values and all investments in debtsecurities (marketable investments) are measured at fair value based on quoted market prices.The change in net unrealized appreciation on these marketable investments is excluded fromexcess of revenues over expenses.

Alternative investments, including hedge funds and private equities, do not have readilyascertainable market values. Investments in securities sold short or traded on a national securitiesexchange are valued based on quoted market prices. Investments in securities that are not tradedand restricted securities of public companies are valued based on amounts reported by the fundmanager and evaluated by management. The reported value of these investments represents theamount Partners HealthCare would expect to receive if it liquidated its investments at the balancesheet date on a nondistressed basis. Investments in hedge funds, private equity, private debt andother private partnerships (collectively, private partnerships) for which Partners HealthCare ownsmore than 5% of the overall investment are generally recorded as equity method investments. Thechange in value of equity method investments is included in excess of revenues over expenses asa component of income from investments. All other investments, including alternative investments,are recorded at cost.

Income from investments (including realized gains and losses, change in value of equity methodinvestments, interest, dividends and endowment income distributions) is included in excess ofrevenues over expenses unless the income or loss is restricted by donor or law. Income frominvestments is reported net of investment-related expenses.



12

Investments whose cost exceeds fair value are reviewed each quarter to determine whether theseinvestments are other-than-temporarily impaired. Externally managed marketable investments withfair value below cost are considered to be other-than-temporarily impaired and, accordingly, theunrealized depreciation is recognized as realized losses through a write-down in the cost basis ofthese investments. All other investments are subject to a further review, which considers factorsincluding the anticipated holding period for the investment and the extent and duration of belowcost valuation. A similar write-down is recorded when the impairment on these investments hasbeen judged to be other-than-temporary.

Depending on any donor-imposed restrictions on the underlying investments, the amount of thewrite-down is reported as a realized loss in either temporarily restricted net assets or in excess ofrevenues over expenses as a component of income from investments, with no adjustment in thecost basis for subsequent recoveries.

Partners HealthCare has an endowment spending policy for pooled endowment funds. A fixeddistribution rate for spending is determined each year which will come from either income and/ornet accumulated appreciation.

Investments Limited as to UseInvestments limited as to use primarily includes assets whose use is contractually limited byexternal parties as well as assets set aside by the boards (or management) for identified purposesand over which the boards (or management) retain control such that the boards (or management)may, at their discretion, subsequently use such assets for other purposes. Certain investmentscorresponding to deferred compensation are accounted for such that all income and appreciation(depreciation) is recorded as a direct addition (reduction) to the asset and corresponding liability.

Derivative InstrumentsDerivatives are recognized on the balance sheet at fair value with changes in the fair valuerecorded in excess of revenue over expenses.

Patient Accounts ReceivablePartners HealthCare receives payments for services rendered from federal and state agencies(under the Medicare and Medicaid programs), managed care payers, commercial insurancecompanies and patients. Patient accounts receivable are reported net of contractual allowancesand reserves for denials, uncompensated care and doubtful accounts. The level of reserves isbased upon management s assessment of historical and expected net collections, business andeconomic conditions, trends in federal and state governmental and private employer health carecoverage and other collection indicators.

Research Grants ReceivablePartners HealthCare receives research funding from departments and agencies of theU.S. Government, industry and other foundation sponsors. Research grants receivable includeamounts due from these sponsors of externally funded research. These amounts have been billedor are billable to the sponsor, or in limited circumstances, represent accelerated spending inanticipation of future funding. Research grants receivable are reported net of reserves foruncollectible accounts.



13

Other Current AssetsOther current assets include prepaids, nonpatient receivables, current portion of pledgesreceivable, premiums receivable and reinsurance recoveries.

Property and EquipmentProperty and equipment is reported on the basis of cost less accumulated depreciation. Donateditems are recorded at fair value at the date of contribution. All research grants received for capitalare recorded in the year of expenditure as a change in unrestricted net assets. Property andequipment is reviewed for impairment whenever events or changes in circumstances indicate thatits carrying amount may not be recoverable. Depreciation of property and equipment is calculatedby use of the straight-line method at rates intended to depreciate the cost of assets over theirestimated useful lives, which generally range from three to fifty years. Interest costs incurred onborrowed funds during the period of construction of capital assets are capitalized, net of anyinterest earned, as a component of the cost of acquiring those assets.

Asset Retirement ObligationsAsset retirement obligations, reported in accrued other, are legal obligations associated with theretirement of long-lived assets. These liabilities are initially recorded at fair value and the relatedasset retirement costs are capitalized by increasing the carrying amount of the related assets bythe same amount as the liability. Asset retirement costs are subsequently depreciated over theuseful lives of the related assets. Partners HealthCare records changes in the liability resultingfrom the passage of time and revisions to either the timing or the amount of the original liabilityestimate. Partners HealthCare reduces these liabilities when the related obligations are settled.

Other AssetsOther assets consist of long-term receivables, deferred financing costs, intangible assets, prepaidground rent, malpractice insurance receivables (Note 14), receivable for settlements with third-party payers, investments in healthcare related limited partnerships and benefit assets for over-funded defined benefit plans. Deferred financing costs are amortized over the terms of the relatedobligations. The carrying value of other assets is evaluated for impairment if the facts andcircumstances suggest that the carrying value may not be recoverable.

Compensated AbsencesIn accordance with formal policies concerning vacation and other compensated absences, accrualsof $273,042 and $259,470 were recorded as of September 30, 2016 and 2015, respectively.

Unexpended Funds on Research GrantsResearch grants received in advance of corresponding grant expenditures are accounted for as adirect addition to investments limited as to use and unexpended funds on research grants.

Self-Insurance ReservesPartners HealthCare is generally self-insured for employee healthcare, disability, workerscompensation and certain other employee benefits. These costs are accounted for on an accrualbasis to include estimates of future payments for claims incurred prior to year end.



14

Net AssetsPermanently restricted net assets include the historical dollar amounts of gifts and the income andgains on such gifts which are required by donors to be permanently retained. Temporarilyrestricted net assets include gifts and the income and gains on permanently restricted net assetswhich can be expended but for which restrictions have not yet been met. Such restrictions includepurpose restrictions where donors have specified the purpose for which the net assets are to bespent, or time restrictions imposed by donors or implied by the nature of the gift (capital projects,pledges to be paid in the future, life income funds) or by interpretations of law (gains available forappropriation but not appropriated in the current period). Unrestricted net assets include all of theremaining net assets of Partners HealthCare. More information can be found in Note 16, NetAssets.

Realized gains and losses are classified as unrestricted net assets unless they are restricted by thedonor or law. Unless permanently restricted by the donor, realized gains and net unrealizedappreciation on permanently restricted gifts are classified as temporarily restricted untilappropriated for spending by Partners HealthCare in accordance with policies established byPartners HealthCare and the Massachusetts Uniform Prudent Management of Institutional FundsAct (UPMIFA). Net losses on permanently restricted endowment funds are classified as areduction to unrestricted net assets until such time as the fair value of these funds exceedshistorical cost.

GiftsUnconditional promises to give cash and other assets to Partners HealthCare are reported at fairvalue at the date the promise is received. Conditional promises to give are recognized when theconditions are substantially met. Gifts are reported as either temporarily or permanently restrictedsupport if they are received with donor stipulations that limit the use of the donated assets.Donor-restricted contributions whose restrictions are met within the same year as received arereported as unrestricted gifts in the accompanying financial statements.

Gifts of long-lived assets with explicit restrictions that specify use of assets and gifts of cash orother assets that must be used to acquire long-lived assets are reported as additions to temporarilyrestricted net assets if the assets are not placed in service during the year.

GrantsGrants and contracts normally provide for the recovery of direct and indirect costs, subject to audit.Partners HealthCare recognizes revenue associated with direct and indirect costs as direct costsare incurred. The recovery of indirect costs is based on predetermined rates for U.S. Governmentgrants and contracts and negotiated rates for other grants and contracts.

Contributed Securitiespolicy is to sell securities contributed by donors upon receipt, unless

prevented from doing so by donor request. For the years ended September 30, 2016 and 2015,contributed securities of $48,160 and $36,742, respectively, were received and liquidated. Donorsrestricted the proceeds received from the sale of these contributed securities of $11,634 and$14,163 for long-term purpose for the years ended September 30, 2016 and 2015, respectively.



15

Statement of OperationsAll activities of Partners HealthCare deemed by management to be ongoing, major and central tothe provision of healthcare services, teaching, research activities and health insurance are reportedas operating revenue and expenses. Other activities are deemed to be nonoperating and includeunrestricted gifts (net of fundraising expenses), external community benefit program support, netchange in unexpended academic and research gifts, change in fair value of interest rate swaps,substantially all income (loss) from investments and interest on advanced borrowings. Academicand research gifts largely consist of donor contributions (and the related investment incomeincluding realized gains and losses) designated to support the clinical, teaching or research effortsof a physician or department as directed by the donor. These gifts are reported as unrestricted, netof related support expenses, when donor restrictions are of a general nature that are inherent in thenormal activities of the organization.

Partners HealthCare recognizes changes in third-party payer settlements and other estimates inthe year of the change in estimate. For the years ended September 30, 2016 and 2015,adjustments to prior year estimates resulted in an increase to income from operations of $12,536and $22,381, respectively.

Effective October 1, 2007, the Centers for Medicare and Medicaid Services (CMS) adopted theMS-DRG patient classification system (MS-DRGs) for inpatient services to better recognizeseverity of illness in Medicare payment rates for acute care hospitals. The adoption of MS-DRGsresulted in the expansion of the number of diagnosis related groups (DRGs), a system ofclassifying patients for purposes of inpatient reimbursement. By increasing the number ofDRGs and more fully taking into account patients severity of illness in Medicare payment rates foracute care hospitals, the use of MS-DRGs encourages hospitals to improve their documentationand coding of patient diagnoses. CMS has determined that the adoption of the MS-DRGs hasincreased aggregate payments to hospitals due to additional documentation and coding without acorresponding increase in actual patient severity of illness.

CMS is required by its enabling statute to maintain budget neutrality by prospectively adjusting theMedicare payment rate to eliminate the effect of changes in DRG classification that do not reflectreal changes in case-mix. CMS requires Congressional authority, however, to recoup anyoverpayments made in prior years. In 2007, Congress granted CMS the authority to recoupoverpayments made to hospitals in 2008 and 2009 resulting from increased coding anddocumentation, which CMS did through rate reductions in 2011 and 2012. Subsequently, underthe American Taxpayer Relief Act of 2012, Congress granted CMS the authority to recoupoverpayments made to hospitals in 2010 through 2012 through rate reductions in 2014 through2017.

In 2013, Partners HealthCare recorded the estimated overpayment amounts received in 2010through 2012 of $79,020 as deferred revenue to be amortized into net patient service revenue in2014 through 2017 to offset the rate reductions. Management believes this accounting treatmentbetter reflects the financial impact of this rate methodology and more accurately presents therecognition of revenue. For the years ended September 30, 2016 and 2015, amortization of theseoverpayments amounted to $23,900 and $15,192, respectively. Partners HealthCare anticipatesamortizing the remaining overpayments of $33,035 in 2017.



16

The statement of operations includes excess (deficit) of revenues over expenses. Changes inunrestricted net assets, which are excluded from excess of revenues over expenses, includechange in net unrealized appreciation on marketable investments, contributions of long-lived assets(including assets acquired using contributions which by donor restriction were to be used foracquisition of such assets) and change in funded status of defined benefit plans.

Net Patient Service RevenuePartners HealthCare maintains agreements with CMS of the United States Department of Healthand Human Services under the Medicare program, the Commonwealth of Massachusetts (theCommonwealth) under the Medicaid program and various managed care payers that governpayment for services rendered to patients covered by these agreements. The agreementsgenerally provide for per case or per diem rates or payments based on discounted charges forinpatient care and discounted charges or fee schedules for outpatient care. Certain contracts alsoprovide for payments that are contingent upon meeting agreed upon quality and efficiencymeasures.

Partners HealthCare recognizes patient service revenue associated with services provided topatients who have third-party payer coverage on the basis of contractual rates for the servicesrendered. For uninsured patients that do not qualify for charity care, Partners HealthCarerecognizes revenue on the basis of its standard rates (subject to discounts) for services provided.On the basis of historical experience, a significant portion of Partners HealthCare s uninsuredpatients are unable or fail to pay for the services provided. Consequently, Partners HealthCarerecords a provision for bad debts related to uninsured patients in the period the services areprovided. For the years ended September 30, 2016 and 2015, patient service revenue net ofcontractual allowances and discounts (before the provision for bad debts) is as follows:

2016 2015

Patient service revenue (net ofcontractual allowances and discounts)

Third-party payers 7,389,738$ 7,156,435$Uninsured patients 309,608 290,534

Total all payers 7,699,346$ 7,446,969$

Net patient service revenue includes estimated retroactive revenue adjustments due to futureaudits, reviews and investigations. Retroactive adjustments are considered in the recognition ofrevenue on an estimated basis in the period the related services are rendered, and such amountsare adjusted in future periods as adjustments become known or as years are no longer subject tosuch audits, reviews and investigations. Contracts, laws and regulations governing the Medicare,Medicaid and uncompensated care programs (Note 1) and managed care payer arrangements arecomplex and subject to interpretation. As a result, there is at least a reasonable possibility thatrecorded estimates will change by a material amount in the near term. A portion of the accrual forsettlements with third-party payers has been classified as long-term because such amounts, bytheir nature or by virtue of regulation or legislation, will not be paid within one year.



17

Partners HealthCare provides either full or partial uncompensated care to patients who cannotafford to pay for their medical services based on income and family size. Uncompensated care isgenerally available to qualifying patients for medically necessary services. Partners HealthCarereports certain bad debts related to emergency services as uncompensated care. Uncompensatedcare is reported at gross charges with an offsetting allowance, as there is no expectation ofcollection. Accordingly, there is no net patient service revenue related to uncompensated care.

Medical Claims and Related ExpensesNHP contracts with various community health centers, hospital-based primary care physicianpractices and other health care providers for the delivery of services to its members andcompensates these providers on a capitated, fee-for-service or per diem basis.

The cost of contracted health care services is accrued in the period in which services are providedand include certain estimated amounts. The estimated liability for medical claims and relatedexpenses is actuarially determined based on analysis of historical claims-paid experience, modifiedfor changes in enrollment, inflation and benefit coverage. The liability for medical claims andrelated expenses represents the anticipated cost of claims incurred but unpaid at the balance sheetdate. The estimates for claims expense may be more or less than the amounts ultimately paidwhen claims are settled. Such changes in estimates are reflected in the current period in theconsolidated statements of operations.

In the normal course of business, NHP identifies and recoups overpayments through reductions infuture payments made to providers and hospitals. Such overpayments are the result of, amongother things, coordination of benefits and provider claim audits. For the years endedSeptember 30, 2016 and 2015, NHP identified approximately $62,433 and $53,396, respectively, ofrecoveries related to claim overpayments made for both current-year and prior-year paid claims,which are reflected as a reduction to medical claims and related expenses in the consolidatedstatements of operations. As of September 30, 2016 and 2015 receivable include$1,718 and $1,723, respectively, related to such overpayments.

Premium RevenuePremiums are due monthly and recorded as earned during the period in which members areeligible to receive services. Premiums received prior to the first day of the coverage period arerecorded as unearned premiums in accounts payable and accrued expenses.

ReinsuranceReinsurance premiums are reported in medical claims and related expenses and reinsurancerecoveries are reported as reductions in medical claims and related expenses.

SettlementsNHP contracts with the Executive Office of Health and Human Services (EOHHS) and certainproviders at negotiated rates based on historical and anticipated experience. These methods ofreimbursement result in settlements based on actual versus anticipated experience which couldresult in either payments due from (to) these providers. Settlements receivable of $40,388 and$78,969 were recorded as of September 30, 2016 and 2015, respectively. Settlements payable of$5,201 and $3,697 were recorded as of September 30, 2016 and 2015, respectively. Thesettlements are intended to include both reported and unreported incurred claims as ofSeptember 30, 2016 and 2015.



18

In 2014, the Affordable Care Act introduced new settlements related to a risk adjustment program,a risk corridor program and a reinsurance program designed to mitigate the transitional impact oninsurers for new members. The risk corridor program and reinsurance program are scheduled toend on December 31, 2016 in accordance with the provision of the Affordable Care Act.estimated net receivable due from the federal government for these programs was $36,801 and$23,687 at September 30, 2016 and 2015, respectively. Similar to the federal program, EOHHS

37,625 and$75,910 at September 30, 2016 and 2015, respectively.

Premium Deficiency ReservePremium deficiency reserves are assessed and recognized on a product line basis based uponexpected premium revenue, medical expense and administrative expense levels, and remainingcontractual obligations using historical experience. As of September 30, 2016 and 2015, premiumdeficiency reserves total approximately $51,735 and $32,636, respectively, and are included inaccrued medical claims and related expenses in the accompanying consolidated financialstatements. The premium deficiency reserves are estimates of anticipated losses in fiscal 2017and 2016, respectively, rela contracts.

Claims Adjustment ExpensesClaims adjustment expenses (CAE) are those costs expected to be incurred in connection with theadjustment and recording of health claims. NHP has recorded an estimate of unpaid CAEassociated with incurred but unpaid claims, which is included in medical claims and relatedexpenses in the accompanying consolidated statements of operations. Management believes theamount of the liability for unpaid CAE as of September 30, 2016for the adjustment and recording of unpaid claims; however, actual expenses may differ from thoseestablished estimates. Adjustments to the estimates for unpaid CAE are reflected in operatingresults in the period in which the change in estimate is identified (Note 9).

Other RevenueOther revenue includes institutional revenue (for example, billing for services provided to otherhealthcare providers), parking, nonpatient pharmacy, tuition revenue and commercialization ofintellectual property.

ReclassificationCertain amounts in the 2015 financial statements have been reclassified to conform with the 2016presentation.



19

3. Acquisitions

Multiple physician practices were acquired during the year ended September 30, 2015 for acombined purchase price of $46,917. In accordance with accounting standards, the purchase pricewas allocated first to tangible assets, then identifiable intangible assets and the remaining allocatedto goodwill.

Assets, liabilities, and net assets assumed as of the acquisition dates are as follows:

AssetsCash and cash equivalents 5,257$

Patient accounts receivable, net 3,762

Property plant and equipment 3,201

Other assets 34,697

Total assets acquired 46,917$

Liabilities

Note payable 2,693$

Accounts payable and accrued expenses 10,457Accrued compensation and benefits 5,087

Accrued professional liability 80

Total liabilities assumed 18,317

Net assets

Unrestricted 28,600

Total net assets 28,600

Total liabilities and net assets 46,917$

A summary of the financial results of the acquired physician practices from the respective dates ofacquisition through September 30, 2015 is included in the 2015 consolidated statements ofoperations and changes in net assets is as follows:

Total operating revenue 88,325$

Total operating expenses 103,431

Loss from operations (15,106)

Nonoperating gains (expenses), net 2

Deficit of revenues over expenses (15,104)

Other changes 1,000

Decrease in unrestricted net assets (14,104)$



20

A summary of the consolidated financial results of Partners HealthCare for the year endedSeptember 30, 2015, as if the transactions had occurred on October 1, 2014 is as follows(unaudited):

Total operating revenue 11,696,236$

Total operating expenses 11,592,219

Income from operations 104,017

Nonoperating gains (expenses), net (198,447)

Deficit of revenues over expenses (94,430)

Pension related changes (639,167)

Other changes (186,096)

Decrease in unrestricted net assets (919,693)$

4. Levels of Capital and Surplus

Risk-based capital (RBC) is a methodology adopted by the National Association of InsuranceCommissioners (NAIC) for determining the minimum level of capital and surplus deemednecessary for an insurer based upon the types of assets held and business written. Pursuant to aguaranty entered into by PHS when it acquired NHP in 2012 (the RBC Guaranty), PHS has

s capital and surplus at a specified minimum level, measured quarterlyin accordance with an RBC methodology permitted by the Massachusetts Division ofInsurance (DOl). The RBC Guaranty may be enforced by the DOI. PHS provided capital to NHPof $123,800 and $117,100 in 2016 and 2015, respectively. In order to comply with its obligationsunder the RBC Guaranty PHS transferred $32,400 to NHP in November 2016.

financial insolvency insurance in an amount equal to the Minimum Net Worth calculation as definedin Massachusetts General Law 176G, Section 25. At December 3and statutory year end), the minimum net worth requirement, as determined in accordance withEOHHS guidelines, was $139,400 and $114,300, respectively.$186,900 and $128,700 at December 31, 2015 and 2014, respectively, and thus exceeded theEOHHS requirements by $47,500 and $14,400, respectively.

5. Investments and Investments Limited as to Use

Investments are either separately invested or included in pooled investment funds within thePartners HealthCare System Pooled Investment Accounts (Partnership). The Partnership isstructured as a single general partnership composed of three investment pools, with PHS andsubstantially all of its affiliates participating in the pools as partners. Each partner s interest in thePartnership is based on its underlying investments in one or more of the three separate pools.Amounts included in the investment pools are accounted for using the fair value method, whereby

income from investments on a monthly basis, to include realized gains and losses, based on theirindividual ownership ratio of the total pool.



21

Among other investments, the Partnership invests in private partnerships whose assets includeequity, fixed income and other investments. As of September 30, 2016, the Partnership hasunfunded commitments of approximately $626,038 which will be drawn down by the variousgeneral partners over the next several years. The maximum annual drawdown is expected to beless than 2% of investments and investments limited as to use.

Investments and investments limited as to use are recorded in the balance sheet as follows:

2016 2015

Current assets

Investments 1,069,006$ 1,354,636$Current portion of investments limited as to use 1,588,787 1,590,203

2,657,793 2,944,839

Long-term assets

Investments limited as to use, less current portion 3,069,175 2,832,744Long-term investments 1,136,528 1,061,176

6,863,496$ 6,838,759$

September 30,

Investments limited as to use consist of the following:

Current Long-Term Current Long-TermPortion Portion Portion Portion

Internally designated funds

Reserved for capital expenditures 706,374$ -$ 863,703$ -$

Unexpended academic and research gifts - 2,456,587 - 2,311,685Deferred compensation - 259,152 - 226,627

Other 410,749 318,772 394,756 263,764

1,117,123 3,034,511 1,258,459 2,802,076

Externally limited fundsUnexpended funds on research 247,423 - 202,137 -

Contributions held for others 1,073 - 1,269 -Professional liability trust fund - 34,664 - 30,668

Held by trustees under debt and otheragreements 223,168 - 128,338 -

471,664 34,664 331,744 30,668

1,588,787$ 3,069,175$ 1,590,203$ 2,832,744$

September 30, 2016 September 30, 2015



22

Investments and investments limited as to use are reported at either fair value or on the equity orcost methods of accounting. The composition of these investments, segregated between pooledinvestments and those that are separately invested, is as follows:

At Fair On Equity On Cost

Value Method Method Total

Pooled investmentsInvested cash equivalents 102,646$ -$ -$ 102,646$

Separately managed investments 1,470,531 - - 1,470,531

Mutual funds 116,568 - - 116,568

Commingled funds 1,133,006 - - 1,133,006Private partnerships - 1,155,879 2,060,638 3,216,517

2,822,751 1,155,879 2,060,638 6,039,268

Separately invested

Invested cash equivalents 205,719 - 15 205,734

Equities 5,527 - 42,714 48,241U.S. Government and domestic

fixed income securities 26,330 - - 26,330

Mutual funds 442,244 - - 442,244

Other 25,084 - 76,595 101,679

704,904 - 119,324 824,228

3,527,655$ 1,155,879$ 2,179,962$ 6,863,496$

September 30, 2016



23

Separately managed investments include cash and equivalents of $235,172, equities of $604,855and fixed income securities of $630,504 as of September 30, 2016.

At Fair On Equity On Cost

Value Method Method Total

Pooled investments

Invested cash equivalents 34,049$ -$ -$ 34,049$

Separately managed investments 1,834,357 - - 1,834,357

Mutual funds 365,035 - - 365,035

Commingled funds 1,157,965 - - 1,157,965

Private partnerships - 744,139 1,991,206 2,735,345

3,391,406 744,139 1,991,206 6,126,751

Separately invested

Invested cash equivalents 135,640 - 16 135,656

Equities 6,247 - 46,237 52,484

U.S. Government and domestic


Mutual funds 397,539 - - 397,539

Other 17,416 - 76,583 93,999

589,172 - 122,836 712,008

3,980,578$ 744,139$ 2,114,042$ 6,838,759$

September 30, 2015

Separately managed investments include cash and equivalents of $212,882, equities of $612,948and fixed income securities of $1,008,527 as of September 30, 2015.

For the private partnerships reflected in the balance sheet at cost, the difference (unrecorded netunrealized appreciation) between the value reported by the investment managers and the cost forthese investments was $928,510 and $863,084 as of September 30, 2016 and 2015, respectively.



24

The fair value and gross unrealized depreciation of investments and investments limited as to use,with a fair value less than cost, that are not deemed to be other-than-temporarily impaired as ofSeptember 30, 2016 are as follows:

Gross Gross

Fair Unrealized Fair Unrealized

Value Depreciation Value Depreciation

Pooled investments

Separately managed investments -$ -$ 99$ (6)$

Commingled funds 134,036 (25,459) 172,377 (3,107)

134,036 (25,459) 172,476 (3,113)

Separately invested

Equities - - 11 (4)

Fixed income securities 7,491 (18) 2,954 (28)

Mutual funds - - 24,803 (1,765)

External trusts - - 1 (20)

7,491 (18) 27,769 (1,817)

141,527$ (25,477)$ 200,245$ (4,930)$

Less than 12 Months 12 Months or Greater

In addition, for certain private partnerships recorded at cost, gross unrealized depreciationamounted to $16,351 as of September 30, 2016, with $6,418 of that amount unrealized for12 months or greater.

Based on management s quantitative and qualitative assessment, investments whose costexceeds fair value are not considered to be other-than-temporarily impaired as of September 30,2016. Management believes these investments will recover their values and there is no intention toliquidate these positions.



25

Investment income and gains (losses) from cash and equivalents, investments, investments limitedas to use and beneficial interests in perpetual trusts are comprised of the following:

2016 2015

Unrestricted

Dividends, interest and other income 35,535$ 59,941$

Endowment income distributions, net of reinvested gains 43,359 39,059

Net realized gains (losses) on investments

Realized gains 87,259 158,402

Other-than-temporary impairment (80,553) (139,474)

Change in value of equity method investments 76,644 (46,860)

Recovery (losses) on endowment funds 4,133 (11,045)

Total investment activity included in excess of

revenues over expenses 166,377 60,023

Change in net unrealized appreciation on marketable

investments 200,042 (224,616)

Total unrestricted investment activity 366,419 (164,593)

Temporarily restricted

Dividends and interest income 2,397 5,286

Endowment income distributions (51,339) (47,133)

Net realized gains (losses) on investments

Realized gains 21,934 31,890

Other-than-temporary impairment (17,604) (24,558)

(44,612) (34,515)

Change in value of equity method investments 22,996 (11,945)

Change in net unrealized appreciation on marketable investments 34,303 (47,396)

(Recovery) losses on endowment funds (4,133) 11,045

53,166 (48,296)

Total temporarily restricted investment activity 8,554 (82,811)

Permanently restricted

Dividends and interest income (9) (3)

Net realized gains on investments 46 58

Change in net unrealized appreciation on marketable investments (340) (2,313)

Change in value of beneficial interests in perpetual trusts (182) (970)

Total permanently restricted investment activity (485) (3,228)

374,488$ (250,632)$




26

Investment income included in operating results and excess of revenues over expenses iscomprised of the following:

2016 2015

Investment income included in operations and reported in

other revenue 12,282$ 11,841$

Investment income included in nonoperating gainsand reported in

Income (loss) from investments 61,102 (37,258)Academic and research gifts, net of expenses 92,993 85,440

Total investment activity included in excess ofrevenues over expenses 166,377$ 60,023$


6. Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liabilityin an orderly transaction between market participants at the measurement date (also referred to asexit price). Therefore, a fair value measurement should be determined based on the assumptionsthat market participants would use in pricing the asset or liability. In determining fair value, the useof various valuation approaches, including market, income and cost approaches, is permitted.

Fair Value HierarchyA fair value hierarchy has been established based on whether the inputs to valuation techniquesare observable or unobservable. Observable inputs reflect market data obtained from independentsources, while unobservable inputs reflect the reporting entity s assumptions about the inputsmarket participants would use. The fair value hierarchy requires the reporting entity to maximizethe use of observable inputs and minimize the use of unobservable inputs when measuring fairvalue. In addition, for hierarchy classification purposes, the reporting entity should not look throughthe form of an investment to the nature of the underlying securities held by an investee.

The hierarchy is described below.

Level 1 Valuations using quoted prices in active markets for identical assets or liabilities.Valuations of these products do not require a significant degree of judgment. Level 1assets and liabilities primarily include debt and equity securities that are traded in anactive exchange market.

Level 2 Valuations using observable inputs other than Level 1 prices such as quoted prices inactive markets for similar assets or liabilities; quoted prices for identical or similarassets or liabilities in markets that are not active; broker or dealer quotations; or otherinputs that are observable or can be corroborated by observable market data forsubstantially the full term of the assets or liabilities. Level 2 assets and liabilitiesprimarily include debt securities with quoted prices that are traded less frequently thanexchange-traded instruments as well as debt securities and derivative contractswhose value is determined using a pricing model with inputs that are observable in themarket or can be derived principally from or corroborated by observable market data.



27

Level 3 Valuations using unobservable inputs that are supported by little or no market activityand are significant to the fair value of the assets or liabilities. Level 3 includes assetsand liabilities whose value is determined using pricing models, discounted cash flowmethodologies, or similar techniques reflecting the reporting entity s assumptionsabout the assumptions market participants would use as well as those requiringsignificant management judgment.

Valuation TechniquesPooled investments (except for private partnerships, which are reported on either the equity or costmethod of accounting), separately invested cash equivalents and debt and equity securities areclassified within Level 1 or Level 2 of the fair value hierarchy as they are valued using quotedmarket prices, broker or dealer quotations, or other observable pricing sources. Certain types ofinvestments are classified within Level 3 of the fair value hierarchy because they have little or nomarket activity and therefore have little or no observable inputs with which to measure fair value.

The valuation of interest rate swaps is determined using widely accepted valuation techniques,including discounted cash flow analysis on the expected cash flows of each derivative. Thisanalysis reflects the contractual terms of the derivatives, including the period to maturity, and usesobservable market-based inputs, including interest rate curves and implied volatilities.

The following tables summarize fair value measurements as of September 30, 2016 and 2015 forfinancial assets and liabilities measured at fair value on a recurring basis:

Quoted Prices Significant

in Active Other Significant

Markets for Observable Unobservable Fair Value at

Identical Items Inputs Inputs September 30,

(Level 1) (Level 2) (Level 3) 2016

Assets

Pooled investments

Invested cash equivalents 102,646$ -$ -$ 102,646$Separately managed investments 1,196,027 274,504 - 1,470,531

Mutual funds 116,568 - - 116,568

Commingled funds - 1,133,006 1,133,006

1,415,241 1,407,510 - 2,822,751

Separately invested

Invested cash equivalents 205,719 - - 205,719Equities 5,527 - - 5,527

U.S. Government and domestic


Mutual funds 442,244 - - 442,244

Other - - 25,084 25,084

679,820 - 25,084 704,904

2,095,061$ 1,407,510$ 25,084$ 3,527,655$

LiabilitiesInterest rate swaps 510,172$ 510,172$

Fair Value Measurements Using



28

Quoted Prices Significant

in Active Other Significant

Markets for Observable Unobservable Fair Value at

Identical Items Inputs Inputs September 30,

(Level 1) (Level 2) (Level 3) 2015

Assets

Pooled investments

Invested cash equivalents 33,027$ 1,021$ -$ 34,048$

Separately managed investments 1,331,564 502,793 - 1,834,357Mutual funds 365,034 - - 365,034

Commingled funds - 1,157,967 - 1,157,967

1,729,625 1,661,781 - 3,391,406

Separately invested

Invested cash equivalents 135,640 - - 135,640

Equities 6,247 - - 6,247U.S. Government and domestic


Mutual funds 397,539 - - 397,539

Other - - 17,416 17,416

571,756 - 17,416 589,172

2,301,381$ 1,661,781$ 17,416$ 3,980,578$

LiabilitiesInterest rate swaps 404,062$ 404,062$


As of and for the years ended September 30, 2016 and 2015, the fair value of the assets andchange in the value of the assets measured using significant unobservable inputs (Level 3) wererelated to beneficial interests in perpetual assets.



29

7. Pledges Receivable and Contributions Receivable From Trusts

Pledges receivable represent unconditional promises to give and are net of allowances foruncollectible amounts. Pledges are recorded at the present value of their estimated future cashflows. Pledges collectible within one year are classified as other current assets, net of allowances,and total $100,280 and $87,229 as of September 30, 2016 and 2015, respectively. Estimated cashflows due after one year are discounted using published treasury bond and note yields that arecommensurate with estimated collection risks. The blended discount rate was 0.9% and 1.0% for2016 and 2015, respectively. Pledges are expected to be collected as follows:

2016 2015

Amounts dueWithin one year 109,111$ 108,865$

In one to five years 126,786 138,411In more than five years 49,693 56,120

Total pledges receivable 285,590 303,396

Less: Unamortized discount 5,540 6,840

280,050 296,556

Less: Allowance for uncollectibles 12,359 26,711

Net pledges receivable 267,691 269,845

Contributions receivable from trusts 27,273 26,448

294,964$ 296,293$

September 30,

8. Property and Equipment

Property and equipment consists of the following:

2016 2015

Land and land improvements 180,156$ 179,954$Buildings and building improvements 6,471,440 5,955,908

Equipment 2,297,392 1,826,766

Construction in progress 1,062,074 1,098,134

10,011,062 9,060,762

Accumulated depreciation (4,129,135) (3,731,980)

Property and equipment, net 5,881,927$ 5,328,782$

September 30,

Depreciation expense for the years ended September 30, 2016 and 2015 was $549,082 and$487,980, respectively. Interest costs, net of interest earned, aggregating $40,042 and $35,063were capitalized in 2016 and 2015, respectively.



30

For the years ended September 30, 2016 and 2015, fully depreciated assets with an original cost of$151,927 and $199,970, respectively, were written off.

9. Accrued Medical Claims and Related Expenses

Accrued medical claims and related expenses include estimates of expected trends in claimsseverity, frequency, and other factors, which could vary as the claims are ultimately settled and arebased principally upon historical experience. For the years ended September 30, 2016 and 2015,changes in estimates resulted in a decrease of accrued medical claims and related expense of$43,872 and $27,221, respectively. Increases (decreases) of this nature occur as the result ofclaim settlements and recoveries during the current year and as additional information is receivedregarding individual claims, causing changes from the original estimates of the cost of theseclaims. Ongoing analysis of the recent loss development trends is also taken into account inevaluating the overall adequacy of the reserves.

Changes in accrued medical claims and related expenses are as follows:

2016 2015

Balance at beginning of year 232,268$ 254,480$

Less:Premium deficiency reserve (32,636) (91,555)

Medical loss ratio rebate payable - (611)

Accrual for claims adjustment expenses (4,877) (4,381)Accrued medical payables - other (14,477) -

Claim recoveries (8,300) (7,567)

Plus: Settlements payable, net 13,058 22,020

Net balance at beginning of year 185,036 172,386

Incurred related to

Current year 2,470,782 2,007,380

Prior years (43,872) (27,221)

Total incurred 2,426,910 1,980,159

Paid related toCurrent year 2,219,247 1,822,513

Prior years 158,685 144,996

Total paid 2,377,932 1,967,509

Net balance at end of year 234,014 185,036

Plus:

Premium deficiency reserve 51,735 32,636

Accrual for claims adjustment expenses 6,192 4,877Accrued medical payables - other 14,577 14,477

Claims recoveries - 8,300

Less: Settlements payable, net (16,652) (13,058)

Balance at end of year 289,866$ 232,268$



31

Medical claims and related expenses in the accompanying consolidated statements of operationsinclude these amounts along with other nonclaims related costs. These nonclaims relatedexpenses were for directly delivered services and medical cost risk sharing and incentives, totalingapproximately $23,545 and $17,422 for the years ended September 30, 2016 and 2015,respectively.

10. Long-Term Obligations

Long-term obligations issued by PHS and its affiliates consist of the following:

2016 2015

Massachusetts Health and Educational Facilities Authority (Authority) Revenue BondsSeries D*, variable interest rate of 0.78% and 0.01%, final maturity in 2017 1,010$ 1,940$Series F*, variable interest rate of 0.80% and 0.29%, final maturity in 2040 237,350 245,500Series G*, average fixed interest rate of 4.92%, variable interestof 0.90% and 0.24%, final maturity in 2047 303,240 316,455

Series H*, variable interest rate of 0.59% and 0.08%, final maturity in 2042 170,915 171,320Series I*, average fixed interest rate of 4.82%, variable interestof 0.84% and 0.01%, final maturity in 2044 157,175 165,960

Series J*, average fixed interest rate of 5.01%, final maturity in 2039 415,010 434,245Series P*, variable interest rate of 0.78% and 0.01%, final maturity in 2027 150,000 150,000

Massachusetts Development Finance Agency (Agency) Revenue BondsSeries K*, average fixed interest rate of 4.99%, variable interestof 0.87% and 0.02%, final maturity in 2046 244,760 331,085

Series L, average fixed interest rate of 4.95%, final maturity in 2041 311,735 320,985Series M*, average fixed interest rate of 4.95%, variable interest rateof 1.18% and 0.34%, final maturity in 2048 493,100 494,175

Series N*, variable interest rate of 0.87% and 0.65%, final maturity in 2044 137,350 139,400Series O*, average fixed interest rate of 4.60%, variable interest rate

of 1.32% and 0.50%, final maturity in 2050 317,615 317,615Series Q*, average fixed interest rate of 4.79%, final maturity in 2047 423,990 -Series R*, variable interest rate of 0.92%, final maturity in 2052 100,000 -

PHS Taxable DebtSeries 2007 taxable bonds, fixed interest rate of 6.26%, final maturity in 2037 100,000 100,000Series 2011 taxable bonds, fixed interest rate of 3.44%, final maturity in 2021 250,000 250,0002012 Taxable Senior Notes, fixed interest rate of 4.11%, final maturity in 2052 400,000 400,0002014 Taxable Senior Notes, fixed interest rate of 4.73%, final maturity in 2044 150,000 150,000Series 2015 taxable bonds, fixed interest rate of 4.12%, final maturity in 2055 300,000 300,0002016 Taxable Senior Notes, fixed interest rate of 3.89%, final maturity in 2046 225,000 -

Other obligations 5,712 6,092Capital lease obligations 796 1,187

Total long-term obligations, par value 4,894,758 4,295,959

Unamortized discounts and premiums, net 154,374 97,065

Total long-term obligations, net 5,049,132 4,393,024

Less: Current portion 441,018 398,990

4,608,114$ 3,994,034$

* Denotes series is issued in multiple subseries.Variable interest rates are presented at September 30, 2016 and 2015, respectively.

September 30,



32

Aggregate maturities and payments of long-term obligations during the next five years andthereafter, and other amounts classified as current liabilities, are as follows:

BondsSupported by Bonds

Partners Supported byScheduled HealthCare Bank

Maturities Liquidity Facilities Total

2017 65,508$ 250,510$ 125,000$ 441,018$2018 70,927 - - 70,927

2019 72,897 - - 72,8972020 75,559 - - 75,5592021 330,788 - - 330,788Thereafter 4,057,943 - - 4,057,943

4,673,622$ 250,510$ 125,000$ 5,049,132$

The scheduled maturities represent annual payments as required under debt repaymentschedules. The current portion of long-term obligations includes the payments scheduled to bemade in 2017 along with bonds supported by Partners HealthCare liquidity and bonds supported bybank facilities (standby bond purchase agreements or letters of credit) with financial institutions thatexpire prior to September 30, 2017. The bonds supported by Partners HealthCare liquidity providethe bondholder with an option to tender the bonds to Partners HealthCare. Accordingly, thesebonds are classified as a current liability. The bonds supported by bank facilities provide thebondholder with an option to tender the bonds to the liquidity provider. Generally acceptedaccounting principles require bonds backed by bank facilities expiring within one year of thebalance sheet date to be classified as a current liability.

Interest expense paid during the years ended September 30, 2016 and 2015 was $185,358 and$165,225, respectively.

In September 2016, PHS issued $225,000 of Partners HealthCare System Taxable Senior Notes.

defined benefit pension plans.

In March 2016, PHS issued $100,000 of Partners HealthCare System Series R Revenue Bonds.Proceeds from the bonds will be used to finance certain capital projects.

In January 2016, PHS issued $423,990 of Partners HealthCare System Series Q Revenue Bonds,plus bond premium of $67,636. The bond proceeds, net of issuance cost of $3,732 were used torefund portions of Series F Bonds ($2,873), Series G Bonds ($8,068) and Series K bonds($75,091) and to finance certain capital projects ($401,862).

In January 2015, PHS issued $317,615 of Partners HealthCare System Series O Revenue Bonds,plus bond premium of $39,969. The bond proceeds, net of issuance costs of $2,814, were used torefund portions of Series F Bonds ($20,865) and Series G Bonds ($119,201) and to finance certaincapital projects ($214,704).



33

In January 2015, PHS issued $300,000 of Partners HealthCare System Taxable Bonds. Proceedsfrom the bonds were used to finance certain capital projects.

Partners HealthCare bonds are general obligations of PHS supported by guarantees from BWHC,Inc. (BWH), MGH and The General Hospital Corporation (the

General) which may be suspended under certain conditions.

PHS debt agreements contain certain covenants, including a minimum debt service coverage ratioand limitations on additional indebtedness and asset transfers.

Credit AgreementPartners HealthCare maintains a $150,000 Credit Agreement (the Agreement) that providesaccess to same day funds. Advances under the Agreement bear a variable rate of interest basedon the London Interbank Offered Rate (LIBOR). As of September 30, 2016, there were noamounts outstanding under the Agreement. The Agreement expires in June 2017.

11. Derivatives

Interest Rate SwapsPartners HealthCare utilizes swap contracts to manage fluctuations in cash flows resulting frominterest rate risk on certain of its variable rate bonds. These bonds expose Partners HealthCare tovariability in interest payments due to changes in interest rates. Management believes that it isprudent to limit the variability of its interest payments. To meet this objective and to takeadvantage of low interest rates, Partners HealthCare entered into various swap contracts involvingthe exchange of fixed rate payments by Partners HealthCare for variable rate payments fromseveral counterparties based on a percentage of LIBOR.

By using swap contracts to manage the risk of changes in interest rates, Partners HealthCareexposes itself to credit risk and market risk. Credit risk is the failure of the counterparty to performunder the terms of the swap contracts. When the fair value of a swap contract is positive, thecounterparty has a liability to Partners HealthCare, which creates credit risk. Partners HealthCareminimizes its credit risk by entering into swap contracts with several counterparties and requiringthe counterparty to post collateral for the benefit of Partners HealthCare based on the credit ratingof the counterparty and the fair value of the swap contract. Conversely, when the fair value of aswap contract is negative, Partners HealthCare has a liability to the counterparty and, therefore, itdoes not possess credit risk. Under certain circumstances, Partners HealthCare may be requiredto post collateral for the benefit of the counterparty. Market risk is the adverse effect on the valueof a financial instrument that results from a change in interest rates. The market risk associatedwith interest rate changes is managed by establishing and monitoring parameters that limit thetypes and degree of market risk that may be undertaken.



34

The following is a summary of the outstanding positions under these swap contracts as ofSeptember 30, 2016:

Notional

Amount Maturity Rate Paid Rate Received

5/1/03 150,000$ 7/1/35 4.40 % 67% 1-month LIBOR

7/1/05 150,000 7/1/40 3.63 % 67% 1-month LIBOR

7/1/05 34,500 7/1/25 5.11 % 67% 6-month LIBOR

7/1/07 150,000 7/1/42 3.46 % 67% 1-month LIBOR

7/1/09 100,000 7/1/44 3.71 % 67% 1-month LIBOR

7/1/11 100,000 7/1/46 3.74 % 67% 1-month LIBOR

7/1/13 100,000 7/1/48 3.80 % 67% 1-month LIBOR7/1/15 50,000 7/1/50 3.80 % 67% 1-month LIBOR4/1/16 50,000 7/1/50 3.93 % 67% 1-month LIBOR

4/1/16 50,000 7/1/52 3.59 % 67% 1-month LIBOR

7/1/17 50,000 7/1/52 3.74 % 67% 1-month LIBOR

Effective Date

Partners HealthCare s swap contracts contain provisions that require collateral to be posted if thefair value of the swap exceeds certain thresholds. The collateral thresholds reflect the currentcredit ratings issued by major credit rating agencies on Partners HealthCare s and thecounterparty s debt. Declines in Partners HealthCare s or the counterparty s credit ratings wouldresult in lower collateral thresholds and, consequently, the potential for additional collateralpostings by Partners HealthCare or the counterparty. As of September 30, 2016 and 2015,Partners HealthCare had posted collateral of $222,926 and $128,208, respectively. PartnersHealthCare has established procedures to ensure that liquidity and securities are available to meetcollateral posting requirements.

Upon the occurrence of certain events of default or termination events identified in the swapcontracts, either Partners HealthCare or the counterparty could terminate the contracts inaccordance with their terms. Termination results in the payment of a termination amount by oneparty that attempts to compensate the other party for its economic losses. If interest rates at thetime of termination are lower than those specified in the swap contract, Partners HealthCare wouldmake a payment to the counterparty. Conversely, if interest rates at such time are higher, thecounterparty would make a payment to Partners HealthCare.

Derivatives - OtherPartners HealthCare also enters into options and futures primarily as hedges on securities andindices primarily related to foreign currency. Forward contracts are used as currency hedges.These agreements are limited in use and generally do not exceed one year.



35

12. Commitments

LeasesPartners HealthCare has capital and noncancelable operating leases for certain buildings andequipment. Minimum future lease commitments under noncancelable leases for the next five yearsand thereafter are as follows:

Capital Operating

Leases Leases

2017 437$ 185,382$2018 396 163,973

2019 - 120,8432020 - 104,4552021 - 88,765Thereafter - 377,891

Total lease payments 833 1,041,309$

Less: Amount representing interest 37

Capital lease obligations at September 30, 2016 796$

Rental expense under operating leases approximated $238,081 in 2016 and $196,946 in 2015.

13. Pension and Postretirement Healthcare Benefit Plans

Substantially all employees of Partners HealthCare are covered under various noncontributorydefined benefit pension plans and various defined contribution pension plans. In addition, certainaffiliates provide subsidized healthcare benefits for retired employees on a self-insured basis, withthe benefit obligation being partially funded. These retiree healthcare benefits are administeredthrough an insurance company and are accounted for on the accrual basis, which includes anestimate of future payments for claims incurred.

Total expense for these plans consists of the following:

2016 2015

Defined benefit plans 287,156$ 233,670$Defined contribution plans 159,974 150,745Postretirement healthcare benefit plans 6,754 4,368

453,884$ 388,783$


Information regarding benefit obligations, plan assets, funded status, expected cash flows and netperiodic benefit cost follows within this footnote.



36

Benefit Obligations

2016 2015 2016 2015

Change in benefit obligationsBenefit obligations at beginning of year 5,678,875$ 5,102,117$ 156,875$ 136,502$

Service cost 295,014 267,328 5,060 5,059Interest cost 262,977 231,953 5,725 4,966Plan amendments (gain) loss (85,804) 5,045 (34,797) -Actuarial (gain) loss 856,616 204,937 16,615 7,622Benefits paid (134,790) (126,127) (5,971) (5,301)Expenses paid (17,174) (6,565) - -Employee contributions 175 187 8,368 8,027

Benefit obligations at end of year 6,855,889$ 5,678,875$ 151,875$ 156,875$

Defined Benefit PostretirementPension Plans Healthcare Benefit Plans

The accumulated benefit obligation for all defined benefit pension plans at the end of 2016 and2015 was $6,485,483 and $5,371,220, respectively.

2016 2015 2016 2015

Weighted-average assumptions used todetermine end of year benefit obligationDiscount rate 3.70% 4.50% 2.40% - 3.50% 3.00% - 4.55%Rate of compensation increase

Professional staff 4.45% 4.45% N/A N/AOther than professional staff 3.00% - 3.50% 3.00% - 3.50% N/A N/A

Healthcare cost trend rate for next year N/A N/A 6.50% 7.00%

Rate to which the cost trend rate is to decline N/A N/A 5.00% 5.00%Year that rate reaches the ultimate trend rate N/A N/A 2020 2020

Defined Benefit Postretirement HealthcarePension Plans Benefit Plans

Assumed healthcare cost trend rates have a significant effect on the amounts reported for thehealthcare plans. A one-percentage-point change in assumed healthcare cost trend rates wouldhave the following effect:

One-Percentage-Point One-Percentage-Point

Increase Decrease

Effect on postretirement benefit obligation 916$ (739)$



37

Plan Assets

2016 2015 2016 2015

Change in plan assetsFair value of plan assets at beginning of year 4,332,095$ 4,365,566$ 73,205$ 68,438$

Actual return on plan assets 376,198 (147,938) 4,120 (3,003)Employer contributions 512,553 246,972 5,704 5,044Employee contributions 175 187 8,368 8,027

Benefits paid (134,790) (126,127) (5,971) (5,301)Expenses paid (17,174) (6,565) - -

Fair value of plan assets at end of year 5,069,057$ 4,332,095$ 85,426$ 73,205$

Postretirement

Pension Plans Healthcare Benefit Plans

Defined Benefit

The assets of the defined benefit pension plans are aggregated in a single master trust (MasterTrust) and managed as one asset pool. The investment objective for the Master Trust is to achievethe highest reasonable total return after considering (i) plan liabilities, (ii) funding status andprojected cash flows, (iii) projected market returns, valuations and correlations for various assetclasses and (iv) Partners HealthCare s ability and willingness to incur market risk.

Oversight of the management of Partners HealthCare s investable assets, including the MasterTrust, is provided by the Investment Committee of the PHS Board of Directors which seeks toachieve incremental returns by manager selection and asset allocation (increasing/decreasingallocations within allowable ranges based on current and projected valuations). The Committee issupported by a professional staff, an outside investment consultant and a pension actuarialconsultant.

Partners HealthCare utilizes a target allocation policy that balances projected returns, correlationsand volatility of various asset classes within the overall risk tolerance. Asset allocations aremanaged based on relative valuations among and within asset classes and the perceived ability ofmanagers to outperform passive benchmarks. Exposure by asset class is the sum of the netexposures reported by each manager. Asset allocation can and will deviate from target exposuresand is regularly monitored for rebalancing opportunities.

The following table presents the capital allocations, reported exposures of the allocations andpolicy benchmarks by manager mandate within the Master Trust. Some managers, particularly realassets and less market sensitive managers, invest allocated capital among multiple policybenchmark asset classes.

Reported Policy Reported PolicyDollars Exposures Benchmark Dollars Exposures Benchmark

Global equity 411,834$ 8 % 10 % 205,596$ 4 % 7 %

Traditional U.S. equity 502,439 10 13 537,524 12 10

Traditional foreign developed equity 605,920 12 11 585,803 14 12

Traditional emerging markets equity 561,745 11 11 552,140 13 11

Private equity 424,014 8 9 388,336 9 8

Real assets 306,147 6 3 284,808 7 7

Less: Market sensitive managers 1,821,446 36 36 1,502,556 35 36

Fixed income managers 435,512 9 7 275,332 6 9

5,069,057$ 100 % 100 % 4,332,095$ 100 % 100 %

September 30, 2016 September 30, 2015



38

Within the Master Trust, assets are allocated to managers with investment mandates that mayrange from a single sub-asset class to very broad mandates; with restrictions that range fromlong-only to unconstrained; and with management structures ranging from separately managedfunds to mutual/commingled funds to private partnerships. Less market sensitive managersemploy absolute return, long/short equity and diversified strategies, which in the aggregate areexpected to generate positive returns on a consistent basis. Other exposures include currency andvolatility based strategies. Inflation defensive strategies include investments in real estate assets,commodities, timber and inflation protection bonds. Investment risks (concentration, correlation,valuation, liquidity, leverage, mandate compliance, etc.) are measured at the manager level as wellas the pool level.

The postretirement healthcare benefit plans assets are invested via mutual funds, commingledfunds and separately managed investments, with the objective of achieving returns to satisfy planobligations and with a level of volatility commensurate with Partners HealthCare s overall financialprofile.

The following table presents plan assets, by form of ownership, as of September 30, 2016 and2015 measured at fair value on a recurring basis using the fair value hierarchy defined in Note 6:

Quoted Prices Significant Investments

in Active Other Valued

Markets for Observable Using NAV as a Fair Value at

Identical Items Inputs Practical September 30,

(Level 1) (Level 2) Expedient 2016

Defined benefit pension plans

Invested cash equivalents 187,184$ -$ -$ 187,184$Separately managed investments 589,274 229,128 - 818,402

Mutual funds 100,478 - - 100,478


Private partnerships - - 2,830,579 2,830,579

876,936 1,361,542 2,830,579 5,069,057

Postretirement healthcare benefit plans

Commingled funds - 65,940 - 65,940

Mutual funds - 12,251 - 12,251

Separately managed investments 7,235 - - 7,235

7,235 78,191 - 85,426

Total plan assets 884,171$ 1,439,733$ 2,830,579$ 5,154,483$




39

Quoted Prices Significant Investments

in Active Other Valued

Markets for Observable Using NAV as a Fair Value at

Identical Items Inputs Practical September 30,

(Level 1) (Level 2) Expedient 2015

Defined benefit pension plans

Invested cash equivalents 43,315$ -$ -$ 43,315$Separately managed investments 366,713 201,603 - 568,316

Mutual funds 257,734 - - 257,734


Private partnerships - - 2,390,149 2,390,149

667,762 1,274,184 2,390,149 4,332,095

Postretirement healthcare benefit plans

Commingled funds - 56,325 6,900 63,225

Mutual funds 5,168 - - 5,168

Separately managed investments 4,812 - - 4,812

9,980 56,325 6,900 73,205

Total plan assets 677,742$ 1,330,509$ 2,397,049$ 4,405,300$


In evaluating the Level at which Partners HealthCare s private partnerships have been classifiedwithin the fair value hierarchy, management has assessed factors including, but not limited to pricetransparency, the ability to redeem these investments at net asset value at the measurement date,and the existence or absence of certain restrictions at the measurement date. Investments inprivate partnerships generally have limited redemption options for investors and, subsequent tofinal closing, may or may not permit subscriptions by new or existing investors. These entities mayalso have the ability to impose gates, lockups and other restrictions on an investor s ability toreadily redeem out of their investment interest in the fund. As of September 30, 2016 and 2015,Partners HealthCare has excluded all assets from the fair value hierarchy for which fair value ismeasured at net asset value per share using the practical expedient.



40

Funded StatusThe funded status of the plans recognized in the balance sheet and the amounts recognized inunrestricted net assets follows:

2016 2015 2016 2015

End of yearFair value of plan assets at measurement date 5,069,057$ 4,332,095$ 85,426$ 73,205$Benefit obligations at measurement date (6,855,889) (5,678,875) (151,875) (156,875)

Funded status (1,786,832)$ (1,346,780)$ (66,449)$ (83,670)$

Amounts recognized in the balance sheet

consist ofCurrent liabilities (6,493)$ (2,116)$ (3,437)$ (3,586)$Long-term liabilities (1,780,339) (1,344,664) (63,012) (80,084)

(1,786,832)$ (1,346,780)$ (66,449)$ (83,670)$

Amounts not yet recognized in net periodicbenefit cost and included in unrestricted

net assets consist ofActuarial net loss (gain) 2,604,947$ 1,850,126$ 28,258$ 11,730$Prior service cost (credit) (79,519) 9,852 (34,797) -

2,525,428$ 1,859,978$ (6,539)$ 11,730$

Amounts recognized in unrestricted net assets

consist ofCurrent year actuarial (gain) loss 844,931$ 698,377$ 17,793$ 15,746$Amortization of actuarial gain (loss) (90,109) (75,983) (1,267) 535Current year prior service cost (credit) (85,804) 4,402 (34,797) -

Amortization of prior service (cost) credit (3,567) (3,910) - -

665,451$ 622,886$ (18,271)$ 16,281$

Defined Benefit PostretirementPension Plans Healthcare Benefit Plans

At the end of 2016 and 2015, the projected benefit obligation, accumulated benefit obligation andfair value of plan assets for pension plans with an accumulated benefit obligation in excess of planassets were as follows:

2016 2015

Accumulated benefit obligation in excess of plan assetsProjected benefit obligation 6,855,789$ 5,678,875$

Accumulated benefit obligation 6,485,483 5,371,220

Fair value of plan assets 5,069,057 4,332,095



41

Expected Cash FlowsInformation about the expected cash flows for the defined benefit and postretirement healthcarebenefit plans is as follows:

Defined

BenefitPension

Plans

Expected employer contributions

2017 353,739$ 7,474$

MedicareSubsidy

Expected benefit payments (receipts)2017 261,364$ 7,627$ (153)$

2018 278,038 7,899 (17)

2019 293,967 9,057 (16)

2020 319,824 10,214 (14)2021 333,578 11,323 (13)

2022-2026 1,901,313 74,125 (43)

Postretirement Healthcare

Benefit Plans

Net Periodic Benefit Cost

2016 2015 2016 2015

Service cost 295,014$ 267,328$ 5,060$ 5,059$Interest cost 262,977 231,953 5,725 4,966Expected return on plan assets (364,511) (345,504) (5,298) (5,123)Amortization of

Prior service cost (credit) 3,567 3,910 - -Actuarial net (gain) loss 90,109 75,983 1,267 (534)

Net periodic benefit cost 287,156$ 233,670$ 6,754$ 4,368$

Pension Plans

Postretirement

Healthcare Benefit Plans

Defined Benefit

Amounts expected to be amortized from unrestricted net assets into net periodic benefit cost duringthe year ending September 30, 2017 are as follows:

Defined PostretirementBenefit Healthcare

Pension BenefitPlans Plans

Actuarial net loss (gain) 160,112$ 1,936$

Prior service cost (credit) (6,662) (5,289)



42

2016 2015 2016 2015

Weighted-average assumptions used

to determine net periodic pension and

postretirement cost

Discount rate 4.50 % 4.40 % 3.00 % - 4.55 % 3.05 % - 4.40 %

Expected return on plan assets 7.75 % 8.00 % 7.50 % 7.50 %

Rate of compensation increase

Professional staff 4.45 % 4.45 % N/A N/A

Other than professional staff 3.00 % - 3.50 % 3.00 % - 3.50 % N/A N/A

Healthcare cost trend rate for this year N/A N/A 7.00 % 7.00 %

Rate to which the cost trend rate is to decline N/A N/A 5.00 % 5.00 %

Year that rate reaches the ultimate trend rate N/A N/A 2021 2021

Postretirement Healthcare

Benefit PlansPension Plans

Defined Benefit

Partners HealthCare uses a long-term return assumption which is validated annually by obtaininglong-term asset return, volatility and correlation projections for relevant asset class indexes;modifying volatility and correlations to reflect the actual historical experience of the activemanagers; calculating the expected return using benchmark weights and indexes; and comparingthe return assumption to the sum of the expected return and the historical outperformance of theactual return versus the benchmark. Partners HealthCare regularly monitors the active risk of theMaster Trust by a statistical regression of the return series of the actual portfolio to that of thepolicy benchmark.

Assumed healthcare cost trend rates have a significant effect on the amounts reported for thehealthcare plans. A one-percentage-point change in assumed healthcare cost trend rates wouldhave the following effect:

Increase Decrease

Effect on service and interest cost 43$ (40)$

One-Percentage-Point

14. Professional Liability Insurance

Partners HealthCare insures substantially all of its professional and general liability risk on aclaims-made basis in cooperation with other healthcare organizations in the Greater Boston areathrough a captive insurance company, Controlled Risk Insurance Company Ltd. (CRICO).PHS owns 10% of CRICO. The investment is accounted for on the cost basis of accounting. Thepolicies cover claims made during their respective terms, but not those occurrences for whichclaims may be made after expiration of the policy, except for certain tail liabilities which CRICO hasassumed on an occurrence basis through December 31, 2016. Management intends to renew itscoverage on a claims-made basis and has no reason to believe that it will be prevented from suchrenewal. During 2015, CRICO announced and paid a dividend to member organizations. As aresult, Partners HealthCare recognized a dividend of $54,779 as a nonoperating gain.



43

Partners HealthCare follows the accounting policy of establishing reserves to cover the ultimatecosts of medical malpractice claims, which include costs associated with litigating or settling claims.The liability also includes an estimated tail liability, established to cover all malpractice claimsincurred but not reported to the insurance company as of the end of the year. The total malpracticeliability of $487,705 and $482,640 as of September 30, 2016 and 2015, respectively, is presentedas an accrued professional liability in the consolidated balance sheets. These reserves have beenrecorded on a discounted basis using an interest rate of 3.00% and 3.50% as of September 30,2016 and 2015, respectively.

Partners HealthCare also recognizes an insurance receivable from CRICO, at the same time that itrecognizes the liability, measured on the same basis as the liability, subject to the need for avaluation allowance for uncollectible amounts. The insurance receivable of $402,649 and$397,958 as of September 30, 2016 and 2015, respectively, is reported as a component of otherassets in the consolidated balance sheets.

Management is not aware of any claims against Partners HealthCare or factors affectingCRICO that would cause the expense for professional liability risks to vary materially from theamount provided.

15. Concentration of Credit Risk

Financial instruments that potentially subject Partners HealthCare to concentration of credit riskconsist of patient accounts receivable, research grants receivable, pledges receivable, premiumsreceivable, certain investments and interest rate swaps.

Partners HealthCare receives a significant portion of its payments for services rendered from alimited number of government and commercial third-party payers, including Medicare, Medicaid,Blue Cross and Blue Shield of Massachusetts, Harvard Pilgrim Health Care and Tufts Health Plan.Research funding is provided through many government and private sponsors. NHP receives asignificant portion of its premium revenue from the Commonwealth. Pledges receivable are duefrom multiple donors. Partners HealthCare assesses the credit risk for pledges based on historyand the financial wherewithal of donors, most of which are individuals or organizations well knownto Partners HealthCare.

Investments, which include government and agency securities, stocks and corporate bonds, andprivate partnerships and other investments are not concentrated in any corporation or industry orwith any single counterparty. Alternative investments are less liquid than Partners HealthCare sother investments. The reported values of the alternative investments may differ significantly fromthe values that would have been used had a ready market for those securities existed. Theseinstruments may contain elements of both credit and market risk. Such risks include, but are notlimited to, limited liquidity, absence of oversight, dependence upon key individuals, emphasis onspeculative investments and nondisclosure of portfolio composition.

Partners HealthCare minimizes the credit risk it is exposed to under interest rate swap agreementsby utilizing several counterparties and requiring the counterparties to post collateral for the benefitof Partners HealthCare when the fair value of the swap is positive. Partners HealthCare minimizesits counterparty risk by contracting with six counterparties, none of which accounts for more than30% of the aggregate notional amount of the swap contracts.



44

16. Net Assets

Restricted net assets are available for the following purposes:

2016 2015

Temporarily restrictedCharity care 90,525$ 89,032$Buildings and equipment 80,644 89,990

Clinical care, research and academic 619,717 586,540

790,886$ 765,562$

Permanently restrictedCharity care 20,001$ 20,550$Buildings and equipment 2,433 2,444

Clinical care, research and academic 600,752 556,584

623,186$ 579,578$

September 30,

EndowmentPartners HealthCare s endowment consists of numerous individual funds established for a varietyof purposes. The endowment includes both donor-restricted endowment funds and fundsdesignated by the boards to function as endowment.

Partners HealthCare has interpreted UPMIFA as requiring the preservation of the value of theoriginal gift of the donor-restricted endowment funds absent explicit donor stipulations to thecontrary. As a result of this interpretation, Partners HealthCare classifies as permanently restrictednet assets (a) the original value of gifts donated to the permanent endowment, (b) the original valueof subsequent gifts donated to the permanent endowment, and (c) accumulations to the permanentendowment made in accordance with the direction of the applicable donor gift instrument at thetime the accumulation is added to the fund. The remaining portion of the donor-restrictedendowment that is not classified in permanently restricted net assets is classified as temporarilyrestricted net assets until those amounts are appropriated for expenditure by Partners HealthCarein a manner consistent with the standard of prudence prescribed by UPMIFA. In accordance withUPMIFA, Partners HealthCare considers several factors in making a determination to appropriateor accumulate donor-restricted endowment funds. These factors include: the duration andpreservation of the fund; the purposes of the organization and the donor-restricted endowmentfund; general economic conditions; the possible effect of inflation and deflation; the expected totalreturn from income and the appreciation of investments; other resources of the organization; andthe investment policies of the organization.

Endowment Funds with DeficitsFrom time to time, the value of assets associated with individual donor-restricted endowment fundsmay fall below the value of the initial and subsequent donor gift amounts. When such endowmentdeficits exist, they are classified as a reduction to unrestricted net assets. Deficits of this naturereported in unrestricted net assets were $7,159 and $11,292 as of September 30, 2016 and 2015,respectively. These deficits resulted from unfavorable market fluctuations that occurred after theinvestment of new permanently restricted contributions or subsequent endowment additions.



45

The following presents the endowment net asset composition by type of fund as of September 30,2016 and 2015 and the changes in endowment assets for the years ended September 30, 2016and 2015:

Temporarily PermanentlyUnrestricted Restricted Restricted Total

Endowment net asset

composition by type of fund

as of September 30, 2016

Donor-restricted endowment funds (7,159)$ 419,900$ 602,658$ 1,015,399$

Board-designated endowment funds 979,199 - - 979,199

Total funds 972,040$ 419,900$ 602,658$ 1,994,598$


Unrestricted Restricted Restricted Total

Changes in endowment net assetsEndowment net assets at

September 30, 2015 874,088$ 410,816$ 558,507$ 1,843,411$

Investment returnInvestment income 2,225 1,628 - 3,853Net realized and unrealized

appreciation (depreciation) 66,408 57,931 54 124,393

Total investment return 68,633 59,559 54 128,246

Contributions 7,138 (102) 44,097 51,133Appropriation of endowment assets

for expenditure (42,464) (50,373) - (92,837)Other changes 64,645 - - 64,645

Total changes 97,952 9,084 44,151 151,187

Endowment net assets atSeptember 30, 2016 972,040$ 419,900$ 602,658$ 1,994,598$



Endowment net asset

composition by type of fundas of September 30, 2015

Donor-restricted endowment funds (11,292)$ 410,816$ 558,507$ 958,031$

Board-designated endowment funds 885,380 - - 885,380

Total funds 874,088$ 410,816$ 558,507$ 1,843,411$



46



Changes in endowment net assets

Endowment net assets atOctober 1, 2014 942,119$ 498,238$ 447,607$ 1,887,964$

Investment return

Investment income 3,856 4,588 (1) 8,443Net realized and unrealizedappreciation (depreciation) (51,213) (40,005) (30) (91,248)

Total investment return (47,357) (35,417) (31) (82,805)

Contributions 5,898 (172) 116,449 122,175Appropriation of endowment assetsfor expenditure (40,515) (49,813) - (90,328)

Other changes 13,943 (2,020) (5,518) 6,405

Total changes (68,031) (87,422) 110,900 (44,553)

Endowment net assets atSeptember 30, 2015 874,088$ 410,816$ 558,507$ 1,843,411$

Conditional PledgeDuring 2009, the General signed an agreement (Ragon Agreement) with The MassachusettsInstitute of Technology (MIT), The President and Fellows of Harvard College (Harvard) and ThePhillip T. and Susan M. Ragon Foundation (Ragon Foundation) to establish the Phillip T. andSusan M. Ragon Institute (Ragon Institute) as a joint research center of the General, MIT andHarvard with the purpose of harnessing the potential of the immune response to combat andconquer human diseases, integrating biomedical research with emerging engineering technologies(with the main initial focus being the development of an AIDS vaccine) and educating and trainingscientists. The Ragon Foundation committed to provide funding for the Ragon Institute of$100,000 over ten years through the General (as the administrative home for the Ragon Institute),beginning retroactively on January 1, 2008. The Ragon Foundation has the ability to slow,suspend or eliminate funding based on restrictions described in the Ragon Agreement.Additionally, any funding not paid by December 31, 2017 would no longer be due by the RagonFoundation. In February 2014, an amendment was signed (Ragon Amendment) that noted that thecurrent agreement would be completed by December 2018 and that an additional $50,000 offunding would be committed by the Ragon Foundation over five years beginning in 2019. Due tothe conditions within the Ragon Agreement, funding is recognized when received, with no pledgereceivable recorded for the balance of the amended commitment.

Through September 30, 2016, total funding of $98,052 was received (including $3,052 ofendowment earnings distributed), with $13,161 received for the year ended September 30, 2016(including $2,161 of endowment earnings distributed), and total net expenses of $78,858 wereincurred, including $7,945 for the year ended September 30, 2016. As of September 30, 2016,unspent funding has been recorded as temporarily restricted net assets, to be released tounrestricted net assets after qualifying expenses have been incurred.



47

17. Functional Expenses

Total operating expenses by function are as follows:

2016 2015

Healthcare services 7,624,800$ 7,167,823$

Research and academic 1,731,772 1,671,225

Medical claims and related expenses 2,017,773 1,652,538

General and administrative 1,193,665 1,067,601

12,568,010$ 11,559,187$


18. Contingencies

Partners HealthCare is subject to complaints, claims and litigation which arise in the normal courseof business. In addition, Partners HealthCare is subject to reviews and investigations by variousfederal and state government agencies to assure compliance with applicable laws, some of whichare subject to different interpretations. Governmental review of compliance by healthcareinstitutions, including Partners HealthCare, has increased.

19. Subsequent Events

Partners HealthCare has assessed the impact of subsequent events through December 9, 2016,the date the audited financial statements were issued. During this period, there were nosubsequent events that require adjustment to the audited financial statements.

Schedule of Expenditures of Federal Awards

Partners HealthCare System, Inc. and Affiliates Schedule of Expenditures of Federal Awards Year Ended September 30, 2016

Research and Development and Research Training Cluster

Direct Research and Development

Total Subrecipient

CFDA Agency CFDA Program CFDA # Expenditures Expenditures

The accompanying notes are an integral part of this schedule.

48

Agency for International Development

USAID Foreign Assistance for Programs Overseas 98.001 1,406,445$ 533,967$

Agency for International Development 1,406,445 533,967

Consumer Product Safety Commission

Consumer Product Safety Commission 93. 938 -

Consumer Product Safety Commission 938 -

Department of Agriculture National Institute of Food and Agriculture

Grants for Agricultural Research, Special Research Grants 10.200 153,525 53,681

Department of Agriculture National Institute of Food and Agriculture 153,525 53,681

Department of Defense

Congressionally Directed Medical Research Programs 93. 60,232 -

Defense Advanced Research Projects Agency 93. 24,398 -

Defense Threat Reduction Agency 93. 1,986,816 1,162,223

Naval Medical Research Unit 93. 165,189 -

U.S. Army Medical Research Acquisition 93. 1,326,662 109,613

Department of Defense 3,563,297 1,271,836

Department of Defense Advanced Research Projects Agency

Research and Technology Development 12.910 1,732,983 687,035

Department of Defense Advanced Research Projects Agency 1,732,983 687,035

Department of Defense Department of the Air Force, Materiel Command

Air Force Defense Research Sciences Program 12.800 2,780,822 -

Department of Defense Department of the Air Force, Materiel Command 2,780,822 -

Department of Defense Department of the Navy, Office of the Chief of Naval Research

Basic and Applied Scientific Research 12.300 578,483 -

Department of Defense Department of the Navy, Office of the Chief of Naval Research 578,483 -




Total Subrecipient



49

Department of Defense Office of the Secretary of Defense

Basic, Applied, and Advanced Research in Science and Engineering 12.630 14,955 -

Community Partners in Suicide Prevention 12.561 1,569,805 -

Department of Defense Office of the Secretary of Defense 1,584,760 -

Department of Defense U.S. Army Materiel Command

Basic Scientific Research 12.431 4,809,953 202,991

Department of Defense U.S. Army Materiel Command 4,809,953 202,991

Department of Defense U.S. Army Medical Command

Military Medical Research and Development 12.420 22,001,356 1,298,358

Department of Defense U.S. Army Medical Command 22,001,356 1,298,358

Department of Education

National Institute on Disability and Rehabilitation Research 84.133 27,859 (43,715)

Department of Education 27,859 (43,715)

Department of Energy

Office of Science Financial Assistance Program 81.049 26,374 -

Department of Energy 26,374 -

Department of Health and Human Services

Assistant Secretary for Preparedness and Response 93. 103,457 -

Center for Disease Control & Prevention 93. 129,136 -

Eastern Cooperative Oncology Group 93. 4,325 -

Food & Drug Administration 93. 1,081,331 875,753

HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 44,474 44,474

National Cancer Institute (NIH-NCI) 93. 33,050 -

National Heart, Lung, and Blood Institute (NIH-NHLBI) 93. 2,020,529 628,564

National Institute of Health (NIH) 93. 2,066,759 14,737

National Institute of Mental Health (NIH-NIMH ) 93. 3,730,188 1,733,944

Health and Human Services Contracts 93. 359,020 -

National Library of Medicine (NIH-NLM) 93. 233 -

NIH-NIDA National Institute On Drug Abuse 93. (1,600) -

Department of Health and Human Services 9,570,902 3,297,472




Total Subrecipient



50

Department of Health and Human Services Administration for Children and Families

Assistance for Torture Victims 93.604 346,669 -

Department of Health and Human Services Administration for Children and Families 346,669 -

Department of Health and Human Services Administration for Community Living

ACL National Institute on Disability, Independent Living, and Rehabilitation Research 93.433 1,313,332 315,857

Department of Health and Human Services Administration for Community Living 1,313,332 315,857

Department of Health and Human Services Agency for Healthcare Research and Quality

Research on Healthcare Costs, Quality and Outcomes 93.226 5,340,181 337,872

Department of Health and Human Services Agency for Healthcare Research and Quality 5,340,181 337,872

Department of Health and Human Services Centers for Disease Control and Prevention

Centers for Disease Control and Prevention Investigations and Technical Assistance 93.283 978,104 73,961

Occupational Safety and Health Program 93.262 2,599,894 182,627

Department of Health and Human Services Centers for Disease Control and Prevention 3,577,998 256,588

Department of Health and Human Services Food and Drug Administration

Food and Drug Administration Research 93.103 1,350,648 322,345

Department of Health and Human Services Food and Drug Administration 1,350,648 322,345

Department of Health and Human Services Health Resources and Services Administration

Advanced Nursing Education Grant Program 93.247 295,475 -

Health Systems Strengthening and HIV/AIDS Prevention, Care and Treatment under the

President's Emergency Plan for AIDS Relief 93.266 64,553 -

Maternal and Child Health Federal Consolidated Programs 93.110 3,042,962 1,555,752

Department of Health and Human Services Health Resources and Services Administration 3,402,990 1,555,752

Department of Health and Human Services National Institutes of Health

Aging Research 93.866 38,034,077 7,790,984

Alcohol Research Programs 93.273 660,101 155,295

Allergy and Infectious Diseases Research 93.855 120,921,291 50,335,625

Arthritis, Musculoskeletal and Skin Diseases Research 93.846 16,537,828 2,451,831

Biomedical Research and Research Training 93.859 25,936,121 4,070,804

Blood Diseases and Resources Research 93.839 7,038,780 1,127,224




Total Subrecipient



51

Cancer Biology Research 93.396 14,509,937 4,128,809

Cancer Cause and Prevention Research 93.393 27,667,769 4,262,263

Cancer Centers Support Grants 93.397 2,219,818 1,027,509

Cancer Control 93.399 1,212,046 -

Cancer Detection and Diagnosis Research 93.394 17,441,502 3,394,903

Cancer Treatment Research 93.395 28,633,919 11,694,872

Cardiovascular Diseases Research 93.837 77,937,975 14,827,711

Child Health and Human Development Extramural Research 93.865 16,371,989 3,638,101

Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 48,778,625 5,893,965

Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 25,506,694 2,764,776

Drug Abuse and Addiction Research Programs 93.279 12,241,025 2,408,429

Environmental Health 93.113 2,243,519 705,641

Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 47,094,488 5,402,018

Human Genome Research 93.172 8,247,236 2,972,353

International Research and Research Training 93.989 282,617 63,502

Lung Diseases Research 93.838 31,429,824 5,156,798

Medical Library Assistance 93.879 1,127,240 275,855

Mental Health Research Grants 93.242 32,896,635 6,063,846

Minority Health and Health Disparities Research 93.307 229,504 59,992

National Center on Sleep Disorders Research 93.233 3,839,628 1,347,621

Nursing Research 93.361 2,679,670 241,657

Oral Diseases and Disorders Research 93.121 3,371,659 231,575

Research and Training in Complementary and Integrative Health 93.213 6,140,259 752,111

Research Infrastructure Programs 93.351 3,541,161 662,633

Research Related to Deafness and Communication Disorders 93.173 2,971,414 660,479

Trans-NIH Research Support 93.310 13,149,746 1,677,504

Vision Research 93.867 4,351,488 257,248

Department of Health and Human Services National Institutes of Health 645,245,585 146,503,934

Department of Veterans Affairs

Department of Veterans Affairs 93. 305,574 -

VA Boston Healthcare System 93. 467,947 -

Veterans Administration Medical Center 93. 387,052 -

Department of Veterans Affairs 1,160,573 -




Total Subrecipient



52

Institute of Museum and Library Services

National Leadership Grants 45.312 1,656 -

Institute of Museum and Library Services 1,656 -

National Aeronautics and Space Administration

Exploration 43.003 1,066,771 -

National Aeronautics and Space Administration 93. 47,518 -

Science 43.001 452,436 -

National Aeronautics and Space Administration 1,566,725 -

National Science Foundation

Biological Sciences 47.074 254,520 -

Computer and Information Science and Engineering 47.070 91,445 5,223

Education and Human Resources 47.076 6,854 -

Engineering Grants 47.041 894,079 377,804

Geosciences 47.050 263,448 40,678

Mathematical and Physical Sciences 47.049 258,586 -

National Science Foundation 1,768,932 423,705

Total Direct Research and Development 713,312,986$ 157,017,678$



Direct Training

Total Subrecipient



53


Military Medical Research and Development 12.420 1,094,406$ -$

Department of Defense U.S. Army Medical Command 1,094,406 -

Department of Energy

Office of Science Financial Assistance Program 81.049 454,062 -

Department of Energy 454,062 -


Career Development Awards 93.277 (22,595) -

Department of Health and Human Services (22,595) -


National Research Service Awards Health Services Research Training 93.225 57 -

Research on Healthcare Costs, Quality and Outcomes 93.226 137,362 -

Department of Health and Human Services Agency for Healthcare Research and Quality 137,419 -


National Research Service Award in Primary Care Medicine 93.186 335,822 -

Department of Health and Human Services Health Resources and Services Administration 335,822 -


Aging Research 93.866 1,684,748 -

Alcohol Research Programs 93.273 446,310 -

Allergy and Infectious Diseases Research 93.855 5,107,339 70,811

Arthritis, Musculoskeletal and Skin Diseases Research 93.846 3,651,299 (3,104)

Biomedical Research and Research Training 93.859 1,250,864 55,163

Blood Diseases and Resources Research 93.839 574,225 -

Cancer Cause and Prevention Research 93.393 784,895 -

Cancer Research Manpower 93.398 7,762,170 399,147

Cardiovascular Diseases Research 93.837 8,901,977 54,178



Direct Training

Total Subrecipient



54

Child Health and Human Development Extramural Research 93.865 2,541,487 37,106

Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 9,947,337 8,414

Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 1,397,805 -

Drug Abuse and Addiction Research Programs 93.279 2,809,907 1,195

Environmental Health 93.113 549,522 10,520

Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 5,344,986 35,057

International Research and Research Training 93.989 577,070 246,898

Lung Diseases Research 93.838 2,084,856 -

Medical Library Assistance 93.879 36,119 -

Mental Health National Research Service Awards for Research Training 93.282 1,125 -

Mental Health Research Grants 93.242 5,343,879 74,977

National Center on Sleep Disorders Research 93.233 226,353 -

Oral Diseases and Disorders Research 93.121 (5,962) -

Research and Training in Complementary and Integrative Health 93.213 529,379 -

Research Related to Deafness and Communication Disorders 93.173 18,183 -

Trans-NIH Research Support 93.310 303,320 -

Vision Research 93.867 170,495 -

Department of Health and Human Services National Institutes of Health 62,039,688 990,362


Social, Behavioral, and Economic Sciences 47.075 118,751 -

National Science Foundation 118,751 -

Total Training 64,157,553$ 990,362$

Total Direct Research and Development and Research Training 777,470,539$ 158,008,040$



Research and Development Pass Through

Total Subrecipient

CFDA Agency CFDA Program Pass-Through Sponsor CFDA # Pass-Through Number Expenditures Expenditures


55

Agency for International Development

USAID Foreign Assistance for Programs Overseas Eastern Virginia Medical School 98.001 AID-OAA-A-10-00068 70,118$ -$

USAID Foreign Assistance for Programs Overseas Eastern Virginia Medical School 98.001 AID-OAA-A-11-00064 120,828 -

USAID Foreign Assistance for Programs Overseas President and Fellows of Harvard College 98.001 AID-AFDA-A-12-00002/2017 79,742 -

USAID Foreign Assistance for Programs Overseas President and Fellows of Harvard College 98.001 USAID-OFDA-A-12-00002/2017 29,070 -

USAID Foreign Assistance for Programs Overseas Seattle Children's Hospital 98.001 AID-OAA-A-14-00049 55,920 17,954

USAID Foreign Assistance for Programs Overseas Tufts University 98.001 AID-OFDA-A-00026 79,624 -

USAID Foreign Assistance for Programs Overseas University of Washington 98.001 AID-OAA-A-15-00034 26,346 -

USAID Foreign Assistance for Programs Overseas University Research Co. LLC 98.001 AID-0AA-A-10-00021 226 -

Agency for International Development 461,874 17,954

Department of Agriculture Economic Research Service

Consumer Data and Nutrition Research University of Kentucky 10.253 58-5000-3-0066 30,912 -

Department of Agriculture Economic Research Service 30,912 -

Department of Defense Advanced Research Projects Agency

Research and Technology Development Massachusetts Institute of Technology 12.910 N66001-11-1-4182 4,138 -

Research and Technology Development President and Fellows of Harvard College 12.910 HR0011-15-C-0094 435,750 -

Department of Defense Advanced Research Projects Agency 439,888 -

Department of Defense Defense Threat Reduction Agency

Scientific Research - Combating Weapons of Mass Destruction Digital Infuzion 12.351 HDTRA1-14-CHEM-BIO-BAA 115,017 -

Scientific Research - Combating Weapons of Mass Destruction Digital Infuzion 12.351 TSWG-14-C-3273 18 -

Department of Defense Defense Threat Reduction Agency 115,035 -

Department of Defense Department of the Air Force, Materiel Command

Air Force Defense Research Sciences Program Massachusetts Institute of Technology 12.800 FA9550-15-0473 32,994 -

Air Force Defense Research Sciences Program University of Washington 12.800 FA9550-15-1-0273 229,535 -

Department of Defense Department of the Air Force, Materiel Command 262,529 -

Department of Defense Department of the Navy, Office of the Chief of Naval Research

Basic and Applied Scientific Research Johns Hopkins University 12.300 N000014-10-1-0278 9,328 -

Basic and Applied Scientific Research President and Fellows of Harvard College 12.300 N00014-15-2917 298,406 -

Basic and Applied Scientific Research Regents of the University of California 12.300 N00014-13-1-0672 283,950 -

Department of Defense Department of the Navy, Office of the Chief of Naval Research 591,684 -

Department of Defense Department of the Navy, SPAWAR

Navy Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance Wake Forest University Health Sciences 12.335 N66001-13-C-2027 390,705 -

Department of Defense Department of the Navy, SPAWAR 390,705 -

Department of Defense Office of the Secretary of Defense

Research on Chemical and Biological Defense The Geneva Foundation 12.360 W911QY-14-1-0002 35,897 -

Department of Defense Office of the Secretary of Defense 35,897 -




Total Subrecipient



56

Department of Defense U.S. Army Materiel Command

Basic Scientific Research Massachusetts Institute of Technology 12.431 W911NF-10-1-0059 3,453 -

Basic Scientific Research Trustees of Boston University 12.431 W911NF-11-2-0056 82,544 -

Department of Defense U.S. Army Materiel Command 85,997 -


Military Medical Research and Development American Burn Association 12.420 W81XWH-11-1-0835 78,571 -

Military Medical Research and Development Beth Israel Deaconess Medical Center 12.420 W81XW-16-1-0042 5,491 -

Military Medical Research and Development Brigham and Women's Hospital, Inc. 12.420 W81XWH-08-2-0159 274 -

Military Medical Research and Development Brigham and Women's Hospital, Inc. 12.420 W81XWH-12-2-0037 129,483 -

Military Medical Research and Development Brigham and Women's Hospital, Inc. 12.420 W81XWH-16-1-1065 2,034 -

Military Medical Research and Development Broad Institute, Inc. 12.420 W81XWH-13-1-0093 898 -

Military Medical Research and Development Children's Hospital of Boston 12.420 W81XWH-12-1-0155 20,237 -

Military Medical Research and Development Children's Hospital of Boston 12.420 W81XWH-15-1-0621 167,133 -

Military Medical Research and Development CIMIT - (Center for the Integration of Medicine and Innovative Technology) 12.420 W81XWH 09 2 0001 85 -

Military Medical Research and Development Dana Farber Cancer Institute 12.420 W81XWH-11-1-0379 18,975 -



Military Medical Research and Development Johns Hopkins School of Public Health 12.420 W81XWH-12-1-0588 3,809 -

Military Medical Research and Development Johns Hopkins University 12.420 W81ZWG-13-2-0060 108,862 -

Military Medical Research and Development Massachusetts General Hospital 12.420 W81XWH-14-1-0543 14,457 -

Military Medical Research and Development Massachusetts General Hospital 12.420 W81XWH-14-2-0008 183,376 -

Military Medical Research and Development New England School of Acupuncture 12.420 W81XWH-14-1-0533 21,772 -

Military Medical Research and Development Northeastern University 12.420 W81XWH-14-1-0092 44,475 -

Military Medical Research and Development President and Fellows of Harvard College 12.420 W81XWH-14-1-0131 130,222 -

Military Medical Research and Development Regents of the University of California 12.420 W81XWH-12-1-0143 (2) -

Military Medical Research and Development Regents of the University of California 12.420 W81XWH-14-2-0176 172,637 -

Military Medical Research and Development Regents of the University of California San Diego 12.420 W81XWH-08-2-0159 242,795 24,520

Military Medical Research and Development Regents of the University of California San Diego 12.420 W81XWH-12-2-0012 8,879 -

Military Medical Research and Development Regents of the University of California San Diego 12.420 W81XWH-15-2-0090 142,437 -

Military Medical Research and Development Rutgers University 12.420 W81XWH-08-2-0034 (1,360) -

Military Medical Research and Development Spaulding Rehabilitation Hospital 12.420 W81XWH-08-2-0159 (12,968) -

Military Medical Research and Development Spaulding Rehabilitation Hospital 12.420 W81XWH-10-1-1043 1,140 -

Military Medical Research and Development Stratatech Corporation 12.420 W81XWH-12-C-0063 (5,720) -

Military Medical Research and Development University of Alabama 12.420 W81XWH-12-1-0155 8,963 -

Military Medical Research and Development University of Alabama at Birmingham 12.420 W81XWH-15-1-0705 74,877 -

Military Medical Research and Development University of California at Los Angeles 12.420 W81XWH-16-10086 34,271 -

Military Medical Research and Development University of California at San Diego 12.420 W81XWH-08-2-0159 315 -

Military Medical Research and Development University of California at San Diego 12.420 W81XWH-15-2-0090 131,684 -

Military Medical Research and Development University of Delaware 12.420 W81XWH-11-2-0222 18,104 -

Military Medical Research and Development University of Pittsburgh 12.420 W81XWH-12-2-0024 34,965 -

Military Medical Research and Development University of Southern California 12.420 W81XWH-12-2-0012 4,070 -

Military Medical Research and Development University of Texas Health Science Center at Houston 12.420 W81XWH-11-1-0240 1,223 -

Military Medical Research and Development Veterans Education and Research Association of Michigan 12.420 W81XWH-11-1-0073 543,495 -

Military Medical Research and Development Wake Forest University Health Sciences 12.420 W81XWH-13-2-0053 378,974 6,292

Military Medical Research and Development Wake Forest University Health Sciences 12.420 W81XWH-13-2-0054 261,785 -

Department of Defense U.S. Army Medical Command 2,987,855 30,812




Total Subrecipient



57

Department of Defense Uniformed Services University of the Health Sciences

Uniformed Services University Medical Research Projects Henry M Jackson Foundation 12.750 HU0001-11-1-0023 1,485,204 -

Uniformed Services University Medical Research Projects Henry M Jackson Foundation 12.750 HU0001-15-2-0028 224,252 -

Department of Defense Uniformed Services University of the Health Sciences 1,709,456 -

Department of Education

National Institute on Disability and Rehabilitation Research Boston University 84.133 H133A130023 (1,126) -

National Institute on Disability and Rehabilitation Research Spaulding Rehabilitation Hospital 84.133 H133A120034 (27,233) -

National Institute on Disability and Rehabilitation Research Spaulding Rehabilitation Hospital 84.133 H133A120085 (40,386) -

National Institute on Disability and Rehabilitation Research Spaulding Rehabilitation Hospital 84.133 H133N110010-12 (7,057) -

National Institute on Disability and Rehabilitation Research Trustees of Boston University 84.133 H133A130023 (7,691) -

Department of Education (83,493) -

Department of Education Institute of Education Sciences

Education Research, Development and Dissemination Ohio State University 84.305 60023887 82,070 10,749

Department of Education Institute of Education Sciences 82,070 10,749


National Center for Education in Maternal and Child Health University of Texas Health Science Center at San Antonio 93.588 5U19AI070412-10 51,135 -

National Institutes of Health Contracts AlphaSense Inc. 93. FA8650-15-M-6655 19,624 -

National Institutes of Health Contracts American Bar Association 93. S-INLEC-14-CA-1036 46,580 -

National Institutes of Health Contracts ARRA-NIH-NCI National Cancer Institute 93. HHSN261201000051I 26,040 -

National Institutes of Health Contracts Arsenal Medical, Inc. 93. W911NF-12-C-0066 42,332 -

National Institutes of Health Contracts Battelle Memorial Institute 93. SP0700-00-D-3180/DO 0783 87 -

National Institutes of Health Contracts Boston Veterans Affairs Medical Center 93. (3,067) -

National Institutes of Health Contracts Broad Institute, Inc. 93. 66102700416-01B1 2,759 -

National Institutes of Health Contracts Broad Institute, Inc. 93. 66102700416-01BI 11,814 -

National Institutes of Health Contracts Broad Institute, Inc. 93. HHSN261201400006C 50,143 -

National Institutes of Health Contracts Broad Institute, Inc. 93. HHSN26620040001C (53) -

National Institutes of Health Contracts Broad Institute, Inc. 93. HHSN268201000029C 92,103 -

National Institutes of Health Contracts Case Western Reserve University 93. HHSN275201100018C (21,040) -

National Institutes of Health Contracts Charles River Analytics, Inc. 93. 2014-13121700006 (5,137) -

National Institutes of Health Contracts Charles River Analytics, Inc. 93. SC1219801 7,459 -

National Institutes of Health Contracts Charles River Analytics, Inc. 93. 30,459 -

National Institutes of Health Contracts Children's Hospital of Boston 93. 1U61TS000237-02 5,446 -

National Institutes of Health Contracts Children's Hospital of Boston 93. HHSN272201400052C 85,103 -

National Institutes of Health Contracts Collagen Medical, LLC 93. HHSN268201400044c 301,278 -

National Institutes of Health Contracts Dallas VAMC 93. 2,446 -

National Institutes of Health Contracts DocBox, Inc. 93. W81XWH-13-C-0107 (3,904) -

National Institutes of Health Contracts Duke University 93. HHSN272201100025C 9,050 -

National Institutes of Health Contracts Educational Development Center, Inc. 93. HHSH250201600001C 8,141 -

National Institutes of Health Contracts EMMES Corporation 93. HHSN263201300005C 77,248 -

National Institutes of Health Contracts Fenway Community Health Center 93. R34MH104083 (435) -

National Institutes of Health Contracts Global Health Service Corps 93. 429,067 -

National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF22301001T/HHSF22320140030I 125,153 -

National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF22301012T-0016 11,512 -

National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF223200910006I 207,030 -




Total Subrecipient



58

National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF223200910006I/HHSF22301007T-000 1,896 -

National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF223200910006I/HHSF22301007T-008 (2,078) -


National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF223200910006I/HHSF22301012T-000 382 -


National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF223200910006I/HHSF22301016T 1,970 -

National Institutes of Health Contracts Harvard Pilgrim Health Care 93. HHSF223200910006I-HHSF22301012T-004 694 -

National Institutes of Health Contracts Harvard Pilgrim Health Care Institute 93. HHSF223200910006I 21,330 -

National Institutes of Health Contracts Harvard Pilgrim Health Care Institute 93. HHSF223200910006I/HHSF22301007T0017 30,764 -

National Institutes of Health Contracts Harvard School of Public Health 93. 5U90TP000417-05 (1) -

National Institutes of Health Contracts Johns Hopkins University 93. HHSN268200736197C 12,639 -

National Institutes of Health Contracts Leidos Biomedical Research Inc 93. HHSN261200800001E 656,398 190,749

National Institutes of Health Contracts Massachusetts General Hospital 93. HHSN268201000033C/N01-HV-00241 18,298 -

National Institutes of Health Contracts Massachusetts General Hospital 93. HHSN268201000044C (3,603) -

National Institutes of Health Contracts Massachusetts Institute of Technology 93. 7000348017 27,710 -

National Institutes of Health Contracts Massachusetts Institute of Technology 93. FA8721-05-C-0002 19,670 -

National Institutes of Health Contracts Massachusetts Institute of Technology 93. HR0011-15-C-0155 118,355 -

National Institutes of Health Contracts Mayo Clinic 93. HHSN2612012000421 37,996 -

National Institutes of Health Contracts Mayo Clinic 93. HHSN261201200042I 1,142 -

National Institutes of Health Contracts Mbarara University of Science and Technology 93. 0757-03 24,799 -

National Institutes of Health Contracts Memorial Sloan-Kettering Institute Cancer Center 93. HHSM-500-2012-00008I 45,740 -

National Institutes of Health Contracts Mount Sinai Hospital 93. HHSN268201000045C (11,143) -

National Institutes of Health Contracts Northeastern University 93. HSHQDC-10-D-00030 (4,810) -

National Institutes of Health Contracts Physical Sciences, Inc. 93. SC-57983-1605-46 44,660 -

National Institutes of Health Contracts Physical Sciences, Inc. 93. W81XWH-12-C-0075 273 -

National Institutes of Health Contracts Polestar Technologies, Inc. 93. W81XWH-10-C-0039 22 -

National Institutes of Health Contracts President and Fellows of Harvard College 93. 027270.387214.0221 29,664 -

National Institutes of Health Contracts President and Fellows of Harvard College 93. HHSA290201000025I 213,470 -

National Institutes of Health Contracts President and Fellows of Harvard College 93. HHSN261201300016C 7,789 -

National Institutes of Health Contracts President and Fellows of Harvard College 93. HHSN275201000020C (13,658) -

National Institutes of Health Contracts President and Fellows of Harvard College 93. HHSN275201500003C 63,192 -

National Institutes of Health Contracts Radiological Society of North America 93. HHSN268201300071C 2 -

National Institutes of Health Contracts Radiological Society of North America 93. HHSN268201500021C 22,039 -

National Institutes of Health Contracts Radiological Society of North America 93. HHSN286201300071C 9,658 -

National Institutes of Health Contracts RAND Corporation 93. HHSA290201000017I (5,417) -

National Institutes of Health Contracts Regents of the University of Michigan 93. HHSN268201100026C 83,548 -

National Institutes of Health Contracts Robin Medical, Inc. 93. HHSN261201200050C 53,738 -

National Institutes of Health Contracts SAIC-Frederick, Inc. 93. HHSN261200800001E 937,795 627,448

National Institutes of Health Contracts Siamab Therapeutics 93. HHSN261201400027C 70,720 -

National Institutes of Health Contracts Social and Scientific Systems, Inc. 93. HHSN261200800001E 85,834 -

National Institutes of Health Contracts Social and Scientific Systems, Inc. 93. HHSN272200900001/2/3I, HHSN27200001 2,016 -

National Institutes of Health Contracts Social and Scientific Systems, Inc. 93. PHR-SSS-S-15-004626 10,278 -

National Institutes of Health Contracts Sylvatica Biotech, Inc 93. W81XWH-15-C-0149 47,474 -

National Institutes of Health Contracts University of Alabama 93. HHSN268201100025C 50,104 -

National Institutes of Health Contracts University of Buffalo 93. HHSN268201100001C (5,057) -

National Institutes of Health Contracts University of Buffalo 93. HHSN268201600001C 283,616 -

National Institutes of Health Contracts University of Cincinnati 93. HHSF223201110112A 4,987 -




Total Subrecipient



59

National Institutes of Health Contracts University of New England 93. 2016-68001-24961 12,785 -

National Institutes of Health Contracts University of Pittsburgh 93. W911QY-15-C-0043 50,499 -

National Institutes of Health Contracts University of Rochester 93. HHSN272201200005C 41,093 -

National Institutes of Health Contracts University of Texas, MD Anderson Cancer Center 93. HHSN261201200034I 02 4,202 -

National Institutes of Health Contracts University of Utah 93. W911NF-15-2-0046 178,045 -

National Institutes of Health Contracts Westat, Inc. 93. HHSD2002013M53968B 208,550 -

Recovery Act – Comparative Effectiveness Research - AHRQ University of Washington - Seattle 93.715 1R01HS019222-01 (2,030) -

Test for Suppression Effects of Advanced Energy University of Colorado 93.999 5U01CA157715-05 104,205 -

Department of Health and Human Services 5,217,952 818,197

Department of Health and Human Services Administration for Children and Families

Assistance for Torture Victims Gulf Coast Jewish Family Services, Inc. 93.604 90ZT0137/01 (6,525) -

Department of Health and Human Services Administration for Children and Families (6,525) -

Department of Health and Human Services Administration for Community Living

ACL National Institute on Disability, Independent Living, and Rehabilitation Research Boston University 93.433 90DP0055-03-00 97,534 -

ACL National Institute on Disability, Independent Living, and Rehabilitation Research Spaulding Rehabilitation Hospital 93.433 90DP00350200 5,171 -

ACL National Institute on Disability, Independent Living, and Rehabilitation Research Spaulding Rehabilitation Hospital 93.433 90DP0035-02-01 23,630 -

ACL National Institute on Disability, Independent Living, and Rehabilitation Research Spaulding Rehabilitation Hospital 93.433 90DP0039-01-00 227,201 -

ACL National Institute on Disability, Independent Living, and Rehabilitation Research Spaulding Rehabilitation Hospital 93.433 90SI5007-02-02 11,340 -

ACL National Institute on Disability, Independent Living, and Rehabilitation Research TIRR Memorial Hermann 93.433 90DP0060 98,101 -

Department of Health and Human Services Administration for Community Living 462,977 -


Research on Healthcare Costs, Quality and Outcomes Boston College 93.226 1R21HS024330-01 36,678 -

Research on Healthcare Costs, Quality and Outcomes Cambridge Health Alliance, PSC 93.226 4R01HS021486-03 12,760 -

Research on Healthcare Costs, Quality and Outcomes Children's Hospital of Boston 93.226 1R18HS023291-01 64,514 -

Research on Healthcare Costs, Quality and Outcomes Duke University 93.226 1P50HS023418-02 213,536 -

Research on Healthcare Costs, Quality and Outcomes Harvard Clinical Research Institute (HCRI) 93.226 1R01HS022966-01 8,537 -

Research on Healthcare Costs, Quality and Outcomes Harvard Pilgrim Health Care 93.226 2R01HS018414-06 10,338 -

Research on Healthcare Costs, Quality and Outcomes Harvard Pilgrim Health Care 93.226 5R18HS021424-04 72,736 -

Research on Healthcare Costs, Quality and Outcomes Harvard School of Public Health 93.226 5R18HS019631-03 8,242 -

Research on Healthcare Costs, Quality and Outcomes Kaiser Foundation Research Institute 93.226 U19HS021107 12,784 -

Research on Healthcare Costs, Quality and Outcomes Northwestern University 93.226 U19HS021093 9,494 -

Research on Healthcare Costs, Quality and Outcomes President and Fellows of Harvard College 93.226 1P30HS024453-01 51,338 -

Research on Healthcare Costs, Quality and Outcomes RAND Corporation 93.226 5R21HS023960-02 63,186 -

Research on Healthcare Costs, Quality and Outcomes Rhode Island Hospital 93.226 7R18HS021666-02 34,927 -

Research on Healthcare Costs, Quality and Outcomes University of Oklahoma Health Sciences Center 93.226 1R18HS023919-01 58,737 -

Research on Healthcare Costs, Quality and Outcomes University of Washington 93.226 1R01HS022972-01 (13,754) -

Research on Healthcare Costs, Quality and Outcomes Women and Infant's Hospital 93.226 1R18HS023460-01 4,199 -

Research on Healthcare Costs, Quality and Outcomes Yale University 93.226 4U18HS016978-09 148,271 -

Research on Healthcare Costs, Quality and Outcomes Yale University 93.226 5R18HS023778-02 14,006 -

Research on Healthcare Costs, Quality and Outcomes Yale University School of Medicine 93.226 1R18HS023778-01 34,483 -





Total Subrecipient



60


Chronic Diseases: Research, Control, and Prevention Yale University 93.068 5R21DP006082-02 75,721 -

Global AIDS African Society for Laboratory Medicine 93.067 U2GGH000710 712 -

Global AIDS Beth Israel Deaconess Medical Center 93.067 5U2GGH0011-40-03 134,985 -

Global AIDS Botswana Harvard AIDS Institute Partnership 93.067 5U2GPS001882-05 (1,622) -

Global AIDS Harvard School of Public Health 93.067 5U01GH000447-04 91,967 -

Global AIDS President and Fellows of Harvard College 93.067 1U2GGH001911-01 58,862 -

Global AIDS President and Fellows of Harvard College 93.067 5U01GH000447-04 57,301 -

Global AIDS President and Fellows of Harvard College 93.067 5U01GH000447-04REV 26,471 -

Global AIDS President and Fellows of Harvard College 93.067 HSPH-01 u/ 1U1GH000770 1,692 -

Global AIDS President and Fellows of Harvard College 93.067 HSPH-01 u/5UGGH000942 17,709 -

Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure Association for Public Health Laboratories 93.065 U60HM000803 9,278 -

Occupational Safety and Health Program California Pacific Medical Center 93.262 5R21OH010204-02 15,511 -

Occupational Safety and Health Program Harvard School of Public Health 93.262 5U19OH008861-08 116,812 -

Occupational Safety and Health Program Northeastern University 93.262 5R21OH010564-02 5,631 -

Occupational Safety and Health Program President and Fellows of Harvard College 93.262 5R01OH002421-21 (1,336) -

PPHF: Racial and Ethnic Approaches to Community Health Program financed solely by Public Prevention and Health Funds Partners in Health 93.738 5NU58DP005874-02-00 126,745 -

Prevention of Disease, Disability, and Death by Infectious Diseases President and Fellows of Harvard College 93.084 5U38PS004644-02 219,244 -

Department of Health and Human Services Centers for Disease Control and Prevention 955,683 -

Department of Health and Human Services Centers for Medicare and Medicaid Services

ACA-Transforming Clinical Practice Initiative: Support and Alignment Networks (SANs) American College of Emergency Physicians 93.639 1L1CMS331479-01-00 62,853 -

Department of Health and Human Services Centers for Medicare and Medicaid Services 62,853 -

Department of Health and Human Services Food and Drug Administration

Food and Drug Administration Research New England Pediatric Device Consortium 93.103 5P50FD004907-03 174,198 -

Food and Drug Administration Research Tufts Medical Center, Inc. 93.103 1R01FD003899-01A4 130,810 -

Food and Drug Administration Research University of Miami 93.103 5R01FD003517-04 (843) -

Department of Health and Human Services Food and Drug Administration 304,165 -


HIV-Related Training and Technical Assistance University of Massachusetts at Worcester 93.145 6U1OHA29294-01-01 7,939 -

Maternal and Child Health Federal Consolidated Programs Educational Development Center, Inc. 93.110 UF4MC26525 101,550 -

Maternal and Child Health Federal Consolidated Programs Mount Sinai School of Medicine 93.110 5H30MC24048-03-00 2,241 -

Nurse Education, Practice Quality and Retention Grants Boston College 93.359 5UD7HP25059-03-00 49,516 -



Aging Research Banner Alzheimer's Institute 93.866 1UF1AG046150-01 56,837 -

Aging Research Beckman Research Institute of the City of Hope 93.866 5R01AG037037-05 613 -

Aging Research Beth Israel Deaconess Medical Center 93.866 1R01AG051658-01 20,391 -

Aging Research Beth Israel Deaconess Medical Center 93.866 5R01AG041869-02 37,231 -

Aging Research BioSensics 93.866 R44AG051374 220,782 -

Aging Research Boston Medical Center 93.866 5P30 AG031679 27,661 -

Aging Research Boston University 93.866 4500002097 58,522 -

Aging Research Boston University 93.866 5R01AG008122-25 71,354 -




Total Subrecipient



61

Aging Research Brandeis University 93.866 5R01AG038375-05 169,753 -

Aging Research Brigham and Women's Hospital - Internal Funds 93.866 01AG048270 (1,423) -

Aging Research Brigham and Women's Hospital, Inc. 93.866 2R21AG048522-02 32,231 -

Aging Research Brigham and Women's Hospital, Inc. 93.866 4P01AG015379-19 1,189,174 -




Aging Research Broad Institute, Inc. 93.866 2RF1AG015819-16 5,646 -

Aging Research Broad Institute, Inc. 93.866 3U01AG046152-02 23,902 -

Aging Research Broad Institute, Inc. 93.866 5R01AG017917-11A1 15,258 -

Aging Research Broad Institute, Inc. 93.866 5R01AG030146-08 16,103 -



Aging Research Broad Institute, Inc. 93.866 5U01AG046152-03 567,048 -

Aging Research Broad Institute, Inc. 93.866 U01AG046152 37,339 -

Aging Research Brown University 93.866 1UH2AG049619-01 (15,460) -

Aging Research Brown University 93.866 4UH3AG049619-02 178,545 -

Aging Research California Pacific Medical Center 93.866 5R01AG026720-09 39,457 -

Aging Research Cold Spring Harbor Laboratories 93.866 5R01AG040209-04 (13,460) -

Aging Research Columbia University 93.866 5U01AG051412-02 311,656 -

Aging Research CorticoMetrics, LLC 93.866 1R41AG052246-01 75,075 -

Aging Research Fred Hutchinson Cancer Research Center 93.866 5R01AG048209-02 88,781 -

Aging Research Function Promoting Therapies, LLC 93.866 1R43AG045011-01A1 72,673 -

Aging Research Hebrew Rehabilitation Center for Aged 93.866 5R01AG025037-10 16,220 -



Aging Research Hebrew Rehabilitation Center for Aged 93.866 R01AG025037 56,201 -

Aging Research Hebrew Senior Life 93.866 90065 26,095 -

Aging Research HOWARD UNIVERSITY 93.866 7R01AG038492-04 1 -

Aging Research Johns Hopkins University 93.866 5R01AG042187-05 31,240 -

Aging Research Massachusetts General Hospital 93.866 2P50AG005134-31 17,858 -

Aging Research Massachusetts General Hospital 93.866 5U01AG032700-05 3,761 -

Aging Research Mayo Clinic 93.866 5U01AG045390-03 280,421 -

Aging Research NCIRE-The Veterans Health Research Institute 93.866 5U01AG024904-10 31,716 -

Aging Research Northern California Institute for Research and Education 93.866 3U01AG024904-10S1 31,549 -

Aging Research Osmic Enterprises, Inc. 93.866 4R44AG051311-02 91,928 -

Aging Research President and Fellows of Harvard College 93.866 1R01AG048917-01A1 23,415 -

Aging Research President and Fellows of Harvard College 93.866 2P01AG032952-06A1 34,326 -

Aging Research President and Fellows of Harvard College 93.866 5P01AG041710-03 7,164 -

Aging Research President and Fellows of Harvard College 93.866 5P30AG024409-11 19,783 -

Aging Research President and Fellows of Harvard College 93.866 5P30AI060354-10 (61) -

Aging Research President and Fellows of Harvard College 93.866 5R01AG011085-22 68,295 -

Aging Research Regents of the University of California 93.866 5R01AG038492-06 230,696 -

Aging Research Regents of the University of California 93.866 5U01AG024904-10 2,754 -

Aging Research Regents of the University of California San Diego 93.866 2U19AG010483-22 346,353 -



Aging Research Regents of the University of California San Diego 93.866 7RF1AG041845-02 (432) -

Aging Research Regents of the University of Michigan 93.866 5R01AG040138-05 50,149 -

Aging Research Research Foundation of State University of New York 93.866 7R01AG040209-05 40,613 -

Aging Research Rush University Medical Center 93.866 1R01AG052583-01 98,607 -




Total Subrecipient



62


Aging Research Rush University Medical Center 93.866 2RF1AG015819-16 156,233 -



Aging Research Skuplt Inc 93.866 1R41AG047021-01 42,109 -

Aging Research Trustees of Boston University 93.866 1R01AG049607-02 442,362 -

Aging Research Trustees of Boston University 93.866 5R01AG016495-14 163,279 -

Aging Research Trustees of Dartmouth College 93.866 1R21AG045618-02 51,458 -

Aging Research University of Connecticut Health Center 93.866 4R01AG022092-10 126,412 -

Aging Research University of Pennsylvania 93.866 5U01AG030644-06 1,516 -

Aging Research University of Pennsylvania 93.866 5U01AG032984-05 (1) -

Aging Research University of Pennsylvania 93.866 5U01AG032984-07 38,312 -

Aging Research University of Pittsburgh 93.866 2R01AG026463-07 28,303 -

Aging Research University of Rochester 93.866 P01AG047200-02 522,381 -

Aging Research University of Southern California 93.866 4U19AG010483-25 82,124 -

Aging Research University of Southern California 93.866 5U01AG024904-10 106,589 -

Aging Research University of Southern California 93.866 RF1AG041845 3,675 -

Aging Research University of Washington 93.866 1R01AG042437-01A1 103,276 -

Aging Research University of Washington - Seattle 93.866 5U01AG016976-18 28,670 -

Aging Research Wake Forest University 93.866 R24 AG044325 11,657 -

Aging Research Washington University 93.866 2UF1AG032438-07 122,341 -

Aging Research Washington University 93.866 5R01AG047644-03 436,118 -

Aging Research Washington University 93.866 5U19AG032438-06 607 -

Aging Research Yuma Therapeutics 93.866 2R42AG042205-02 117,247 -

Alcohol Research Programs Heprotech Inc 93.273 1R43AA023707-01 12,780 -

Alcohol Research Programs President and Fellows of Harvard College 93.273 4R01AA012974-15 41,789 -

Allergy and Infectious Diseases Research Benaroya Research Institute at Virginia Mason 93.855 5UM1AI109565-02 227,880 -

Allergy and Infectious Diseases Research Benaroya Research Institute at Virginia Mason 93.855 5UM1AI109565-03 4,968,677 -

Allergy and Infectious Diseases Research Beth Israel Deaconess Medical Center 93.855 1UM1AI124377-01 42,852 -

Allergy and Infectious Diseases Research Beth Israel Deaconess Medical Center 93.855 2UM1AI069412-08 (109) -

Allergy and Infectious Diseases Research Beth Israel Deaconess Medical Center 93.855 5U01AI102427-04 34,327 -

Allergy and Infectious Diseases Research Beth Israel Deaconess Medical Center 93.855 5U19AI096040-04 66,099 -

Allergy and Infectious Diseases Research Beth Israel Deaconess Medical Center 93.855 5UM1AI069412-10 1,514,770 -

Allergy and Infectious Diseases Research Board of Trustees of the Leland Stanford Junior University, The 93.855 5U19AI057229-13 59,847 -

Allergy and Infectious Diseases Research Brigham and Women's Hospital, Inc. 93.855 1R01AI108538-01A1 98,871 -

Allergy and Infectious Diseases Research Brigham and Women's Hospital, Inc. 93.855 1R21AI114448-01 134,650 -

Allergy and Infectious Diseases Research Brigham and Women's Hospital, Inc. 93.855 2UM1AI068636-08 70,067 -



Allergy and Infectious Diseases Research Brigham and Women's Hospital, Inc. 93.855 5UM1AI068636-10 1,013,440 -


Allergy and Infectious Diseases Research Brigham and Women's Hospital, Inc. 93.855 7U01AI117841-02 327,775 -

Allergy and Infectious Diseases Research Broad Institute, Inc. 93.855 1R21AI112704-01 24,927 -


Allergy and Infectious Diseases Research Broad Institute, Inc. 93.855 2015-MGH-49 (58,877) -




Allergy and Infectious Diseases Research Broad Institute, Inc. 93.855 WU-14-266 / 1U19AI109725 12,482 -

Allergy and Infectious Diseases Research Broad Institute, Inc. 93.855 WU-14-266 / U19AI109725 9,439 -

Allergy and Infectious Diseases Research Centre for the AIDS Programme of Research 93.855 1R01AI111936 -02 135,149 -

Allergy and Infectious Diseases Research Children's Hospital of Boston 93.855 4R01AI099204-05 178,257 -




Total Subrecipient



63




Allergy and Infectious Diseases Research Columbia University 93.855 1R01AI124413-01 7,102 -




Allergy and Infectious Diseases Research Columbia University 93.855 5U19AI067773-12 8,408 -

Allergy and Infectious Diseases Research Columbia University 93.855 7P01AI045897-16 468,221 -


Allergy and Infectious Diseases Research Cornell University Weill Medical College 93.855 U19AI111143-02 116,751 -

Allergy and Infectious Diseases Research Dana Farber Cancer Institute 93.855 4R01A1101897-05 98,284 -

Allergy and Infectious Diseases Research Dana Farber Cancer Institute 93.855 5P01AI045757-17 343,330 -

Allergy and Infectious Diseases Research Duke University 93.855 5U19AI056363-10 2,517 -

Allergy and Infectious Diseases Research Duke University 93.855 5UM1AI100645-04 84,287 -

Allergy and Infectious Diseases Research Emory University 93.855 1U19AI111211-02S1 34,665 -

Allergy and Infectious Diseases Research Enumeral Biomedical Corp 93.855 A221556 66,554 -

Allergy and Infectious Diseases Research Feinstein Institute for Medical Research 93.855 1UH2AR067688-01 129,009 -

Allergy and Infectious Diseases Research Feinstein Institute for Medical Research 93.855 1UH2AR067688-02 101,075 -

Allergy and Infectious Diseases Research FHI 360 93.855 UM1AI068619 2,469 -

Allergy and Infectious Diseases Research Fraunhofer CMI 93.855 5R01AI101446-04 36,938 -

Allergy and Infectious Diseases Research Fred Hutchinson Cancer Research Center 93.855 5UM1AI068614-09 80,692 -

Allergy and Infectious Diseases Research Fred Hutchinson Cancer Research Center 93.855 5UM1AI068614-10 615,296 -

Allergy and Infectious Diseases Research GHESKIO Centers 93.855 5UMIAI069421-09 75,226 -

Allergy and Infectious Diseases Research Harvard Medical School 93.855 5P01AI054904-10 29 -

Allergy and Infectious Diseases Research Harvard Medical School 93.855 5U19AI109740-02 29,437 -



Allergy and Infectious Diseases Research Harvard School of Public Health 93.855 5U01AI114235-02 12,264 -

Allergy and Infectious Diseases Research Harvard School of Public Health 93.855 5UM1AI069456-09 81,617 -

Allergy and Infectious Diseases Research Institute for Clinical Research, Inc. 93.855 1U01AI068641 559 -

Allergy and Infectious Diseases Research Integrated BioTherapeutics, Inc 93.855 5R43AI106162-02 179,274 -

Allergy and Infectious Diseases Research Johns Hopkins University 93.855 5U24AI116833-02 267,870 -

Allergy and Infectious Diseases Research Johns Hopkins University 93.855 5UM1AI068632-10 55,658 -

Allergy and Infectious Diseases Research Lynntech 93.855 1R43AI109938-01 44,470 -

Allergy and Infectious Diseases Research Mass General Hospital - CIMIT 93.855 5UM1AI069472-07 (17) -

Allergy and Infectious Diseases Research Massachusetts Eye and Ear Infirmary 93.855 5P01AI083214-08 610,946 -

Allergy and Infectious Diseases Research Massachusetts General Hospital 93.855 1U01AI117841-01 15,178 -

Allergy and Infectious Diseases Research Massachusetts General Hospital 93.855 4R33AI110165-03 6,690 -

Allergy and Infectious Diseases Research Massachusetts General Hospital 93.855 5R01AI037691-20 (119) -






Allergy and Infectious Diseases Research Massachusetts Institute of Technology 93.855 1R01AI111860-01 8,026 -

Allergy and Infectious Diseases Research Microbiotix, Inc 93.855 1R41AI118037-01 138,082 -

Allergy and Infectious Diseases Research National Jewish Health 93.855 4U01AI097073-04 93,115 -

Allergy and Infectious Diseases Research NIH-NIAID National Institute of Allergy and Infectious Diseases 93.855 5UM1AI068636-10 (720) -




Total Subrecipient



64

;; Allergy and Infectious Diseases Research Oregon Health & Science University (OHSU) 93.855 5U01AI095776-04 (3,108) -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 1R21AI117304-01A1 5,556 -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 1R56AI114617-01 (23,334) -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 1U19AI109755-01 7,870 -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 2P01AI056299-13 78,359 -



Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 2R37AI059371-11 20,606 -






Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 5PO1AI112521-03 309,321 -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 5R01AI024643-26 (7) -







Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 5UM1AI068616-10 57,260 -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 5UM1AI104681-04 1,541 -


Allergy and Infectious Diseases Research Scripps Research Institute 93.855 1UM1AI100663-02 748,453 -

Allergy and Infectious Diseases Research Scripps Research Institute 93.855 5U19 AI109762-03 12,691 -

Allergy and Infectious Diseases Research Sloan Kettering Institute for Cancer Research 93.855 5R33A1098802-05 141,273 -

Allergy and Infectious Diseases Research Social and Scientific Systems, Inc. 93.855 HHSN272200900001/2/3I 4,214 -

Allergy and Infectious Diseases Research Stanford University 93.855 5R01AI093282-05 22,840 -

Allergy and Infectious Diseases Research Universal Stabilization Technologies, Inc. 93.855 4R33AI094508-03 68,885 -

Allergy and Infectious Diseases Research University of Alabama at Birmingham 93.855 5R01AI111475-03 660,309 -

Allergy and Infectious Diseases Research University of California 93.855 5R01AI104824-02 (5) -

Allergy and Infectious Diseases Research University of California at San Diego 93.855 3U24AI117966-02S1 89,576 -

Allergy and Infectious Diseases Research University of California at San Francisco 93.855 1UM1AI110498-01 441,938 111,937

Allergy and Infectious Diseases Research University of California at San Francisco 93.855 5P30AI027763-23 107,286 -

Allergy and Infectious Diseases Research University of Chicago 93.855 4R01AI103342-04 47,991 -

Allergy and Infectious Diseases Research University of Colorado 93.855 1R21AI124859-01 48,859 -

Allergy and Infectious Diseases Research University of Maryland 93.855 5R01AI120008-02 105,997 -

Allergy and Infectious Diseases Research University of Maryland at Baltimore 93.855 1R01AI087452-06 31,241 -

Allergy and Infectious Diseases Research University of Maryland at Baltimore 93.855 5U19AI082655-07 664,953 -

Allergy and Infectious Diseases Research University of Maryland at Baltimore 93.855 AI090873 (1,037) -

Allergy and Infectious Diseases Research University of Massachusetts Medical Center 93.855 1R01AI123286-01 79,690 -

Allergy and Infectious Diseases Research University of Pennsylvania 93.855 5R01AI047833-14 96,840 -

Allergy and Infectious Diseases Research University of Pittsburgh 93.855 5P01AI108545-02 110,023 -

Allergy and Infectious Diseases Research University of Texas Health Science Center at San Antonio 93.855 2U19AI070412-08 (3,294) -

Allergy and Infectious Diseases Research University of Texas Health Science Center at San Antonio 93.855 5U19 AI070412-09 73,764 -

Allergy and Infectious Diseases Research University of Texas Health Science Center at San Antonio 93.855 5U19AI070412-09 52,740 -

Allergy and Infectious Diseases Research University of Texas Health Science Center at San Antonio 93.855 5U19AI070412-10 24,857 -

Allergy and Infectious Diseases Research University of Wisconsin 93.855 5U01AI102456-02 3 -




Total Subrecipient



65

Allergy and Infectious Diseases Research University of Wisconsin 93.855 5U01AI102456-03 36,356 -

Allergy and Infectious Diseases Research University of Wisconsin - Madison 93.855 5U01AI102456-03 34,541 -

Allergy and Infectious Diseases Research Vanderbilt University 93.855 2R01AI077505-06A1 96,194 -

Allergy and Infectious Diseases Research Washington University 93.855 5U19AI109725-02 81,654 -

Allergy and Infectious Diseases Research Washington University 93.855 5U19AI109725-03 769,284 -

Allergy and Infectious Diseases Research Yale University 93.855 5P01AI039671-19 416 -

Allergy and Infectious Diseases Research Yale University 93.855 5R01AI112438-04 19,060 -

Allergy and Infectious Diseases Research Yale University 93.855 7601A104824-04 24,598 -

Arthritis, Musculoskeletal and Skin Diseases Research Brigham and Women's Hospital, Inc. 93.846 1R01AR065538-01A1 98,316 -

Arthritis, Musculoskeletal and Skin Diseases Research Brigham and Women's Hospital, Inc. 93.846 1U01AR068043-01A1 71,664 -

Arthritis, Musculoskeletal and Skin Diseases Research Brigham and Women's Hospital, Inc. 93.846 5R01AR064367-02 433,391 -



Arthritis, Musculoskeletal and Skin Diseases Research Broad Institute, Inc. 93.846 2015-BWH-21 1,027 -

Arthritis, Musculoskeletal and Skin Diseases Research Case Western Reserve University 93.846 1R01AR066193-01 348,369 -

Arthritis, Musculoskeletal and Skin Diseases Research Feinstein Institute for Medical Research 93.846 5UH2AR067694-02 77,271 -

Arthritis, Musculoskeletal and Skin Diseases Research Feinstein Institute for Medical Research 93.846 5UH2AR067694-03 52,194 -

Arthritis, Musculoskeletal and Skin Diseases Research Forsyth Institute, The 93.846 1R01AR064793 76,505 -

Arthritis, Musculoskeletal and Skin Diseases Research Massachusetts General Hospital 93.846 7R01AR065944-04 154,992 -

Arthritis, Musculoskeletal and Skin Diseases Research Mayo Clinic 93.846 7R01AR050243-10/10 (17,852) -

Arthritis, Musculoskeletal and Skin Diseases Research Mount Sinai School of Medicine 93.846 5R21AR065968-02 127,574 -

Arthritis, Musculoskeletal and Skin Diseases Research Regents of the University of California 93.846 1UH2AR067688-01 3,378 -

Arthritis, Musculoskeletal and Skin Diseases Research Stanford University 93.846 5R01AR057837-06 413,741 -

Arthritis, Musculoskeletal and Skin Diseases Research Stanford University 93.846 7R01AR057837-02 (189) -

Arthritis, Musculoskeletal and Skin Diseases Research Superconducting Systems, Inc. 93.846 4R44AR065903-02 180,564 -

Arthritis, Musculoskeletal and Skin Diseases Research Tufts Medical Center, Inc. 93.846 5R01AR065977-02 24,705 -

Arthritis, Musculoskeletal and Skin Diseases Research Tufts Medical Center, Inc. 93.846 5R01AR066378-02 363,258 -

Arthritis, Musculoskeletal and Skin Diseases Research University of Colorado 93.846 1R01AR065441-01 13,808 -

Arthritis, Musculoskeletal and Skin Diseases Research University of Michigan 93.846 5R01AR062066-04 972 -

Arthritis, Musculoskeletal and Skin Diseases Research University of Minnesota 93.846 4R01AR063070-04 98,191 -

Arthritis, Musculoskeletal and Skin Diseases Research University of South Carolina 93.846 5R56AR063745-02 (13,133) -

Arthritis, Musculoskeletal and Skin Diseases Research Wake Forest University 93.846 1U01AR068658-01 72,907 -

Biomedical Research and Research Training Beth Israel Deaconess Medical Center 93.859 5R01GM073894-08 (6,353) -

Biomedical Research and Research Training Bridge 12 Technologies Inc 93.859 1R43GM110875-01 (13,405) -

Biomedical Research and Research Training Brigham and Women's Hospital, Inc. 93.859 5P01GM061354-12 905,157 -

Biomedical Research and Research Training Brigham and Women's Hospital, Inc. 93.859 P01-GM061354 585,039 -

Biomedical Research and Research Training Brown University 93.859 5R01GM098461-05 110,653 -

Biomedical Research and Research Training Children's Hospital of Boston 93.859 5R01GM104303-02 1,479 -

Biomedical Research and Research Training Dana Farber Cancer Institute 93.859 5R01GM107427-03 211,357 -

Biomedical Research and Research Training Massachusetts Institute of Technology 93.859 5R01GM101420-04 206,872 -

Biomedical Research and Research Training Mayo Clinic 93.859 5U19GM061388-15 (733) -

Biomedical Research and Research Training Mount Sinai School of Medicine 93.859 5R01GM114472-02 49,873 -

Biomedical Research and Research Training President and Fellows of Harvard College 93.859 1R01GM116525-01 89,002 -

Biomedical Research and Research Training President and Fellows of Harvard College 93.859 3R01GM083303-07S1 11,410 -

Biomedical Research and Research Training President and Fellows of Harvard College 93.859 5P01GM047467-24 257,965 -



Biomedical Research and Research Training President and Fellows of Harvard College 93.859 5P01GM099177-04 (17,997) -





Total Subrecipient



66

Biomedical Research and Research Training President and Fellows of Harvard College 93.859 P30 AI060354 4,075 -

Biomedical Research and Research Training University of California at San Diego 93.859 2R01GM032373-32 103,761 -

Biomedical Research and Research Training University of California at San Francisco 93.859 1R01GM117163-01 128,259 -

Biomedical Research and Research Training University of Mississippi Medical Center 93.859 1R01GM103799 1,804 -

Biomedical Research and Research Training University of Mississippi Medical Center 93.859 5R01GM103799-05 1,920 -

Biomedical Research and Research Training University of Pittsburgh 93.859 3R01GM097471-04 19,959 -


Biomedical Research and Research Training University of Pittsburgh 93.859 5R01GM097471-04 (37,642) -


Biomedical Research and Research Training University of Pittsburgh, School of Medicine 93.859 1R01GM101197-02 35,762 -

Biomedical Research and Research Training University of Texas, MD Anderson Cancer Center 93.859 1R01GM116024-01 103,164 -

Blood Diseases and Resources Research Brigham and Women's Hospital, Inc. 93.839 4R01HL116854-04 129,797 -

Blood Diseases and Resources Research Brown University 93.839 1U01HL114476-03 96,744 -

Blood Diseases and Resources Research Children's Hospital of Boston 93.839 2P01HL095489-06A1 93,991 -

Blood Diseases and Resources Research Children's Hospital of Boston 93.839 5P01HL032262-34 211,435 -

Blood Diseases and Resources Research Children's Hospital of Boston 93.839 5P01HL095489-05 91,338 -

Blood Diseases and Resources Research Children's Hospital of Boston 93.839 5R01HL069990-11 32,699 -

Blood Diseases and Resources Research Children's Hospital of Boston 93.839 5U01HL117720-04 342,640 -

Blood Diseases and Resources Research Dana Farber Cancer Institute 93.839 4P50HL110790-05 315,376 60,746

Blood Diseases and Resources Research Dana Farber Cancer Institute 93.839 5P50HL110790-03 4,165 -

Blood Diseases and Resources Research Dana Farber Cancer Institute 93.839 5P50HL110790-05 158,044 -

Blood Diseases and Resources Research Dana Farber Cancer Institute 93.839 5U01HL069249 128 -

Blood Diseases and Resources Research Dana Farber Cancer Institute 93.839 U01HL69249 (1,286) -

Blood Diseases and Resources Research National Marrow Donor Program 93.839 U01HL69249 (3,759) -

Blood Diseases and Resources Research Regents of the University of Minnesota 93.839 1R21HL130818-01 16,728 -

Blood Diseases and Resources Research University of Massachusetts Medical School 93.839 5R01HL125089-02 153,114 -

Blood Diseases and Resources Research Washington University 93.839 5U01HL088476-05 2,612 -

Cancer Biology Research Beth Israel Deaconess Medical Center 93.396 1U01CA199252-01 451,579 -

Cancer Biology Research Brigham and Women's Hospital, Inc. 93.396 4P01CA120964-10 157,565 -

Cancer Biology Research Broad Institute, Inc. 93.396 4U24CA180922-04 7,521 -

Cancer Biology Research Broad Institute, Inc. 93.396 5R01CA184922-03 12,535 -

Cancer Biology Research Broad Institute, Inc. 93.396 R01CA182461 831 -

Cancer Biology Research Children's Hospital of Boston 93.396 1R01CA193675-01A1 6,597 -

Cancer Biology Research Dana Farber Cancer Institute 93.396 2R01CA042368-29A1 (1) -

Cancer Biology Research Dana Farber Cancer Institute 93.396 2R01CA131945-06A1 79,305 -

Cancer Biology Research Dana Farber Cancer Institute 93.396 5P01CA080111-18 11,811 -

Cancer Biology Research Georgetown University 93.396 5R01CA170653-04 131,084 -

Cancer Biology Research Indiana University 93.396 5R01CA155332-04 (25,342) -

Cancer Biology Research inVicro 93.396 5R44CA157090-04 27,196 -

Cancer Biology Research Massachusetts General Hospital 93.396 5U19CA179563-03 338,155 -

Cancer Biology Research MD Anderson Cancer Center 93.396 5P01CA117969-10 94,275 -

Cancer Biology Research Mount Sinai School of Medicine 93.396 5P01CA080058-15 (87) -

Cancer Biology Research President and Fellows of Harvard College 93.396 5R01CA092433-13 18,458 -

Cancer Biology Research Regents of the University of California 93.396 5R01CA172667-03 46,296 -




Total Subrecipient



67

Cancer Biology Research Scripps Research Institute 93.396 2R01CA132630-08 53,857 -

Cancer Biology Research University of California at Irvine 93.396 5R01CA190964-02 293,107 -

Cancer Biology Research University of Texas, MD Anderson Cancer Center 93.396 5P01CA117969-10 30,625 -

Cancer Biology Research Washington University 93.396 5P01CA101937-13 306,904 -

Cancer Cause and Prevention Research Baylor College of Medicine 93.393 5R01CA139020-05 93,862 -

Cancer Cause and Prevention Research Beth Israel Deaconess Medical Center 93.393 1R21CA187642-01A1 186,520 -

Cancer Cause and Prevention Research Beth Israel Deaconess Medical Center 93.393 5R01CA170549-04 178,208 -

Cancer Cause and Prevention Research Board of Trustees of the Leland Stanford Junior University, The 93.393 1R01CA183904-01A1 12,840 -

Cancer Cause and Prevention Research Brigham and Women's Hospital, Inc. 93.393 5R01CA160679-03 (3,650) -

Cancer Cause and Prevention Research Brown University 93.393 1R21CA198216-01 33,470 -

Cancer Cause and Prevention Research California Pacific Medical Center 93.393 5R21CA158808-02 (427) -

Cancer Cause and Prevention Research Children's Hospital 93.393 1R21CA191735-01A1 8,761 -

Cancer Cause and Prevention Research Dana Farber Cancer Institute 93.393 1R03CA188140-02 24,299 -

Cancer Cause and Prevention Research Dana Farber Cancer Institute 93.393 5R01CA151993-05 (2,476) -

Cancer Cause and Prevention Research Dana Farber Cancer Institute 93.393 5R35CA197735-02 120,083 -

Cancer Cause and Prevention Research Fred Hutchinson Cancer Research Center 93.393 1U24CA180996-01A1 (26,448) -

Cancer Cause and Prevention Research Fred Hutchinson Cancer Research Center 93.393 2U01CA137088-06 179,439 -

Cancer Cause and Prevention Research Fred Hutchinson Cancer Research Center 93.393 4R01CA176272-04 91,083 -




Cancer Cause and Prevention Research Group Health Research Institute 93.393 5P01CA154292-05 92,852 -

Cancer Cause and Prevention Research Harvard Pilgrim Health Care 93.393 5R01CA172639-03 31,341 -

Cancer Cause and Prevention Research IGI Technologies, Inc. 93.393 5R42CA137886-03 (6,766) -

Cancer Cause and Prevention Research International Agency for Research on Cancer 93.393 5U01CA155340-03 28,851 -

Cancer Cause and Prevention Research Kaiser Foundation Research Institute 93.393 UM1CA1736-02 3,704 -

Cancer Cause and Prevention Research Massachusetts Institute of Technology 93.393 7R01CA160860-03 92,419 -

Cancer Cause and Prevention Research Memorial Sloan-Kettering Institute Cancer Center 93.393 5U01CA152959-04 2,405 -

Cancer Cause and Prevention Research Northeastern University 93.393 1U01CA193632-01A1 16,425 -

Cancer Cause and Prevention Research Ohio State University 93.393 4P01CA163205-04 16,292 -

Cancer Cause and Prevention Research Ohio State University 93.393 5P01CA163205-04 297,420 37,870

Cancer Cause and Prevention Research President and Fellows of Harvard College 93.393 1R03CA195098-01A1 11,007 -

Cancer Cause and Prevention Research President and Fellows of Harvard College 93.393 4UM1CA176726-04 1,993,894 -

Cancer Cause and Prevention Research President and Fellows of Harvard College 93.393 5R01CA050385-27 350,724 -




Cancer Cause and Prevention Research President and Fellows of Harvard College 93.393 5U01CA199334-02 58,133 -

Cancer Cause and Prevention Research President and Fellows of Harvard College 93.393 5UM1CA167552-05 277,634 -

Cancer Cause and Prevention Research Regents of the University of Michigan 93.393 1U01CA199284-01 212,924 -

Cancer Cause and Prevention Research Regents of the University of Michigan 93.393 5R01CA152192-05 23,912 -

Cancer Cause and Prevention Research Regents of the University of Michigan 93.393 5R21CA172892-03 6,557 -

Cancer Cause and Prevention Research Roswell Park Cancer Institute 93.393 7U24CA180996-03 165,895 -

Cancer Cause and Prevention Research Sloan Kettering Institute for Cancer Research 93.393 5U01CA199335-02 141,375 -




Total Subrecipient



68

Cancer Cause and Prevention Research Temple University 93.393 1R01CA158361-01A1 8,272 -

Cancer Cause and Prevention Research Trustees of Dartmouth College 93.393 1P01CA154292-01A1 92,795 -

Cancer Cause and Prevention Research Trustees of Indiana University 93.393 1R03CA188568-02 20,439 -

Cancer Cause and Prevention Research Trustees of Indiana University 93.393 7R01CA157823-04 35,691 -

Cancer Cause and Prevention Research Trustees of Indiana University 93.393 7R03CA167741-03 (3,804) -

Cancer Cause and Prevention Research University of Colorado at Denver 93.393 5R01CA181207-02 15,770 -

Cancer Cause and Prevention Research University of Hawaii 93.393 5P01CA168530-04 33,642 -

Cancer Cause and Prevention Research University of Maryland 93.393 7R01CA163018-04 583 -

Cancer Cause and Prevention Research University Of Massachusetts 93.393 5R01CA166666-04 34,268 (30,457)

Cancer Cause and Prevention Research University of Massachusetts at Amherst 93.393 5R03CA186228-02 16,327 -

Cancer Cause and Prevention Research University of Massachusetts at Amherst 93.393 5U01CA049449-25 207,871 -

Cancer Cause and Prevention Research University of Pennsylvania 93.393 5R01CA133004-05 (4,112) -

Cancer Cause and Prevention Research University of Rochester 93.393 1R01CA157823-01A1 (2,744) -

Cancer Cause and Prevention Research University of Texas, MD Anderson Cancer Center 93.393 5R01CA186566-02 13,516 -

Cancer Cause and Prevention Research University of Vermont 93.393 1R21CA137650-01A2 24,731 -

Cancer Cause and Prevention Research University of Washington 93.393 4R01CA173754-04 73,006 -

Cancer Cause and Prevention Research Vanderbilt University 93.393 1R01CA190428-01A1 116,711 -

Cancer Centers Support Grants Beth Israel Deaconess Medical Center 93.397 2P50CA101942-11A1 587,055 -

Cancer Centers Support Grants Beth Israel Deaconess Medical Center 93.397 5P50CA101942-10 (6,653) -

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 1U54CA156732-05 (3,014) -

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 3P30CA006516·51S2 Revised 40,549 -

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 3P30CA006516-51S4 15,831 -

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 4P30CA006516-51 1,381,480 -

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 4P50CA127003-09 786,897 -

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 5P30CA006516-51 1,251,714 -






Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 5U54CA193461-02 410,595 -

Cancer Centers Support Grants Dana Farber Cancer Institute 93.397 W81XWH-13-1-0029 12,932 -

Cancer Centers Support Grants Dana Farber Partners Cancer Care 93.397 5U54CA001685-03 53,938 -

Cancer Centers Support Grants Dana Farber/Harvard Cancer Center 93.397 2P50CA090381-13 12,107 -

Cancer Centers Support Grants Dana Farber/Harvard Cancer Center 93.397 5P50CA090381-13 82,219 -

Cancer Centers Support Grants Dartmouth College 93.397 5U54CA163307-04 189,738 -

Cancer Centers Support Grants Dartmouth College 93.397 5U54CA163307-05 30,511 -

Cancer Centers Support Grants Dartmouth College 93.397 U54CA163307-02 144,351 -

Cancer Centers Support Grants Johns Hopkins University 93.397 5P50CA098252-12 5,822 -

Cancer Centers Support Grants Massachusetts General Hospital 93.397 4P50CA165962-04 24,169 -

Cancer Centers Support Grants Massachusetts General Hospital 93.397 5P50CA165962-02 (43,067) -

Cancer Centers Support Grants Massachusetts Institute of Technology 93.397 5U54CA151884-05 97,842 -

Cancer Centers Support Grants Massachusetts Institute of Technology 93.397 U54CA151884 3,587 -

Cancer Centers Support Grants Mayo Clinic 93.397 5P50CA116201-09 (2,923) -




Total Subrecipient



69

Cancer Centers Support Grants MD Anderson Cancer Center 93.397 5U54CA163125-05 179,793 -

Cancer Centers Support Grants President and Fellows of Harvard College 93.397 1U54CA155626-04 277,232 -

Cancer Centers Support Grants President and Fellows of Harvard College 93.397 5U54CA155626-05 266,518 -

Cancer Centers Support Grants SARC 93.397 5U54CA168512-02 (15,261) -

Cancer Centers Support Grants SARC 93.397 5U54CA168512-03 82,334 -

Cancer Centers Support Grants SARC 93.397 5U54CA168512-04 287,016 -

Cancer Centers Support Grants University of Pennsylvania 93.397 5U54CA163313-05 181,014 -

Cancer Centers Support Grants University of Pittsburgh 93.397 5P50CA121973-07 (609) -

Cancer Centers Support Grants University of Texas, MD Anderson Cancer Center 93.397 5U54CA163191-06 137,073 -

Cancer Centers Support Grants Washington University 93.397 4P50CA171963-04 37,883 -

Cancer Centers Support Grants Washington University 93.397 5U54CA155496-04 (147) -

Cancer Control Arizona State University 93.399 5U01CA117374-10 17,773 -

Cancer Control Mayo Clinic 93.399 1UG1CA189823-01 72,632 -

Cancer Control President and Fellows of Harvard College 93.399 5P50CA148596-05 12,861 -

Cancer Control University of Texas, MD Anderson Cancer Center 93.399 2P50CA083639-14 (127) -

Cancer Detection and Diagnosis Research Baylor College of Medicine 93.394 5R01CA181275-02 101,739 -

Cancer Detection and Diagnosis Research Board of Trustees of the University of Illinois (The) 93.394 CA177462A 55,084 -

Cancer Detection and Diagnosis Research Brigham and Women's Hospital, Inc. 93.394 2R01CA120528-09 36,898 -

Cancer Detection and Diagnosis Research Brigham and Women's Hospital, Inc. 93.394 5R01CA120528-10 17,369 -

Cancer Detection and Diagnosis Research Brigham and Women's Hospital, Inc. 93.394 5U24CA180918-03 107,404 -

Cancer Detection and Diagnosis Research Broad Institute, Inc. 93.394 2015-A57v2 88,312 -

Cancer Detection and Diagnosis Research Broad Institute, Inc. 93.394 2015-A58 37,740 -

Cancer Detection and Diagnosis Research Broad Institute, Inc. 93.394 2015-A59v2 33,966 -

Cancer Detection and Diagnosis Research Broad Institute, Inc. 93.394 5U24CA160034-05 92,316 -

Cancer Detection and Diagnosis Research Broad Institute, Inc. 93.394 U24CA143845 28,167 -

Cancer Detection and Diagnosis Research Collagen Medical, LLC 93.394 1R44CA200186-01A1 86,596 -

Cancer Detection and Diagnosis Research CorticoMetrics, LLC 93.394 1R41CA183150-01A1 36,353 -

Cancer Detection and Diagnosis Research Dana Farber Cancer Institute 93.394 1U01CA190234-01 17,800 -

Cancer Detection and Diagnosis Research Dana Farber Cancer Institute 93.394 4R01CA114465-10 46,034 -

Cancer Detection and Diagnosis Research Dana Farber Cancer Institute 93.394 5R01CA114465-09 517 -




Cancer Detection and Diagnosis Research Dana Farber Cancer Institute 93.394 5R21CA167800-02 (30) -





Cancer Detection and Diagnosis Research IQ Medical Imaging LLC 93.394 1R41CA192600-01A1 107,800 -

Cancer Detection and Diagnosis Research IQ Medical Imaging LLC 93.394 A222465.01 26,197 -

Cancer Detection and Diagnosis Research Massachusetts General Hospital 93.394 1R01CA203873-01 5,106 -

Cancer Detection and Diagnosis Research Massachusetts General Hospital 93.394 3R01CA115746-08S1 70,328 -

Cancer Detection and Diagnosis Research Massachusetts General Hospital 93.394 4R01CA115746-09 98,082 -

Cancer Detection and Diagnosis Research Massachusetts General Hospital 93.394 5U01CA182367-02 102,758 -




Total Subrecipient



70

Cancer Detection and Diagnosis Research New York University School of Medicine 93.394 1R01CA178949-01 67,293 -

Cancer Detection and Diagnosis Research Northeastern University 93.394 5U01CA151452-05 18,112 -

Cancer Detection and Diagnosis Research NRG Oncology 93.394 1U24CA196067-01 22,351 -

Cancer Detection and Diagnosis Research Ohio State University 93.394 5R01CA134451-07 34,876 -

Cancer Detection and Diagnosis Research Oregon Health & Science University (OHSU) 93.394 5U01CA154602-05 21,643 -

Cancer Detection and Diagnosis Research Physical Sciences, Inc. 93.394 1R41CA192446-01 11,363 -

Cancer Detection and Diagnosis Research Robin Medical, Inc. 93.394 1R43CA193134-01 16,307 -

Cancer Detection and Diagnosis Research Sloan Kettering Institute for Cancer Research 93.394 5R01CA182076-02 75,397 -

Cancer Detection and Diagnosis Research University of California at Irvine 93.394 5R01CA142989-06 1,884 -

Cancer Detection and Diagnosis Research University of Texas Health Science Center at San Antonio 93.394 3U01CA086402 108,312 -

Cancer Detection and Diagnosis Research University of Texas Health Science Center at San Antonio 93.394 U01CA086402 28,756 -

Cancer Detection and Diagnosis Research University of Texas Southwestern Medical Center 93.394 5R01CA154475-04 (2,619) -

Cancer Detection and Diagnosis Research Washington University 93.394 1U24CA196171-02 102,348 -

Cancer Detection and Diagnosis Research Washington University 93.394 HHSN261201000061C 31,749 -

Cancer Research Manpower Massachusetts General Hospital 93.398 5R25CA181000-02 5,201 -

Cancer Treatment Research American College of Radiology 93.395 1U24CA180803-02 10,693 -

Cancer Treatment Research Beth Israel Deaconess Medical Center 93.395 5R01CA183605-04 21,107 -

Cancer Treatment Research Boston University 93.395 5R01CA149561-03 33,917 -

Cancer Treatment Research Brandeis University 93.395 2R01CA142746-06A1 76,758 -

Cancer Treatment Research Brigham and Women's Hospital, Inc. 93.395 7U01CA031946-29 (629) -

Cancer Treatment Research Brigham and Women's Hospital, Inc. 93.395 U10CA031946 194,463 -

Cancer Treatment Research Broad Institute, Inc. 93.395 4P01CA163222-04 3,116 -

Cancer Treatment Research Celdara Medical LLC 93.395 1R43CA192540-01 95,639 -

Cancer Treatment Research Children's Hospital of Boston 93.395 5R01CA158467-04 110,847 -

Cancer Treatment Research Children's Hospital of Philadelphia (The) 93.395 1U10CA180886 19,129 -

Cancer Treatment Research Children's Hospital of Philadelphia (The) 93.395 1UG1CA189955 2,696 -

Cancer Treatment Research Children's Hospital of Philadelphia (The) 93.395 U10CA095861 5,869 -

Cancer Treatment Research Collagen Medical, LLC 93.395 1R43CA186433-01 9,176 -

Cancer Treatment Research Cornell University Weill Medical College 93.395 1R35CA197730-01 32,750 -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 5UG1CA189823-02 92,020 -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 1U10CA180867-02 7,759 -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 4P01CA154303-05 53,944 -



Cancer Treatment Research Dana Farber Cancer Institute 93.395 5R01CA135257-08 601 -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 5R01CA140594-08 348,268 -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 5R01CA178264-03 155,551 -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 5U10CA180867-03 (7,621) -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 5UM1CA186709-03 309,973 -

Cancer Treatment Research Dana Farber Cancer Institute 93.395 R01CA150226 2,476 -

Cancer Treatment Research ECOG ACRIN Cancer Research Group 93.395 1U10CA180820-03 40,935 -

Cancer Treatment Research ECOG ACRIN Cancer Research Group 93.395 1UG1CA189828-03 15,757 -



Cancer Treatment Research Johns Hopkins University 93.395 5U01CA137443-05 (10,852) -

Cancer Treatment Research Johns Hopkins University 93.395 5UM1CA137443-07 16,577 -

Cancer Treatment Research Massachusetts General Hospital 93.395 4P01CA069246-19 163,975 -

Cancer Treatment Research Massachusetts General Hospital 93.395 5P01CA069246-19 21,522 -

Cancer Treatment Research Mayo Clinic 93.395 1UG1CA189823-02 220,361 -




Total Subrecipient



71

Cancer Treatment Research New York University School of Medicine 93.395 5R01CA176502-03 173,591 -

Cancer Treatment Research NRG Oncology 93.395 5U10CA180868-02 6,852 -

Cancer Treatment Research Regents of the University of California San Diego 93.395 5P01CA081534-15 4,374 -

Cancer Treatment Research Scripps Research Institute 93.395 5R01CA178315-02 38,887 -

Cancer Treatment Research Swedish Medical Center 93.395 1R01CA184283-02 216,718 -

Cancer Treatment Research Temple University 93.395 4R01CA166144-05 30,686 -

Cancer Treatment Research University of Alabama at Birmingham 93.395 5R21CA173120-02 92,410 -

Cancer Treatment Research University of Massachusetts at Lowell 93.395 R01CA137108 (1,519) -

Cancer Treatment Research Washington State University 93.395 4R01CA164366-05 10,888 -

Cardiovascular Diseases Research Albert Einstein College of Medicine 93.837 1R01HL130861-01 142,630 -

Cardiovascular Diseases Research Beth Israel Deaconess Medical Center 93.837 1R01HL111465-01A1 269,327 -

Cardiovascular Diseases Research Beth Israel Deaconess Medical Center 93.837 1R01HL122547-01A1 21,129 -

Cardiovascular Diseases Research Beth Israel Deaconess Medical Center 93.837 5P01HL076540-10 (6,856) -

Cardiovascular Diseases Research Beth Israel Deaconess Medical Center 93.837 5R01HL109634-04 16,464 -

Cardiovascular Diseases Research Beth Israel Deaconess Medical Center 93.837 5R01HL122547-02 26,634 -

Cardiovascular Diseases Research Beth Israel Deaconess Medical Center 93.837 5T32HL007734-22 47,961 -

Cardiovascular Diseases Research Beth Israel Deaconess Medical Center 93.837 7R01HL122987-03 (6,957) -

Cardiovascular Diseases Research Brigham and Women's Hospital, Inc. 93.837 1U54HL119145-03 164,710 -

Cardiovascular Diseases Research Brigham and Women's Hospital, Inc. 93.837 4U01HL101422-04 10,024


Cardiovascular Diseases Research Brigham and Women's Hospital, Inc. 93.837 5R01HL114805-03 (401) -

Cardiovascular Diseases Research Brigham and Women's Hospital, Inc. 93.837 5R01HL117713-03 1,181 -

Cardiovascular Diseases Research Brigham and Women's Hospital, Inc. 93.837 5U01HL101422 141,488 -

Cardiovascular Diseases Research Brigham and Women's Hospital, Inc. 93.837 5U54HL119145-02 (25,417) -



Cardiovascular Diseases Research Broad Institute, Inc. 93.837 13R01HL092577-0651 2,475 -

Cardiovascular Diseases Research Broad Institute, Inc. 93.837 1R01HL131015-01 12,282 -

Cardiovascular Diseases Research Broad Institute, Inc. 93.837 R01HL107816/2015-MGH-85 14,546 -

Cardiovascular Diseases Research Broad Institute, Inc. 93.837 R01HL13105 1,834 -

Cardiovascular Diseases Research Children's Hospital of Boston 93.837 1R01 HL128694-01 91,075 -

Cardiovascular Diseases Research Children's Hospital of Boston 93.837 1R56HL128154-01A1 136,336 -

Cardiovascular Diseases Research Children's Hospital of Boston 93.837 2UM1HL098147 - 07 219,767 -

Cardiovascular Diseases Research Children's Hospital of Boston 93.837 5U01HL098147-06 232,673 -

Cardiovascular Diseases Research Children's Hospital of Oakland 93.837 5U19HL069757-14 (4) -

Cardiovascular Diseases Research Cleveland Clinic Foundation 93.837 5U34HL123416-02 16,456 -

Cardiovascular Diseases Research Columbia University 93.837 1R01HL127464-01A1 193,091 -

Cardiovascular Diseases Research Columbia University 93.837 1R01HL132412-01 32,326 -

Cardiovascular Diseases Research Columbia University 93.837 5R01HL109711-05 48,812 -

Cardiovascular Diseases Research Cornell University Weill Medical College 93.837 5U34HL115015-02 2,610 -

Cardiovascular Diseases Research Duke University 93.837 4U10HL084904-10 46,019 -

Cardiovascular Diseases Research Duke University 93.837 5U01HL084904 (365) -

Cardiovascular Diseases Research Duke University 93.837 5U10HL084904 14,348 -



Cardiovascular Diseases Research Duke University 93.837 R01HL105448 12,607 -

Cardiovascular Diseases Research Duke University 93.837 U01HL084904-08 41,228 -

Cardiovascular Diseases Research Duke University 93.837 U10HL084904 75,161 -

Cardiovascular Diseases Research Duke University 93.837 U10HL084904-07 8,157 -




Total Subrecipient



72

Cardiovascular Diseases Research Emory University 93.837 4U01HL105561-05 290,596 -

Cardiovascular Diseases Research Emory University 93.837 5R01HL119798-03 28,563 -

Cardiovascular Diseases Research Fred Hutchinson Cancer Research Center 93.837 5U01HL100395-07 39,819 -

Cardiovascular Diseases Research George Washington University 93.837 R01HL101274-05 89,337 -

Cardiovascular Diseases Research Harvard Pilgrim Health Care 93.837 5R01HL096905-05 29,734 -

Cardiovascular Diseases Research Harvard University 93.837 1U19HL129903-02 252,845 -

Cardiovascular Diseases Research Icahn School of Medicine at Mount Sinai 93.837 5R01HL118440-03 16,166 -

Cardiovascular Diseases Research Icahn School of Medicine at Mount Sinai 93.837 5R01HL128056-02 74,875 -

Cardiovascular Diseases Research Icon Clinical Research 93.837 1U01HL117006-01A1 1,235 -

Cardiovascular Diseases Research Johns Hopkins University School of Medicine 93.837 5R01HL112299-03 20,366 -

Cardiovascular Diseases Research Massachusetts General Hospital 93.837 1R01HL107268-05 37,679 -



Cardiovascular Diseases Research Massachusetts General Hospital 93.837 1R01HL128099-01A1 18,741 -


Cardiovascular Diseases Research Massachusetts General Hospital 93.837 4U10HL110337-05 243,249 -








Cardiovascular Diseases Research Massachusetts Institute of Technology 93.837 1-R34-HL125859-01A1 63,613 -

Cardiovascular Diseases Research Michigan State University 93.837 1R01HL130624-01 228,656 -

Cardiovascular Diseases Research MONTREAL HEART INSTITUTE 93.837 1U01HL105561-01 10,272 -

Cardiovascular Diseases Research Mount Sinai School of Medicine 93.837 2U01HL088942-07 936 -

Cardiovascular Diseases Research Mount Sinai School of Medicine 93.837 4U01HL088942-09 300,781 -

Cardiovascular Diseases Research Mt. Sinai Medical 93.837 5U01HL088942-08 8,338 -

Cardiovascular Diseases Research National Marrow Donor Program 93.837 1R01HL085707-01A2 2,107 -

Cardiovascular Diseases Research New England Research Institute, Inc. 93.837 1U01HL105463 15 -

Cardiovascular Diseases Research New England Research Institute, Inc. (NERI) 93.837 5U01HL107407-02 11,749 -

Cardiovascular Diseases Research New England Research Institute, Inc. (NERI) 93.837 U01HL107407 16 -

Cardiovascular Diseases Research New York University School of Medicine 93.837 R01HL119153 4,284 -

Cardiovascular Diseases Research New York University School of Medicine 93.837 U01HL105907 6,687 -

Cardiovascular Diseases Research NIH-NHLBI National Heart, Lung, and Blood Institute 93.837 4U54HL119145-04 (2,483) -

Cardiovascular Diseases Research Northwestern University 93.837 1R01HL122328 10,550 -

Cardiovascular Diseases Research Oregon Health & Science University (OHSU) 93.837 5R01HL118277-04 21,370 -

Cardiovascular Diseases Research PENN STATE UNIVERSITY 93.837 5U10HL098115-06 (10) -

Cardiovascular Diseases Research PENN STATE UNIVERSITY 93.837 5U10HL098115-07 750,792 245,200

Cardiovascular Diseases Research President and Fellows of Harvard College 93.837 1U19HL129903-01 554,588 -

Cardiovascular Diseases Research President and Fellows of Harvard College 93.837 5R01 HL104284-04 49,868 -

Cardiovascular Diseases Research President and Fellows of Harvard College 93.837 5R01HL035464-25 3,649 -






Total Subrecipient



73

Cardiovascular Diseases Research President and Fellows of Harvard College 93.837 7U01HL100408-07 249,796 -

Cardiovascular Diseases Research Regents of the University of California 93.837 4R01HL114918-04 20,989 -



Cardiovascular Diseases Research Regents of the University of Minnesota 93.837 1R01HL131049-01A1 29,423 -

Cardiovascular Diseases Research Riparian Pharmaceuticals, Inc. 93.837 1R41HL118826-01 (19,765) -

Cardiovascular Diseases Research RTI INTERNATIONAL 93.837 5U10HL119991-03 176,150 -

Cardiovascular Diseases Research Spaulding Rehabilitation Hospital 93.837 4R01HL117037-04 27,939 -

Cardiovascular Diseases Research SUNDRY 93.837 5U54HL119145-02 46,524 -

Cardiovascular Diseases Research The Society of Thoracic Surgeons 93.837 R01HL122261 28,358 -

Cardiovascular Diseases Research Trustees of Boston University 93.837 1R01HL127426-01 24,699 -

Cardiovascular Diseases Research Trustees of Boston University 93.837 5R01HL128914-02 519,700 -

Cardiovascular Diseases Research Trustees of Boston University 93.837 5U01AG049505-03 174 -

Cardiovascular Diseases Research Trustees of Dartmouth College 93.837 1R01HL122372-01A1 38,975 -

Cardiovascular Diseases Research Tufts University 93.837 1R01HL130735-01A1 22,145 -

Cardiovascular Diseases Research Tufts University 93.837 5R01HL115189-04 46,319 -

Cardiovascular Diseases Research University of Alabama at Birmingham 93.837 1R01HL126596-01 129,015 -

Cardiovascular Diseases Research University of California at San Diego 93.837 5U01HL126494-03 137,028 -

Cardiovascular Diseases Research University of California at San Francisco 93.837 1R01HL125034-01A1 106,046 -

Cardiovascular Diseases Research University of California at San Francisco 93.837 1R56 HL125034-01 (906) -

Cardiovascular Diseases Research University of Maryland 93.837 5U01HL099997-07 16,810 -

Cardiovascular Diseases Research University of Maryland 93.837 5U01HL105198-10 113,305 -

Cardiovascular Diseases Research University of Maryland at Baltimore 93.837 5U01HL099997-06 17,465 -

Cardiovascular Diseases Research University of Maryland at Baltimore 93.837 5U01HL099997-07 1,541 -

Cardiovascular Diseases Research University of Massachusetts at Amherst 93.837 R01HL122241-02 36,065 -

Cardiovascular Diseases Research University of Michigan 93.837 5R01HL127564-02 448,470 -

Cardiovascular Diseases Research University of Mississippi Medical Center 93.837 5R01HL110068-04 154,801 -

Cardiovascular Diseases Research University of Mississippi Medical Center 93.837 R25HL126145 8,113 -

Cardiovascular Diseases Research University of Pennsylvania 93.837 1U01HL125388-01A1 26,004 -

Cardiovascular Diseases Research University of Pennsylvania 93.837 4U54HL117798-05 132,171 -

Cardiovascular Diseases Research University of Pennsylvania 93.837 5R01HL111883-04 331,610 -

Cardiovascular Diseases Research University of Pennsylvania 93.837 5R01HL118018-03 7,439 -

Cardiovascular Diseases Research University of Pennsylvania 93.837 5U54HL117798-04 42,727 -

Cardiovascular Diseases Research University of Pittsburgh 93.837 4R01HL119246-04 26,684 -

Cardiovascular Diseases Research University of Virginia 93.837 4U01HL117006-04 226,468 -

Cardiovascular Diseases Research University of Virginia 93.837 5U01HL117006-02 159,483 -

Cardiovascular Diseases Research University of Washington 93.837 5R01HL120393-03 82,948 -

Cardiovascular Diseases Research University of Washington 93.837 5R01HL130770-02 139,151 -

Cardiovascular Diseases Research University of Wisconsin - Madison 93.837 5R01HL119946-03 2,797 -

Cardiovascular Diseases Research Vanderbilt University 93.837 5R01HL112746-04 33,173 -

Cardiovascular Diseases Research Vanderbilt University 93.837 5U19HL065962-13 (1) -

Cardiovascular Diseases Research Vanderbilt University 93.837 7 R01 HL102780-04 34,531 -

Cardiovascular Diseases Research Vanderbilt University Medical Center 93.837 5R01HL112746-04 78,059 -

Cardiovascular Diseases Research Wake Forest University Health Sciences 93.837 1R01HL111362 52,475 -

Cardiovascular Diseases Research Wake Forest University Health Sciences 93.837 2R56HL104199-05 34,877 -

Cardiovascular Diseases Research Washington University 93.837 5U34HL123831-02 7,205 -

Cardiovascular Diseases Research Washington University School of Medicine 93.837 5R01HL118305-03 59,686 -

Cardiovascular Diseases Research Weill-Cornell Medical College 93.837 1R01HL128278-01 66,333 -

Cardiovascular Diseases Research Wright State University 93.837 4R01HL056653-17 38,268 -




Total Subrecipient



74

Cardiovascular Diseases Research Yale University 93.837 1R01HL115295-01 4,753 -

Child Health and Human Development Extramural Research Barrett Technology 93.865 R43HD080278 64,062 -

Child Health and Human Development Extramural Research BioSensics 93.865 R44HD080308 142,790 -

Child Health and Human Development Extramural Research Boston College 93.865 5R00HD068506-05 4 -

Child Health and Human Development Extramural Research Boston Medical Center 93.865 5R01HD072069-05 6,143 -

Child Health and Human Development Extramural Research Boston University 93.865 5R01HD064595-05 237 -

Child Health and Human Development Extramural Research Boston University 93.865 5R01HD067270-04 10,898 -

Child Health and Human Development Extramural Research Brandeis University 93.865 7R01HD074581-04 3,845 -

Child Health and Human Development Extramural Research Broad Institute, Inc. 93.865 R01 HD081256 67,761 -

Child Health and Human Development Extramural Research Case Western Reserve University 93.865 5R01HD077220-02 110,681 -

Child Health and Human Development Extramural Research Children's Hospital of Boston 93.865 1U01HD087211-01 54,468 -


Child Health and Human Development Extramural Research Children's Hospital of Boston 93.865 5R01HD076258-02 40,007 -

Child Health and Human Development Extramural Research Children's Hospital of Boston 93.865 5R01HD76258-02 82,614 -


Child Health and Human Development Extramural Research Cornell University Medical Center 93.865 4R01HD069776-05 4,718 -

Child Health and Human Development Extramural Research Duke University 93.865 7U01HD073984-05 217,390 -

Child Health and Human Development Extramural Research Emory University 93.865 5R01HD075655-02 (348) -

Child Health and Human Development Extramural Research Fenway Community Health Center 93.865 U01HD068040 3,047 -

Child Health and Human Development Extramural Research FHI 360 93.865 5R01HD077888-03 324,530 -

Child Health and Human Development Extramural Research Harvard School of Public Health 93.865 5R01HD061265-05 33,346 -

Child Health and Human Development Extramural Research Harvard School of Public Health 93.865 5R01HD080471-02 22,889 -

Child Health and Human Development Extramural Research Health Research, Inc. 93.865 5R01HD061916-05 61,092 -

Child Health and Human Development Extramural Research Johns Hopkins School of Public Health 93.865 R01HD066156 62,897 -

Child Health and Human Development Extramural Research Judge Baker Children's Center 93.865 5R01HD060986-03 (109) -

Child Health and Human Development Extramural Research Massachusetts General Hospital 93.865 5R21HD073553-02 10,058 -

Child Health and Human Development Extramural Research Massachusetts General Hospital 93.865 5U54HD028138-25 185,196 -

Child Health and Human Development Extramural Research Massachusetts General Hospital 93.865 7R01HD060986-05 27,087 -

Child Health and Human Development Extramural Research Miriam Hospital (The) 93.865 5R01HD078515-02 41,841 -

Child Health and Human Development Extramural Research President and Fellows of Harvard College 93.865 1R01HD080471-03 27,010 -

Child Health and Human Development Extramural Research Regents of the University of California 93.865 1R01HD078748-02 168,003 -

Child Health and Human Development Extramural Research Regents of the University of Minnesota 93.865 1R01HD088176-01 5,149 -

Child Health and Human Development Extramural Research Rehabilitation Institute of Chicago 93.865 R24HD050821-06 (5,158) -

Child Health and Human Development Extramural Research Trustees of Boston University 93.865 1R01HD067270-01 78,723 -

Child Health and Human Development Extramural Research Trustees of Boston University 93.865 5R24HD065688 4,987 -

Child Health and Human Development Extramural Research University of Massachusetts at Amherst 93.865 5R01HD078517-03 160,858 -

Child Health and Human Development Extramural Research University of Massachusetts at Boston 93.865 1R01HD083267-01 31,536 -

Child Health and Human Development Extramural Research University of Massachusetts at Worcester 93.865 5R01HD074581-03 5,090 -

Child Health and Human Development Extramural Research University of Michigan 93.865 1R56HD085284-01A1 19,169 -

Child Health and Human Development Extramural Research University of North Carolina, Chapel Hill 93.865 1U01HD073984-01 (99,444) -

Child Health and Human Development Extramural Research University of Wisconsin - Madison 93.865 5P01HD076892-02 430,681 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Albert Einstein College of Medicine of Yeshiva University 93.847 5R01DK102952-03 460,023 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Baylor College of Medicine 93.847 1R01DK104832-01A1 370 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Beth Israel Deaconess Medical Center 93.847 1R01DK098525-01A1 113,204 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Beth Israel Deaconess Medical Center 93.847 1R01DK103902-01A1 13,500 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Beth Israel Deaconess Medical Center 93.847 3U01DK082919-07S1 (4,123) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Beth Israel Deaconess Medical Center 93.847 5R01DK088826-06 40,656 -




Total Subrecipient



75

Diabetes, Digestive, and Kidney Diseases Extramural Research Beth Israel Deaconess Medical Center 93.847 5U01DK082919-07 (20,972) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Beth Israel Deaconess Medical Center 93.847 U01DK082919-08 237,911 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Medical Center 93.847 1R03DK104000-01A1 24,592 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Medical Center 93.847 2P30DK046200-22 21,316 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Medical Center 93.847 5P30DK046200-22 (65) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Medical Center 93.847 5P30DK046200-23 9,048 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Medical Center 93.847 5R01DK088782-06 112,972 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Medical Center 93.847 P30 DK046200-24 22,397 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Boston Obesity Nutrition Research Center @ Boston Medical Center 93.847 5P30DK046200-19 (7,597) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Brigham and Women's Hospital, Inc. 93.847 1R01DK104772-01A1 7,103 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Brigham and Women's Hospital, Inc. 93.847 5R01DK084064-02 58,696 -




Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 1137106 / 5R24DK080261 110,922 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 1R01DK092405-01A1 28,312 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 1R01DK098032-01 9,496 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 1U54DK105566-01 84 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 5R01DK064869-13 10,171 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 5R01DK098032 37,083 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 5U54DK105566-02 192,685 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, Inc. 93.847 U01DK105554 32,051 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Broad Institute, MIT 93.847 5U54DK105566-02 636,387 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Case Western Reserve University 93.847 1DP3DK101074-01 (5,444) 2,255

Diabetes, Digestive, and Kidney Diseases Extramural Research Case Western Reserve University 93.847 1DP3DK104438-01 25,783 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Case Western Reserve University 93.847 3U01DK094157-05 412,554 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Cedar-Sinai Medical Center 93.847 1R21DK105405-02 37,644 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Celdara Medical LLC 93.847 5R44DK103389-03 182,463 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Children's Hospital of Boston 93.847 2P30DK034854-31 223,107 -



Diabetes, Digestive, and Kidney Diseases Extramural Research Children's Hospital of Boston 93.847 5R01DK087992-05 71,054 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Children's Hospital of Boston 93.847 7R24DK099808-03 162,483 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Columbia University 93.847 5U54DK104309-02 44,905 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Columbia University 93.847 7R01DK083352-06 41,675 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Fred Hutchinson Cancer Research Center 93.847 5R24DK099808-02 289 -

Diabetes, Digestive, and Kidney Diseases Extramural Research George Washington University 93.847 2U01DK048489-22 146,838 -

Diabetes, Digestive, and Kidney Diseases Extramural Research George Washington University 93.847 5U01DK048489-21 (4,847) -

Diabetes, Digestive, and Kidney Diseases Extramural Research George Washington University 93.847 5U01DK061230-11 287,602 110,263

Diabetes, Digestive, and Kidney Diseases Extramural Research George Washington University 93.847 5U01DK098246-02 731,317 7,274

Diabetes, Digestive, and Kidney Diseases Extramural Research George Washington University 93.847 5U01DK098246-04 135,082 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Georgia Regents University 93.847 5U24DK076169-10 4,664 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Joslin Diabetes Center 93.847 1U34DK107917-01 16,152 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Joslin Diabetes Center 93.847 1UC4DK101108-01 2,229 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Joslin Diabetes Center 93.847 4-T32DK007260-40 65,145 -




Total Subrecipient



76

Diabetes, Digestive, and Kidney Diseases Extramural Research Joslin Diabetes Center 93.847 5P30DK036836-29 19,703 -

Diabetes, Digestive, and Kidney Diseases Extramural Research LP Information Technology 93.847 1R41DK105612-01 29,277 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Maine Medical Center 93.847 2R24DK092759-05 521,269 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Massachusetts General Hospital 93.847 2P30DK040561-16A1 14,620 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Massachusetts General Hospital 93.847 2P30DK057520-16 32,401 -




Diabetes, Digestive, and Kidney Diseases Extramural Research Massachusetts General Hospital 93.847 5P30DK057521 51 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Massachusetts General Hospital 93.847 5P30DK057521-15 (24,883) -


Diabetes, Digestive, and Kidney Diseases Extramural Research Massachusetts General Hospital 93.847 5R01DK049302-19 65,525 -





Diabetes, Digestive, and Kidney Diseases Extramural Research Medical University of South Carolina 93.847 1U01DK104833-02 26,937 -

Diabetes, Digestive, and Kidney Diseases Extramural Research MONTREAL HEART INSTITUTE 93.847 2U01DK062432-15 220,437 -

Diabetes, Digestive, and Kidney Diseases Extramural Research MONTREAL HEART INSTITUTE 93.847 5R01DK064869-13 292,609 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Mount Sinai School of Medicine 93.847 2R01DK080789-06A1 (6,133) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Northeastern University 93.847 1R01DK109316-01 5,870 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Northwestern University 93.847 1R01DK102815-01A1 76,668 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Northwestern University 93.847 5R21DK100754-02 35,928 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Northwestern University 93.847 7R01DK076116-07 (6,875) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Organ Solutions 93.847 1R41DK100052-01 58,147 -

Diabetes, Digestive, and Kidney Diseases Extramural Research President and Fellows of Harvard College 93.847 1R01DK108200-01A1 42,711 -

Diabetes, Digestive, and Kidney Diseases Extramural Research President and Fellows of Harvard College 93.847 1UC4DK104165-01 601,755 -

Diabetes, Digestive, and Kidney Diseases Extramural Research President and Fellows of Harvard College 93.847 5P01DK056246-15 203,256 -

Diabetes, Digestive, and Kidney Diseases Extramural Research President and Fellows of Harvard College 93.847 5R01DK088718-05 681 -

Diabetes, Digestive, and Kidney Diseases Extramural Research President and Fellows of Harvard College 93.847 5R24DK103074-02 230,014 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Rush University 93.847 1R01DK101350-01 386,626 -

Diabetes, Digestive, and Kidney Diseases Extramural Research San Diego State University 93.847 1R01DK099360-02 186,246 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Trustees of Boston University 93.847 1UC4DK108612-01 246,028 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Trustees of Boston University 93.847 3DP3DK101084-01S1 89,495 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Trustees of Boston University 93.847 5R01DK097657-02 (10,994) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Tufts Medical Center, Inc. 93.847 5R01DK090401-04 (21,763) -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Alabama at Birmingham 93.847 3P30DK079337-08S1 69,867 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Chicago 93.847 5R01DK098435-03 151,317 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Maryland at Baltimore 93.847 2P30DK090868-07 55,429 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Massachusetts at Worcester 93.847 5R01DK095728-03 64,296 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of New Mexico 93.847 5R01DK083424-03 15,558 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of North Carolina, Chapel Hill 93.847 5U01DK092239-05 1,742 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Notre Dame 93.847 4R01DK100237-04 150,846 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Pennsylvania 93.847 5U01DK099919-03S1 177,728 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Pittsburgh 93.847 1R01DK102495-03 111,584 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Southern California 93.847 1U01DK107350-01 70,658 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Washington 93.847 2R01DK088762-06 34,410 -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Washington 93.847 R01DK088762-05 (3,461) -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Washington - Seattle 93.847 2R01DK088762-06 150,031 -




Total Subrecipient



77

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Washington - Seattle 93.847 5R01DK088762-03 (862) -

Diabetes, Digestive, and Kidney Diseases Extramural Research University of Wyoming 93.847 1R15DK092696-01A1 60,789 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Vanderbilt University 93.847 5R01DK103658-02 200,580 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Vanderbilt University Medical Center 93.847 5R01DK096994-03 74,962 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Vanderbilt University Medical Center 93.847 7R01DK081572-06 97,997 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Virginia Commonwealth University 93.847 5R01DK094818-03 57,448 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Virtici LLC 93.847 1R43DK101197-01A1 6,154 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Boston University 93.286 5U54EB015403-04 142,543 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Case Western Reserve University 93.286 4R01EB017219-04 148,191 -

Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 5U01EB20955-02 38,433 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Children's Hospital of Boston 93.286 5R01EB017337-03 678,799 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Cleveland Clinic Foundation 93.286 5R01EB014296-04 (21,703) -

Discovery and Applied Research for Technological Innovations to Improve Human Health Cornell University 93.286 4R01EB017274-04 354,407 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Kitware, Inc 93.286 5R01EB014955-03 18,770 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Lehigh University 93.286 R15EB019704 42,144 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Massachusetts General Hospital 93.286 5R01EB014947-04 38,737 -

Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 5U54EB015408-02 (5,442) -

Discovery and Applied Research for Technological Innovations to Improve Human Health Mayo Clinic Arizona 93.286 1R21EB021148-01A1 52,744 -

Discovery and Applied Research for Technological Innovations to Improve Human Health New York University School of Medicine 93.286 5U01EB018760-02 89,799 -

Discovery and Applied Research for Technological Innovations to Improve Human Health President and Fellows of Harvard College 93.286 5R01EB014703-04 (19,859) -

Discovery and Applied Research for Technological Innovations to Improve Human Health Rensselaer Polytechnic Institute 93.286 5R01EB015478-04 18,850 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Rutgers University 93.286 5R01EB020036-02 135,689 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Stanford University 93.286 5R01EB015776-05 52,513 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Sunnybrook Health Science Center 93.286 7R01EB003268-11 102,557 -

Discovery and Applied Research for Technological Innovations to Improve Human Health Trustees of Boston University 93.286 4R01EB016102-04 281,124 -

Discovery and Applied Research for Technological Innovations to Improve Human Health University of California at San Diego 93.286 5R01EB000790-10 85,387 -

Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 5R01EB012597-04 (9,531) -

Discovery and Applied Research for Technological Innovations to Improve Human Health University of California, San Diego Medical Center 93.286 5R01EB009282-07 168,955 -

Discovery and Applied Research for Technological Innovations to Improve Human Health University of Illinois at Urbana Champaign 93.286 R21EB018001 26,212 -

Discovery and Applied Research for Technological Innovations to Improve Human Health University of Pennsylvania 93.286 5R01EB018464-02 78,883 -

Drug Abuse and Addiction Research Programs Beth Israel Deaconess Medical Center 93.279 5R01DA036298-04 167,469 -

Drug Abuse and Addiction Research Programs Boston Medical Center 93.279 1R01DA031059-01A1 30,073 -

Drug Abuse and Addiction Research Programs Inflexxion 93.279 1R43DA026359-01 754 -

Drug Abuse and Addiction Research Programs McLean Hospital Corporation 93.279 3UG1DA015831-15S1 24,170 -

Drug Abuse and Addiction Research Programs McLean Hospital Corporation 93.279 5R01DA029141-03 33,640 -

Drug Abuse and Addiction Research Programs McLean Hospital Corporation 93.279 5R21DA031925-02 2,967 -

Drug Abuse and Addiction Research Programs Mount Sinai Hospital 93.279 5P01DA008227-24 43,427 -

Drug Abuse and Addiction Research Programs Northeastern University 93.279 4R37DA023142-10 246,875 -

Drug Abuse and Addiction Research Programs President and Fellows of Harvard College 93.279 1R01DA035214-03 38,206 -

Drug Abuse and Addiction Research Programs President and Fellows of Harvard College 93.279 5R01DA034022-02 18,335 -

Drug Abuse and Addiction Research Programs President and Fellows of Harvard College 93.279 P30DA035772 38,866 -

Drug Abuse and Addiction Research Programs Regents of the University of California 93.279 5R01DA031056-03 (1,637) -

Drug Abuse and Addiction Research Programs Regents of the University of California San Diego 93.279 5U24DA041123-02 192,107 -

Drug Abuse and Addiction Research Programs SFC Fluidics LLC 93.279 1R43DA041173-01 52,875 -




Total Subrecipient



78

Drug Abuse and Addiction Research Programs Southern Illinois University2 93.279 4R01DA036032-04 11,595 -

Drug Abuse and Addiction Research Programs Stony Brook University 93.279 5R21DA038467-02 (1,485) -

Drug Abuse and Addiction Research Programs UNIVERSITY OF ARIZONA 93.279 5R01DA034975-02 (58,792) -

Drug Abuse and Addiction Research Programs University of Florida 93.279 5R01DA039044-02 141,472 -

Drug Abuse and Addiction Research Programs University of Hawaii 93.279 5R01DA019912-08 54,655 -

Drug Abuse and Addiction Research Programs University of Massachusetts at Worcester 93.279 5R01DA031081-04 5,603 -

Drug Abuse and Addiction Research Programs University of New Mexico 93.279 5R01 DA016017-14 79,262 -

Drug Abuse and Addiction Research Programs University of New Mexico 93.279 5R01DA031056-06 6,536 -

Drug Abuse and Addiction Research Programs University of Pennsylvania 93.279 4R01DA032776-05 11,352 -

Drug Abuse and Addiction Research Programs University of Pennsylvania 93.279 4R01DA033641-05 152,365 -

Environmental Health Natural Pharmacia International, Inc. 93.113 1R430D020186 (13,257) -

Environmental Health President and Fellows of Harvard College 93.113 1R21ES024236-01 9,565 -







Environmental Health President and Fellows of Harvard College 93.113 5R21ES019982-02 596 -

Environmental Health President and Fellows of Harvard College 93.113 P30ES000002 69,270 -

Environmental Health Regents of the University of California 93.113 5R01ES023316-03 188,835 -

Environmental Health The Curators of the University of Missouri 93.113 5R01ES021394-05 120,191 -

Environmental Health Trustees of Dartmouth College 93.113 4P01ES022832-04 17,179 -

Environmental Health Tufts University 93.113 5R01ES008314-19 31,142 -

Environmental Health University of Illinois at Urbana Champaign 93.113 5P01ES022848-02 161,929 -

Environmental Health University of Michigan 93.113 5R01ES018872-04 9,900 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Advanced MRI Technologies LLC 93.853 4R44NS084788 37,728 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Azevan Pharmaceuticals, Inc. 93.853 1U44NS090616-01A1 272,399 22,409

Extramural Research Programs in the Neurosciences and Neurological Disorders Beth Israel Deaconess Medical Center 93.853 1R21NS091627-01A1 21,521 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Beth Israel Deaconess Medical Center 93.853 5U01NS074425-03 3,073 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Boston University 93.853 5R01NS072023-05 124,787 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Boston University Medical Center 93.853 2R56NS078337-04 13,878 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Boston University Medical Center 93.853 5R01NS078337-03 (8,273) -

Extramural Research Programs in the Neurosciences and Neurological Disorders Brain Plasticity Institute 93.853 2R44NS71780-03A-1 (30,580) -

Extramural Research Programs in the Neurosciences and Neurological Disorders Brigham and Women's Hospital - Internal Funds 93.853 1R01NS085002-01A1 (1,602) -

Extramural Research Programs in the Neurosciences and Neurological Disorders Brigham and Women's Hospital, Inc. 93.853 5U54NS079201-04 1,070,747 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Broad Institute, Inc. 93.853 5400000084/R24NS092983 69,385 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Broad Institute, Inc. 93.853 U01NS082079 2,493 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Brown University 93.853 5R01NS079533-05 37,032 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Case Western Reserve University 93.853 1U01NS082329-01A1 29,144 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Case Western Reserve University 93.853 5U01NS082329-04 1,738,603 154,933

Extramural Research Programs in the Neurosciences and Neurological Disorders Cedars-Sinai Research Institute 93.853 5U01NS088312-03 1,517,765 25,010

Extramural Research Programs in the Neurosciences and Neurological Disorders Children's Hospital 93.853 5R01NS066929-05 1,330 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Children's Hospital of Boston 93.853 5R01NS066929-05 4,976 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Columbia University 93.853 5P50NS049060-09 (22,664) -

Extramural Research Programs in the Neurosciences and Neurological Disorders Convergence Medical Devices, Inc. 93.853 2R44NS070385 15,287 -




Total Subrecipient



79

Extramural Research Programs in the Neurosciences and Neurological Disorders Cornell University Weill Medical College 93.853 1UH3NS095554-01 70,517 -

Extramural Research Programs in the Neurosciences and Neurological Disorders CorticoMetrics, LLC 93.853 1R44NS089090-01A1 106,410 -

Extramural Research Programs in the Neurosciences and Neurological Disorders CorticoMetrics, LLC 93.853 2R44NS083101-02A1 174,928 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Electrical Geodesics, Inc. 93.853 2R44NS071988-03A1 208,364 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Emory University 93.853 5 U01 NS038455-13S1 8,986 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Emory University 93.853 5U01NS038455-14 763,501 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Highland Instruments 93.853 1R44NS080632-01 224,890 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Icahn School of Medicine at Mount Sinai 93.853 4R01NS081282-04 32,914 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Icahn School of Medicine at Mount Sinai 93.853 5R01NS088160-02 47,682 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Indiana University 93.853 1R21NS095139-01 188,507 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Indiana University 93.853 5R01NS078173-04 162,310 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Iron Horse Diagnostics, Inc. 93.853 5R42NS083227-03 32,312 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Massachusetts General Hospital 93.853 4U10NS077360-06 43,883 -



Extramural Research Programs in the Neurosciences and Neurological Disorders Massachusetts General Hospital 93.853 5R01NS062092-05 (2,491) -


Extramural Research Programs in the Neurosciences and Neurological Disorders Massachusetts General Hospital 93.853 U01NS062835 24,105 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Massachusetts Institute of Technology 93.853 5R01NS078839-05 143,210 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Mayo Clinic Jacksonville 93.853 5U01NS080168-03 1,698 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Mount Sinai School of Medicine 93.853 5U01NS086625-03 273,808 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Northwestern University 93.853 5R21NS084210-02 46,200 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Northwestern University 93.853 5U01NS080818-03 70,181 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Ohio State University 93.853 5R01NS043246-10 5,370 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Ohio State University 93.853 5U01NS079163 45,817 3,309

Extramural Research Programs in the Neurosciences and Neurological Disorders POSIT SCIENCE CORPORATION 93.853 6R44NS071780-05 186,811 -

Extramural Research Programs in the Neurosciences and Neurological Disorders President and Fellows of Harvard College 93.853 1R01NS089619-01A1 151,887 -

Extramural Research Programs in the Neurosciences and Neurological Disorders President and Fellows of Harvard College 93.853 5R01NS045893-10 67,448 -

Extramural Research Programs in the Neurosciences and Neurological Disorders President and Fellows of Harvard College 93.853 5R01NS073124-06 (1,404) -

Extramural Research Programs in the Neurosciences and Neurological Disorders President and Fellows of Harvard College 93.853 5R01NS086882-03 48,046 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Regents of the University of California 93.853 5R01NS071463-05 9,327 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Regents of the University of California 93.853 5R01NS081180-03 171,952 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Regents of the University of California 93.853 5U01NS086090-03 269,663 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Regents of the University of Michigan 93.853 1U01NS088034 5 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Regents of the University of Michigan 93.853 5-U01NS056975-10 26,189 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Regents of the University of Michigan 93.853 U01NS062091 5,329 -



Extramural Research Programs in the Neurosciences and Neurological Disorders Regents of the University of Minnesota 93.853 5R01NS080816-02 37,567 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Rush University Medical Center 93.853 5R01NS084965-03 235,155 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Rutgers University 93.853 R01NS038384-05 5,268 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Skuplt Inc 93.853 2R44NS070385 77,353 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Tristan Technologies Inc. 93.853 4R44NS090894-02 61,480 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Trustees of Boston University 93.853 1U01NS093334-01 300,791 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Trustees of Boston University 93.853 2R01NS017950-33 5,335 -






Total Subrecipient



80

Extramural Research Programs in the Neurosciences and Neurological Disorders Trustees of Boston University 93.853 5U01NS086659-03 203,766 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Trustees of Indiana University 93.853 1R21NS087379-01A1 (81) -

Extramural Research Programs in the Neurosciences and Neurological Disorders Tufts University 93.853 1R01NS092847-01 251,607 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of California at San Francisco 93.853 3U54NS092089-02 10,823 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of California at San Francisco 93.853 4U01NS086090-04 169,122 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Cincinnati 93.853 5U01NS069763-05 209,687 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Maryland at Baltimore 93.853 5U01NS069208-03 30,400 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Maryland at Baltimore 93.853 5U01NS069208-04 15,114 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Massachusetts at Worcester 93.853 1R01NS091552-01A1 65,105 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Massachusetts at Worcester 93.853 5R01NS038194-15 (109) -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Massachusetts at Worcester 93.853 5R01NS079836-03 49,329 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Massachusetts at Worcester 93.853 5U01NS064096-04 (6,171) -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Massachusetts Medical School 93.853 1R01NS098747-01 30,610 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Medicine and Dentistry of New Jersey 93.853 5R01NS038384-05 557 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Minnesota 93.853 5U01NS062091-04 1,552 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Pennsylvania 93.853 5R24NS092986-02 136,096 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Pennsylvania 93.853 5U01NS069545-02 (134,284) -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Pittsburgh 93.853 1R01NS096755-01 11,449 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Pittsburgh 93.853 1U01NS081041-01A1 1,340 -

Extramural Research Programs in the Neurosciences and Neurological Disorders University of Southern California 93.853 5R21NS087194-02 96,555 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Vanderbilt University 93.853 2R01NS049251-08 243,089 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Virginia Commonwealth University 93.853 5R01NS070715-08 73,037 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Wake Forest University 93.853 5R01NS058949-06 46,793 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Wake Forest University 93.853 R01NS058949 179,306 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Wake Forest University Health Sciences 93.853 R01NS058949 14,318 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Washington University 93.853 1U01NS084970-02 20,785 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Yale University 93.853 1U01NS084495-04 1,229,543 219,632

Family Smoking Prevention and Tobacco Control Act Regulatory Research Pennsylvania State University 93.077 5P50DA036107-03 478,526 -

Human Genome Research Brigham and Women's Hospital, Inc. 93.172 1U01HG008685-02 362,002 -

Human Genome Research Broad Institute, Inc. 93.172 1UM1HG008895-01 5,157 -

Human Genome Research Broad Institute, Inc. 93.172 1UM1HG008900-01 34,187 -

Human Genome Research Broad Institute, Inc. 93.172 2RM1HG006193 29,683 -

Human Genome Research Broad Institute, Inc. 93.172 5400000014 8,942 -

Human Genome Research Broad Institute, Inc. 93.172 5P50HG006193-05 250,970 -

Human Genome Research Broad Institute, Inc. 93.172 5R01HG008131-02 37,393 -

Human Genome Research Broad Institute, Inc. 93.172 5U54HG006991-04 144,040 -

Human Genome Research Broad Institute, Inc. 93.172 U01HG006569 2,494 -

Human Genome Research Broad Institute, Inc. 93.172 U54HG006991 43,211 -

Human Genome Research Broad Institute, Inc. 93.172 UM1HG008895 16,780 -

Human Genome Research Broad Institute, Inc. 93.172 UM1HG008900 59,377 -

Human Genome Research Case Western Reserve University 93.172 5R01HG005691-03 13,951 -

Human Genome Research Dana Farber Cancer Institute 93.172 3U01HG006492·04S2 14,190 -

Human Genome Research Dana Farber Cancer Institute 93.172 5P50HG004233-07 (8,843) -

Human Genome Research Dana Farber Cancer Institute 93.172 5P50HG004233-08 102,171 -

Human Genome Research Dana Farber Cancer Institute 93.172 5U01HG006492-04 44,860 -

Human Genome Research Fred Hutchinson Cancer Research Center 93.172 5U41HG004059-10 (2,420) -




Total Subrecipient



81

Human Genome Research Griffin Laboratories 93.172 5R42DC011212-03 96,408 -

Human Genome Research Jackson Laboratories 93.172 5U41GH007497-03 15,606 -

Human Genome Research Massachusetts Institute of Technology 93.172 1R01HG008363-02 301,242 -

Human Genome Research Mount Sinai School of Medicine 93.172 3U01HG007033-03S1 102,548 -

Human Genome Research Mount Sinai School of Medicine 93.172 7U01HG007033-03 (16,158) -

Human Genome Research President and Fellows of Harvard College 93.172 1U01HG009088-01 85,709 -

Human Genome Research President and Fellows of Harvard College 93.172 1U54HG007963-01 784,144 -

Human Genome Research President and Fellows of Harvard College 93.172 5P50HG005550-05 (380) -

Human Genome Research Regents of the University of California 93.172 4R01HG007063-04 48,363 -

Human Genome Research Roswell Park Cancer Institute 93.172 7U41HG00405910-11 86,310 -

Human Genome Research Roswell Park Cancer Institute 93.172 2U41HG00405912 11,006 -

Human Genome Research Stanford University 93.172 5P01HG000205-27 111,348 -

International Research and Research Training American University of Beirut 93.989 1D43TW009118-01A1 10,157 -

International Research and Research Training Vanderbilt University 93.989 5R25TW009337-04 94,230 4,967

Lung Diseases Research Baystate Medical Center 93.838 5U01HL122989-03 43,154 -

Lung Diseases Research Baystate Medical Center 93.838 5U01HL123009-03 3,402 -

Lung Diseases Research Beth Israel Deaconess Medical Center 93.838 5R01HL111430-03 (62,242) -

Lung Diseases Research Beth Israel Deaconess Medical Center 93.838 5U01HL123009-02 40,646 -

Lung Diseases Research Beth Israel Deaconess Medical Center 93.838 5U01HL123022-03 34,484 -

Lung Diseases Research Boston University Medical Center 93.838 5R01HL108678-04 (6,332) -

Lung Diseases Research Boston University Medical Center 93.838 5R01HL111574-05 44,860 -

Lung Diseases Research Brigham and Women's Hospital, Inc. 93.838 5P01HL108801-04 184,169 -

Lung Diseases Research Columbia University 93.838 5R01HL086936-07 39,936 -

Lung Diseases Research Cornell University 93.838 4P01HL114501-04 803,403 -

Lung Diseases Research Cornell University 93.838 4P01HL114501-05 174,413 -

Lung Diseases Research Cornell University Weill Medical College 93.838 4P01HL114501-04 857,466 -

Lung Diseases Research Cornell University Weill Medical College 93.838 7R01HL060234-13 (3,147) -

Lung Diseases Research Dana Farber Cancer Institute 93.838 5R01HL111759-03 214,849 -

Lung Diseases Research Duke University 93.838 5U10HL080413-05 677 -

Lung Diseases Research Johns Hopkins University 93.838 5U01HL121812-03 5,479 -

Lung Diseases Research Mayo Clinic 93.838 2R01HL092961-05A1 133,153 -

Lung Diseases Research Mayo Clinic 93.838 5U01HL108712-03 30,878 -

Lung Diseases Research National Jewish Health 93.838 5R01HL089897-08 91,436 -

Lung Diseases Research Pennsylvania State University 93.838 4U10HL109086-06 95,403 -

Lung Diseases Research President and Fellows of Harvard College 93.838 4R01HL114769-04 92,949 -

Lung Diseases Research President and Fellows of Harvard College 93.838 5P01HL120839-03 506,442 -

Lung Diseases Research President and Fellows of Harvard College 93.838 5R01HL060710-13 92,133 -

Lung Diseases Research Regents of the University of California 93.838 5U01HL108713-02 80,538 -

Lung Diseases Research Rensselaer Polytechnic Institute 93.838 5R01HL119248-03 79,199 -

Lung Diseases Research Trustees of Boston University 93.838 4R01HL116163-04 238,481 -

Lung Diseases Research Trustees of Boston University 93.838 R01HL098437-04 10,516 -

Lung Diseases Research University of Alabama 93.838 5R01HL116213-04 141,676 -

Lung Diseases Research University of Alabama at Birmingham 93.838 5R01HL119960-04 1,621 -

Lung Diseases Research University of California at San Francisco 93.838 5U01HL108713-03 83,044 -

Lung Diseases Research University of Michigan 93.838 5R01HL118017-03 6,394 -

Lung Diseases Research University of Mississippi Medical Center 93.838 5R01HL110068-04 57,925 -

Lung Diseases Research University of Pittsburgh 93.838 5R01HL124021-04 20,702 -

Lung Diseases Research University of Rochester 93.838 1R01HL120908 39,117 -

Mental Health Research Grants Beth Israel Deaconess Medical Center 93.242 1R01MH107579-01 140,867 -






Total Subrecipient



82


Mental Health Research Grants Beth Israel Deaconess Medical Center 93.242 5U01MH081928-07 181,468 -

Mental Health Research Grants Boston University School of Medicine 93.242 2R21MH106796-02 39,373 -

Mental Health Research Grants Brigham and Women's Hospital, Inc. 93.242 1R01MH101244-02 133,091 -

Mental Health Research Grants Brigham and Women's Hospital, Inc. 93.242 1U01MH109977-01 10,239 -




Mental Health Research Grants Brigham and Women's Hospital, Inc. 93.242 5R01MH091448-05 (26) -

Mental Health Research Grants Broad Institute, Inc. 93.242 1R01MH094469-01 19,531 -




Mental Health Research Grants Broad Institute, Inc. 93.242 5U01MH100229-03 120,053 -

Mental Health Research Grants Broad Institute, Inc. 93.242 5U01MH105669-02 55,570 -

Mental Health Research Grants Broad Institute, Inc. 93.242 R01MH105500-01 23,080 -

Mental Health Research Grants Brown University 93.242 5R01MH106174-03 114,081 -

Mental Health Research Grants Brown University 93.242 5R34MH097820-03 45,514 -

Mental Health Research Grants Butler Hospital 93.242 5P50MH086400-05 (357) -

Mental Health Research Grants Butler Hospital 93.242 5U01MH076179-05 (2,461) -

Mental Health Research Grants Children's Hospital of Boston 93.242 5R01MH078829-19 70,257 -



Mental Health Research Grants Children's Memorial Hospital (Illinois) 93.242 5R01MH094323-05 (99) -

Mental Health Research Grants Cogito Corporation 93.242 1R44MH107065-01 202,421 -

Mental Health Research Grants Cogito Corporation 93.242 2R44MH100748-02 486,991 -

Mental Health Research Grants Columbia University 93.242 1R01 MH099322-01A1 (8,661) -

Mental Health Research Grants Columbia University 93.242 1R01MH101269-01A1 (5,089) -

Mental Health Research Grants Columbia University 93.242 1R21MH102570 - 01A1 (47,389) -

Mental Health Research Grants Columbia University 93.242 5U01MH105670-03 17,293 -

Mental Health Research Grants ExQor Technologies Inc 93.242 1R43MH108481-01 12,809 -

Mental Health Research Grants Fenway Community Health Center 93.242 5R34MH095584 (4,813) -

Mental Health Research Grants Fenway Community Health Center 93.242 5UM1AI069412-08 (272) -

Mental Health Research Grants FHC 93.242 1R43MH107037-01A1 81,736 -

Mental Health Research Grants Florida International University 93.242 5R21MH103054-02 16,696 -

Mental Health Research Grants Harvard School of Public Health 93.242 5R01MH087344-05 2,443 -

Mental Health Research Grants Henry M Jackson Foundation 93.242 5U01MH087981 (1,566) -

Mental Health Research Grants Johns Hopkins University 93.242 5R01MH104553-02 70,387 -

Mental Health Research Grants King's College London 93.242 5R01MH100470-03 21,550 -

Mental Health Research Grants Massachusetts General Hospital 93.242 223505 (2,992) -

Mental Health Research Grants Massachusetts General Hospital 93.242 4R01MH097964-05 74,896 -










Total Subrecipient



83

Mental Health Research Grants Massachusetts Institute of Technology 93.242 1R01MN091115-04 45,008 -

Mental Health Research Grants Massachusetts Institute of Technology 93.242 1U01MH108168-01 359,731 -

Mental Health Research Grants Massachusetts Institute of Technology 93.242 5U01MH108168-02 72,101 -

Mental Health Research Grants McLean Hospital Corporation 93.242 1R01MH104560-02 188,495 -

Mental Health Research Grants McLean Hospital Corporation 93.242 2R37MH068376-12A1 50,087 -



Mental Health Research Grants McLean Hospital Corporation 93.242 5R01MH068376-11 (1,441) -

Mental Health Research Grants McLean Hospital Corporation 93.242 5R21MH096107-02 988 -

Mental Health Research Grants Mount Sinai School of Medicine 93.242 5P50MH096890-05 126,075 -

Mental Health Research Grants President and Fellows of Harvard College 93.242 1DP2MH103909-01 (5,925) -

Mental Health Research Grants President and Fellows of Harvard College 93.242 3P50MH106933-02S1 247,211 80,195

Mental Health Research Grants President and Fellows of Harvard College 93.242 5P50MH106933-02 40,130 -

Mental Health Research Grants President and Fellows of Harvard College 93.242 5P50MH106933-03 1,905,991 -

Mental Health Research Grants President and Fellows of Harvard College 93.242 5R01MH100216-03 346,565 -



Mental Health Research Grants Regents of the University of California 93.242 5R24MH106096-03 130,394 -

Mental Health Research Grants Regents of the University of California 93.242 R01MH096767 (13,992) -

Mental Health Research Grants Research Foundation for Mental Hygiene, Inc. 93.242 5R01MH099322-04 61,655 -

Mental Health Research Grants San Diego State University 93.242 1R21MH103603-01 (162) -

Mental Health Research Grants SUNY Upstate Medical University 93.242 5R01MH064824-13 29,102 -

Mental Health Research Grants Superconducting Systems, Inc. 93.242 6R44MH097272-04 4,466 -

Mental Health Research Grants Torrey Pines Institute for Molecular Studies 93.242 1R01MH085607-01A2 (46,930) -

Mental Health Research Grants University of California at Davis 93.242 1R01MH100030-02 30,174 -

Mental Health Research Grants University of California at Los Angeles 93.242 1R34MH104072-01 (68) -

Mental Health Research Grants University of California at San Diego 93.242 1R01MH106595-01A1 41,631 -

Mental Health Research Grants University of Chicago 93.242 5R01MH100155-03 112,820 17,768

Mental Health Research Grants University of Florida 93.242 7R01MH085607-05 140,173 -

Mental Health Research Grants University of Florida 93.242 R01 MH096767 63,750 -

Mental Health Research Grants University of Illinois at Chicago 93.242 4R01MH099993-04 184,717 -

Mental Health Research Grants University of Miami 93.242 1R01MH103770-01A1 64,719 -

Mental Health Research Grants University of Miami 93.242 1R01MH110441-01 90,362 -

Mental Health Research Grants University of Minnesota 93.242 5R24MH105998-03 31,365 -

Mental Health Research Grants University of Pittsburgh 93.242 1R01MH093246-02 18,902 -

Mental Health Research Grants University of Pittsburgh 93.242 5R01MH107797-02 82,352 -

Mental Health Research Grants University of Rochester 93.242 1P50MH086400-05 881 -

Mental Health Research Grants University of Rochester 93.242 2R01MH045573-26 190,590 -

Mental Health Research Grants University of Rochester 93.242 5P50MH106435-02 42,844 -

Mental Health Research Grants University of Rochester 93.242 R01MH107371 20,969 -

Mental Health Research Grants University of Texas at Austin 93.242 5R01MH104562-03 100,524 -

Mental Health Research Grants University of Texas Southwestern Medical Center 93.242 5U01MH092221-04 137,235 -

Mental Health Research Grants University of Texas Southwestern Medical Center 93.242 N01MH090003 (3,111) -

Mental Health Research Grants University of Texas Southwestern Medical Center 93.242 U01MH092221-04 101,158 -

Mental Health Research Grants University of Washington 93.242 5R01MH095507-04 32,863 -

Mental Health Research Grants University of Wisconsin - Madison 93.242 5R01MH097464-03 50,113 -

Mental Health Research Grants Yale University 93.242 5R01MH105203-03 424,104 -




Total Subrecipient



84

Minority Health and Health Disparities Research Dana Farber Cancer Institute 93.307 5P60MD006900-04 12,283 -

Minority Health and Health Disparities Research Environment and Health Group, Inc. 93.307 R43MD009454-02 15,860 -

Minority Health and Health Disparities Research Fenway Community Health Center 93.307 5R24MD008073-03 (544) -

National Center for Advancing Translational Sciences EXCMR 93.350 9R24TR000473-02 9,304 -

National Center for Advancing Translational Sciences Harvard Catalyst - The Harvard Clinical and Translational Science Center 93.350 3UL1TR001086-02S2 85,968 -

National Center for Advancing Translational Sciences Harvard Medical School 93.350 4UH3TR000504-03 29,438 -

National Center for Advancing Translational Sciences Harvard Medical School 93.350 5UL1TR001102-03 68,474 -

National Center for Advancing Translational Sciences President and Fellows of Harvard College 93.350 1UL1TR001102-01 (10,071) -

National Center for Advancing Translational Sciences President and Fellows of Harvard College 93.350 4UL1TR001102-04 8,046,917 -

National Center for Advancing Translational Sciences President and Fellows of Harvard College 93.350 5UL1TR001102-02 66,819 -



National Center for Advancing Translational Sciences President and Fellows of Harvard College 93.350 5UL1TR001102-04 REVISED 4,242,215 -

National Center for Advancing Translational Sciences University of Pittsburgh 93.350 3UL1TR000005-09S1 (10,768) -

National Center for Advancing Translational Sciences University of Pittsburgh 93.350 4UH3TR000503-03 (1,182) -

National Center for Advancing Translational Sciences University of Pittsburgh 93.350 5UL1TR000005-10 2,500 -

National Center for Research Resources Brigham and Women's Hospital, Inc. 93.389 2P41RR019703-10 (669) -

National Center on Sleep Disorders Research Beth Israel Deaconess Medical Center 93.233 5P01HL095491-07 422,975 -

National Center on Sleep Disorders Research Beth Israel Deaconess Medical Center 93.233 5R01HL110350-04 59,983 -

National Center on Sleep Disorders Research University of Pittsburgh 93.233 5R01HL110350-05/01028485 122,607 -

NIEHS Superfund Hazardous Substances Basic Research and Education Trustees of Boston University 93.143 5P42ES007381-20 72,194 -

Nursing Research Boston College 93.361 1R15NR013274-02 (1,713) -

Nursing Research Penn State University College of Medicine 93.361 5R01NR012757-03 106,911 -

Nursing Research President and Fellows of Harvard College 93.361 5R01NR013945-03 28,430 -

Nursing Research Regents of the University of California 93.361 1R01NR015591-02 45,305 -

Nursing Research University of Pittsburgh 93.361 1R01NR014831-01A1 21,822 -

Oral Diseases and Disorders Research Brigham and Women's Hospital, Inc. 93.121 5U01DE024443-02 213,538 -

Oral Diseases and Disorders Research Broad Institute, Inc. 93.121 R01DE022087 7,292 -

Oral Diseases and Disorders Research Carolinas HealthCare System 93.121 5R01DE023375-02 20,390 -

Oral Diseases and Disorders Research Carolinas HealthCare System 93.121 5U01DE022939-05 408,076 -

Oral Diseases and Disorders Research Forsyth Institute, The 93.121 1R01DE025020-01 68,038 -

Oral Diseases and Disorders Research Forsyth Institute, The 93.121 5R01DE024468-03 166,015 -

Oral Diseases and Disorders Research Massachusetts Institute of Technology 93.121 5R01DE013023-15 (3,543) -

Oral Diseases and Disorders Research President and Fellows of Harvard College 93.121 5R01DE013349-16 107,072 -

Oral Diseases and Disorders Research Stanford University 93.121 1R01DE024971-01A1 65,803 -

Oral Diseases and Disorders Research Stanford University 93.121 5R01DE021468-05 21,163 -

Oral Diseases and Disorders Research University of North Carolina, Chapel Hill 93.121 5U01DE017018-11 161,088 -

Research and Training in Complementary and Integrative Health Beth Israel Deaconess Medical Center 93.213 5R01AT005436-05 (224) -

Research and Training in Complementary and Integrative Health Beth Israel Deaconess Medical Center 93.213 5R01AT006358-05 34,113 -

Research and Training in Complementary and Integrative Health Boston University 93.213 5R01AT007257-04 70,624 -

Research and Training in Complementary and Integrative Health Boston University 93.213 5R01AT007483-03 (3,916) -

Research and Training in Complementary and Integrative Health Brown University 93.213 1UH2AT009145-01 32,289 -

Research and Training in Complementary and Integrative Health Emory University 93.213 5UG3AT008857-02 447,006 3,286

Research and Training in Complementary and Integrative Health Highland Instruments 93.213 5R44AT008637-02 95,834 -

Research and Training in Complementary and Integrative Health Massachusetts General Hospital 93.213 5P01AT006663-05 76,969 -

Research and Training in Complementary and Integrative Health Massachusetts General Hospital 93.213 5R01AT005280-05 4,955 -

Research and Training in Complementary and Integrative Health Massachusetts General Hospital 93.213 5R01AT006464-05 (8) -

Research and Training in Complementary and Integrative Health Massachusetts General Hospital 93.213 5U01AT000613-07 13,249 -

Research and Training in Complementary and Integrative Health Miriam Hospital (The) 93.213 5R34 AT007569-04 15,482 -




Total Subrecipient



85

Research and Training in Complementary and Integrative Health University of Michigan 93.213 5R01AT007550-02 135,209 -

Research and Training in Complementary and Integrative Health University of Texas Health Science Center at San Antonio 93.213 5R01AT008422-03 19,635 -

Research and Training in Complementary and Integrative Health Wake Forest University 93.213 5P50AT002782-10 237,147 -

Research and Training in Complementary and Integrative Health Wake Forest University Health Sciences 93.213 P50 AT002782 156 -

Research Related to Deafness and Communication Disorders Arizona State University 93.173 14-362 29,974 -

Research Related to Deafness and Communication Disorders Boston University 93.173 4P50DC013027-05 176,079 -

Research Related to Deafness and Communication Disorders Duke University 93.173 1U24DC012206-01A1 4,060 -

Research Related to Deafness and Communication Disorders Icahn School of Medicine at Mount Sinai 93.173 5R01DC011805-05 121,919 -

Research Related to Deafness and Communication Disorders Mass Eye and Ear Institute 93.173 1R01DC014924-01 52,517 -

Research Related to Deafness and Communication Disorders Mass Eye and Ear Institute 93.173 5R01DC000194-32 65,828 -

Research Related to Deafness and Communication Disorders Massachusetts Eye and Ear Infirmary 93.173 1R21DC014909-01A1 18,685 -

Research Related to Deafness and Communication Disorders Massachusetts Institute of Technology 93.173 1R01DC011339-01A1 46,591 -

Research Related to Deafness and Communication Disorders MGH Institute of Health Professions 93.173 1R01DC013547-03 15,663 -

Research Related to Deafness and Communication Disorders Northwestern University 93.173 4P50DC012283-04 191,723 -

Research Related to Deafness and Communication Disorders PENN STATE UNIVERSITY 93.173 2R01DC005642-10A1 8,237 -

Research Related to Deafness and Communication Disorders Stanford University 93.173 5R01DC014034-02 146,350 29,876

Research Related to Deafness and Communication Disorders Trustees of Boston University 93.173 1R01DC015570-01 3,787 -

Research Related to Deafness and Communication Disorders Trustees of Boston University 93.173 5R01DC002852-20 25,486 -

Trans-NIH Recovery Act Research Support Broad Institute, Inc. 93.701 5U54DK102557-03 17,958 -

Trans-NIH Recovery Act Research Support California Institute of Technology 93.701 21B-1096343 775,141 -

Trans-NIH Recovery Act Research Support Johns Hopkins University 93.701 5U01CA137443-05 2,001 -

Trans-NIH Research Support Beth Israel Deaconess Medical Center 93.310 4UH2TR000901-03 57,714 -

Trans-NIH Research Support Beth Israel Deaconess Medical Center 93.310 4UH3TR000901-03 158,589 -

Trans-NIH Research Support Brigham and Women's Hospital, Inc. 93.310 5U01HG007690-02 2,944 -

Trans-NIH Research Support Brigham and Women's Hospital, Inc. 93.310 5U01HG007690-03 293,013 -

Trans-NIH Research Support Broad Institute, Inc. 93.310 2016-MGH-2 50,007 -

Trans-NIH Research Support Broad Institute, Inc. 93.310 3R01MH101820-02S1 33,588 -

Trans-NIH Research Support Broad Institute, Inc. 93.310 3U54DK102557-03 135,616 -

Trans-NIH Research Support Broad Institute, Inc. 93.310 R01DK092405 (1,564) -

Trans-NIH Research Support Broad Institute, Inc. 93.310 U01HG007610 12,464 -

Trans-NIH Research Support Dana Farber Cancer Institute 93.310 3R01HL111759-02S1 21,638 -

Trans-NIH Research Support Massachusetts Institute of Technology 93.310 5R01GM104948-05 330,731 -

Trans-NIH Research Support New York University School of Medicine 93.310 1R25EB020389-01A1 17,924 -

Trans-NIH Research Support President and Fellows of Harvard College 93.310 5DP1EB016985-03 (3,580) -

Trans-NIH Research Support President and Fellows of Harvard College 93.310 R25GM114818-02 12,384 -

Trans-NIH Research Support Regents of the University of California 93.310 5UH2TR000931-02 (22,055) -

Trans-NIH Research Support University of Massachusetts Medical School 93.310 5UH3TR000888-04 320,471 -

Trans-NIH Research Support University of Southern California 93.310 5UH3TR000967-03 45,101 -

Vision Research Children's Hospital of Boston 93.867 1R01EY025794-01A1 31,392 -

Vision Research Massachusetts Eye and Ear Infirmary 93.867 5R01EY015473-12 205,341 -

Vision Research Massachusetts Eye and Ear Infirmary 93.867 5R01EY020928-05 168,100 -

Vision Research Massachusetts Institute of Technology 93.867 5P30EY002621-39 31,648 -

Vision Research Oregon Health & Science University (OHSU) 93.867 5R01EY019474-05 66,766 -

Vision Research Tufts University 93.867 5R01EY021820-02 132,580 -

Vision Research University of Utah 93.867 R01EY022663 2,567 -

Department of Health and Human Services National Institutes of Health 136,218,406 1,106,473




Total Subrecipient



86

Department of Health and Human Services Office of the Secretary

Advancing System Improvements for Key Issues in Women's Health Johns Hopkins University 93.088 6ASTWH150032-01-03 130,456 -

Measuring Interoperability Progress through Individuals’ Access and Use of the Electronic Health Data University of Massachusetts at Worcester 93.857 5U01HL126495-03 51,468 -

Department of Health and Human Services Office of the Secretary 181,924 -

Department of Homeland Security

Assistance to Firefighters Grant Cambridge Health Alliance, PSC 97.044 EMW-2011-FP-00663 520 -

Centers for Homeland Security Northeastern University 97.061 2008-ST-061-ED0001 (191) -

Centers for Homeland Security Northeastern University 97.061 HSHQDC-10-D-00030 (51,294) -

Department of Homeland Security (50,965) -

Environmental Protection Agency Office of Research and Development (ORD)

Science To Achieve Results (STAR) Research Program Trustees of Dartmouth College 66.509 RD-83544201 24,814 -

Science To Achieve Results (STAR) Research Program University of Illinois at Urbana Champaign 66.509 83543401 47,527 -

Environmental Protection Agency Office of Research and Development (ORD) 72,341 -

National Aeronautics and Space Administration

Aeronautics National Space Biomedical Research Institute (NSBRI) 43.002 HFP00006 109,870 -







Aeronautics National Space Biomedical Research Institute (NSBRI) 43.002 NBPF00010 38,148 -



Aeronautics National Space Biomedical Research Institute (NSBRI) 43.002 NCC9-58 86,755 -

Aeronautics National Space Biomedical Research Institute (NSBRI) 43.002 SMST02701 61,132 -

Aeronautics National Space Biomedical Research Institute (NSBRI) 43.002 SMST02801 (141,792) -

Aeronautics National Space Biomedical Research Institute (NSBRI) 43.002 SMST04201 387,448 -

Exploration Thomas Jefferson University 43.003 NNX15AC14G 114,831 -

Exploration University of Pennsylvania 43.003 NNX15AK76A 34,700 -

Science Massachusetts Institute of Technology 43.001 NNX15AF85G 125,491 -

Space Operations CASIS (Center for the Advancement of Science in Space) 43.007 NNH11CD70A 7,936 -

National Aeronautics and Space Administration 1,326,313 -


Biological Sciences Duke University 47.074 0929226 138,360 -

Biological Sciences Duke University 47.074 IOS-929226 (6,158) -

Biological Sciences Lehigh University 47.074 1455613 43,578 -

Computer and Information Science and Engineering Fred Hutchinson Cancer Research Center 47.070 IIS-1247813 (25,285) -

Computer and Information Science and Engineering University of Pennsylvania 47.070 CNS-1035712 120,291 -

Engineering Grants Argosy Omnimedia, Inc. 47.041 1416946 (554) -

Engineering Grants Biosight LLC 47.041 MGH 22815 5,163 -

Engineering Grants Lumicell Diagnostics, Inc. 47.041 1152489 (11,193) -




Total Subrecipient



87

Engineering Grants Lumicell Diagnostics, Inc. 47.041 1152489 (A221225) 24,185 -

Engineering Grants Nanofiber Solutions, LLC 47.041 CBET-1545139 21,711 -

Engineering Grants Remedium Technologies, Inc. 47.041 IIP-1256477 (2) -

Engineering Grants Research Foundation of State University of New York 47.041 CBET-1264440 102,371 -

Engineering Grants Veristride 47.041 NSF-IIP-1331108 22,133 -

Mathematical and Physical Sciences Trustees of Boston University 47.049 DMS-1042134 42,538 -

Office of International Science and Engineering CRDF Global 47.079 OISE-9531011 1,919 -

Social, Behavioral, and Economic Sciences Trustees of Boston University 47.075 SMA-0835976 31,180 -

National Science Foundation 510,237 -

Total Research and Development Pass Through 153,372,028$ 1,984,185$



Training Pass Through

Total Subrecipient



88


National Research Service Awards Health Services Research Training Children's Hospital of Boston 93.225 5T32HS000063-22 41,641$ -$

National Research Service Awards Health Services Research Training Children's Hospital of Boston 93.225 5T32HS000063-23 10,923 -

Research on Healthcare Costs, Quality and Outcomes Children's Hospital of Boston 93.226 1K12HS022986-02 133,073 -



Maternal and Child Health Federal Consolidated Programs President and Fellows of Harvard College 93.110 114946.6001 26,817 -



Aging Research Beth Israel Deaconess Medical Center 93.866 5T32AG23480-10 (2,008) -

Aging Research Harvard Medical School 93.866 5T32AG000222-24 135,453 -

Aging Research President and Fellows of Harvard College 93.866 2T32AG000222-23 7,002 -

Aging Research President and Fellows of Harvard College 93.866 5T32AG000222-24 61,547 -

Aging Research University of North Carolina, Chapel Hill 93.866 5K23AG038548-02 5,939 -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 5K08AI104767-04 5,315 -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 5T32AI007433-21 (466) -

Allergy and Infectious Diseases Research President and Fellows of Harvard College 93.855 5T32AI007433-22 27,380 -




Blood Diseases and Resources Research Children's Hospital of Boston 93.839 4T32HL066987-15 71,758 -

Blood Diseases and Resources Research Children's Hospital of Boston 93.839 5T32HL066987-14 36,147 -

Cancer Research Manpower Dana Farber Cancer Institute 93.398 5T32CA009361-32 (17,203) (17,203)

Cancer Research Manpower President and Fellows of Harvard College 93.398 5T32CA009001-39 (6,306) -

Cancer Research Manpower President and Fellows of Harvard College 93.398 5T32CA009001-40 53,534 -

Cancer Research Manpower President and Fellows of Harvard College 93.398 5T32MH017119-30 52,124 -

Cancer Research Manpower President and Fellows of Harvard College 93.398 T32CA009001 56,852 -






Training Pass Through

Total Subrecipient



89

Cardiovascular Diseases Research Newark Beth Israel Medical Center 93.837 5K23HL083096-05 283 -

Child Health and Human Development Extramural Research Children's Hospital of Boston 93.865 5K12HD052896-08 (3) -

Child Health and Human Development Extramural Research Children's Hospital of Boston 93.865 5T32HD040128-12 21,420 -

Child Health and Human Development Extramural Research President and Fellows of Harvard College 93.865 2T32HD060454-06A1 20,287 -

Child Health and Human Development Extramural Research University of Pittsburgh 93.865 5K12HD001097-18 1,207 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Beth Israel Medical Center 93.847 5T32DK007199-37 53,148 -

Diabetes, Digestive, and Kidney Diseases Extramural Research Cedar-Sinai Medical Center 93.847 5K23DK085148-05 (1) -

Diabetes, Digestive, and Kidney Diseases Extramural Research Children's Hospital of Boston 93.847 5K23DK102600-02 26,827 -

Drug Abuse and Addiction Research Programs Miriam Hospital (The) 93.279 5T32DA13911-15 24,930 -

Environmental Health President and Fellows of Harvard College 93.113 2T32ES007069-36 31,614 -

Extramural Research Programs in the Neurosciences and Neurological Disorders Massachusetts General Hospital 93.853 K12NS080223 93,052 -

Extramural Research Programs in the Neurosciences and Neurological Disorders President and Fellows of Harvard College 93.853 3T32NS048005-10S1 (24) -

Extramural Research Programs in the Neurosciences and Neurological Disorders President and Fellows of Harvard College 93.853 5T32NS048005-12 13,029 -

International Research and Research Training Instituto de Efectividad Clinica y Sanitaria 93.989 5D43TW009126-04 26,960 -

International Research and Research Training University of California at Berkeley 93.989 5R25TW009338-04 103,581 18,500

International Research and Research Training Vanderbilt University 93.989 5R25TW009337-03 1,121 -

Mental Health Research Grants Harvard Medical School 93.242 5T32MH019733-19 (495) -

Mental Health Research Grants Judge Baker Children's Center 93.242 5T32MH016259-35 36,921 -



Mental Health Research Grants Massachusetts General Hospital 93.242 5K23MH100450-03 48,673 -

Mental Health Research Grants University of South Florida 93.242 1D43MH108169-01A1 12,350 -

National Center for Advancing Translational Sciences President and Fellows of Harvard College 93.350 4KL2TR001100-04 552,942 -



Research and Training in Complementary and Integrative Health Beth Israel Deaconess Medical Center 93.213 2T32AT000051-16 31,731 -

Research and Training in Complementary and Integrative Health Beth Israel Deaconess Medical Center 93.213 5K24AT004095-09 (1,754) -

Research and Training in Complementary and Integrative Health Beth Israel Deaconess Medical Center 93.213 5T32AT000051-17 135,195 -

Research and Training in Complementary and Integrative Health Tufts Medical Center, Inc. 93.213 5K24AT007323-03 27,189 -

Vision Research Schepens Eye Research Institute 93.867 5T32EY007145-17 (1,625) -

Department of Health and Human Services National Institutes of Health 2,387,294 1,297

Total Training Pass Through 2,599,748$ 1,297$

Total Research and Development and Research Training Custer 933,442,315$ 159,993,522$


Student Financial Aid Cluster

Total Subrecipient



90

Department of Education Office of Federal Student Aid

Federal Direct Student Loans 84.268 34,433,116$ -$

Department of Education Office of Federal Student Aid 34,433,116 -


ARRA - Nurse Faculty Loan Program Fiscal Year 2016 Beginning Balance 93.408 23,772 -

Department of Health and Human Services 23,772 -


Nurse Faculty Loan Program (NFLP) 93.264 61,278 -

Nurse Faculty Loan Program (NFLP) Fiscal Year 2016 Beginning Balance 93.264 250,429 -


Total Student Financial Aid Cluster 34,768,595$ -$


Other Programs

Total Subrecipient



91

Department of Agriculture Food and Nutrition Service

Special Supplemental Nutrition Program for Women, Infants, and Children Massachusetts Department of Public Health 10.557 INTF3502M03162726104 205,783$ -$

Special Supplemental Nutrition Program for Women, Infants, and Children Massachusetts Department of Public Health 10.557 INTF3502M03162726128 202,514 -



Special Supplemental Nutrition Program for Women, Infants, and Children-Vouchers Massachusetts Department of Public Health 10.557 4,856,625 -

Total 10.557 6,515,143 -

Department of Agriculture Food and Nutrition 6,515,143 -

Department of Education Office of Special Education and Rehabilitative Services

Special Education-Grants for Infants and Families Massachusetts Department of Public Health 84.181 INTF3601HH2500224167 (215) -

Special Education-Grants for Infants and Families Massachusetts Department of Public Health 84.181 INTF3617HH2500224057 91,500 -

Total 84.181 91,285 -

Department of Education Office of Special Education and Rehabilitative Services 91,285 -


Health Resources and Services Administration (HRSA) Commonwealth Of Massachusetts 93. INTF4942MM3100119020 155,038 -

Centers for Disease Control Massachusetts Department of Public Health 93. INTF3050HH4300422025 9 -

Centers for Disease Control Massachusetts Department of Public Health 93. INTF3122HH4300522044 4,124 -

Total 93. 159,171 -

Department of Health and Human Services 159,171 -


Affordable Care Act (ACA) Childhood Obesity Research Demonstration Massachusetts Department of Public Health 93.535 5U18DP003370-04 120,921 -

Affordable Care Act (ACA) Childhood Obesity Research Demonstration Massachusetts Department of Public Health 93.535 INTF4123H78500224043 929 -

Total 93.535 121,850 -

Birth Defects and Developmental Disabilities - Prevention and Surveillance Massachusetts Department of Public Health 93.073 INTF3122H78500224039 42,631 -

Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human

Immunodeficiency Virus (HIV) Infection in Selected Population Groups Massachusetts Department of Public Health 93.943 INTF5180HH2500224007 53,894 -

Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human

Immunodeficiency Virus (HIV) Infection in Selected Population Groups Massachusetts Department of Public Health 93.943 INTF5180HH2W40199011 976 -

Total 93.943 54,870 -

Partnerships to Improve Community Health Boston Public Health Commission, City of Boston 93.331 1U58DP005788-01 11,357 -

PPHF: Racial and Ethnic Approaches to Community Health Program financed solely by Public Prevention and Health Funds BOSTON PUBLIC HEALTH COMMISSION 93.738 5NU58DP005629-02 13,976 -

Department of Health and Human Services Centers for Disease Control and Prevention 244,684 -


Affordable Care Act (ACA) Maternal, Infant, and Early Childhood Home Visiting Program Massachusetts Department of Public Health 93.505 INTF3617MM3W11712007 319,878 -

Affordable Care Act (ACA) Maternal, Infant, and Early Childhood Home Visiting Program Massachusetts Department of Public Health 93.505 INTF3617MM3W11712010 349,670 -

Total 93.505 669,548 -

Coordinated Services and Access to Research for Women, Infants, Children, and Youth Dimock Community Health Center 93.153 2H12HA24846-04-00 76,811 -

Coordinated Services and Access to Research for Women, Infants, Children, and Youth Dimock Community Health Center 93.153 H12HA24846A0 (10,775) -

Total 93.153 66,036 -


Other Programs

Total Subrecipient



92

HIV Care Formula Grants Franklin Regional Council of Governments 93.917 12,256 -

HIV Care Formula Grants Massachusetts Department of Public Health 93.917 INTF4943MM3200120017 376,115 -

Total 93.917 388,371 -

HIV Emergency Relief Project Grants BOSTON PUBLIC HEALTH COMMISSION 93.914 6H89HA00011-21-06 113,210 -

HIV Emergency Relief Project Grants BOSTON PUBLIC HEALTH COMMISSION 93.914 37,969 -

Total 93.914 151,179 -

Maternal and Child Health Federal Consolidated Programs Commonwealth Of Massachusetts 93.110 INTF3121M04403616016 11,121 -

Maternal and Child Health Federal Consolidated Programs Icahn School of Medicine at Mount Sinai 93.110 5H30MN24048-04 18,523 -

Total 93.110 29,644 -

Department of Health and Human Services Health Resources and Services Administration 1,304,778 -

Department of Health and Human Services Office of Population Affairs

Family Planning Services Action For Boston Community Development 93.217 FPHPA016027-01-00 439,704 -

Department of Health and Human Services Office of Population Affairs 439,704 -

Department of Health and Human Services Office of the Secretary

Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities Massachusetts Department of Public Health 93.817 3,167 -

Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities Massachusetts Department of Public Health 93.817 INTF6207PP1W16005708 273,199 -

Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities Massachusetts Department of Public Health 93.817 INTF6207PP1W16052704 31,340 -

307,706 -

National Bioterrorism Hospital Preparedness Program Boston Public Health Commission, City of Boston 93.889 4221011-2261011 11,143 -

National Bioterrorism Hospital Preparedness Program Boston Public Health Commission, City of Boston 93.889 HMCC FY16 ASPR 4221011-2261011 19,116 -

National Bioterrorism Hospital Preparedness Program Commonwealth Of Massachusetts 93.889 INTF6207PP1204215659 999 -

National Bioterrorism Hospital Preparedness Program Commonwealth Of Massachusetts 93.889 INTF6207PP1W16028699 11,365 -

National Bioterrorism Hospital Preparedness Program Franklin Regional Council of Governments 93.889 3,673 -

National Bioterrorism Hospital Preparedness Program International Institute of Greater Lawrence 93.889 26,958 -

National Bioterrorism Hospital Preparedness Program Massachusetts Board of Health 93.889 161326 17,079 -

National Bioterrorism Hospital Preparedness Program Massachusetts Department of Public Health 93.889 4221011-2261011 3,529 -

National Bioterrorism Hospital Preparedness Program Massachusetts Department of Public Health 93.889 INTF6207PP1204215487 13,397 -

National Bioterrorism Hospital Preparedness Program Massachusetts Department of Public Health 93.889 INTF6207PP1204215649 7 -

National Bioterrorism Hospital Preparedness Program Massachusetts Department of Public Health 93.889 INTF6207PP1204215668 856 -

National Bioterrorism Hospital Preparedness Program Massachusetts Department of Public Health 93.889 (105) -

National Bioterrorism Hospital Preparedness Program Massachusetts League of Community Health Centers 93.889 8,728 -

116,745 -

Department of Health and Human Services Office of the Secretary 424,451 -

Department of Health and Human Services Substance Abuse and Mental Health Services Administration

Block Grants for Prevention and Treatment of Substance Abuse Commonwealth Of Massachusetts 93.959 INTF2351MM3802114012 130,201 -

Substance Abuse and Mental Health Services Projects of Regional and National Significance Massachusetts Department of Mental Health 93.243 SCDMH651001663334BRIG 22,898 -

Substance Abuse and Mental Health Services Projects of Regional and National Significance Massachusetts Department of Public Health 93.243 INTF3121MM3W16001019 16,560 -

39,458 -

Department of Health and Human Services Substance Abuse and Mental Health Services Administration 169,659 -


Other Programs

Total Subrecipient



93

Department of Housing and Urban Development Office of Community Planning and Development

Continuum of Care Program Hilltown Community Development Corp. 14.267 MA0401L1T071201 91,115 -

Continuum of Care Program Hilltown Community Development Corp. 14.267 MA0468L1T071508 16,151 -

107,266 -

Housing Opportunities for Persons with AIDS City of Springfield 14.241 20150112 91,749 -

Housing Opportunities for Persons with AIDS City of Springfield 14.241 29,585 -

121,334 -

Department of Housing and Urban Development Office of Community Planning and Development 228,600 -

Department of Justice Office of Juvenile Justice and Delinquency Prevention

Reduction and Prevention of Children's Exposure to Violence Boston Public Health Commission, City of Boston 16.730 4432005.3442005 4,308 -

Department of Justice Office of Juvenile Justice and Delinquency Prevention 4,308 -

Department of Justice Violence Against Women Office

OVW Technical Assistance Initiative BOSTON PUBLIC HEALTH COMMISSION 16.526 2013-HI-AX-K008 4,968 -

Department of Justice Violence Against Women Office 4,968 -

Indian Health Service

National Institutes of Health Contracts 93. HHSI285201500016P 69,122 -

Indian Health Service 69,122 -

Total Other Programs 9,655,873$ -$

Total Federal Expenditures 977,866,783$ 159,993,522$

Partners HealthCare System, Inc. and Affiliates Notes to Schedule of Expenditures of Federal Awards September 30, 2016

94

1. Organization

Partners HealthCare System, Inc. (PHS) is the sole member of The Massachusetts General

Hospital (MGH), Brigham and Women’s Health Care, Inc. (BWHC), NSMC HealthCare, Inc.

(NSMC), Newton-Wellesley Health Care System, Inc. (NWHCS), Partners Continuing Care, Inc.

(PCC), Partners HealthCare International, LLC (PHI) and Neighborhood Health Plan, Incorporated

(NHP). The two physicians who serve as the President and Chief Executive Officer of PHS (PHS

CEO) and the Chief Clinical Officer of PHS are the members of Partners Community Physicians

Organization, Inc. (PCPO) formerly known as Partners Community HealthCare, Inc. The individual

serving as the PHS CEO is the sole member of Partners Medical International, Inc. (PMI). PHS,

together with all of its affiliates, is referred to as “Partners HealthCare.”

The Boards of MGH, Wentworth-Douglass Health System and Wentworth-Douglass Hospital

(WDH) have entered into a definitive agreement pursuant to which MGH will become the parent

organization of WDH and its affiliates. The parties have completed due diligence and expect to

complete the regulatory approval process in the near future. The transaction is expected to close in

fiscal 2017.

Partners HealthCare currently operates two tertiary and seven community acute care hospitals in

Massachusetts, one facility providing inpatient and outpatient mental health services and three

facilities providing inpatient and outpatient services in rehabilitation medicine and long-term care.

Partners HealthCare also operates physician organizations and practices, a home health agency,

nursing homes and a graduate level program for health professions. Partners HealthCare provides

services to patients primarily from the Greater Boston area as well as New England and beyond. In

addition, Partners HealthCare is a nonuniversity-based non-profit private medical research

enterprise and is a principal teaching affiliate of the medical and dental schools of Harvard

University. Partners HealthCare also operates a licensed, not-for-profit managed care organization

that provides health insurance products to the Medical Assistance Program (Medicaid),

Commonwealth Care (a series of health insurance plans for adults who meet income and other

eligibility requirements) and commercial populations.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the grant

activity of Partners HealthCare and is recorded on the accrual basis of accounting.

The information in the Schedule is presented in accordance with 2 CFR 200 Uniform Guidance

requirements. Therefore, some amounts presented in the Schedule may differ from amounts

presented in or used in the preparation of the basic consolidated financial statements. Negative

amounts represent adjustments to amounts reported as expenditures in prior years. Catalog of

Federal Domestic Assistance (CFDA), pass-through award numbers and expenditures are

provided where available.

Partners HealthCare System, Inc. and Affiliates Notes to Schedule of Expenditures of Federal Awards September 30, 2016

95

The Schedule combines expenditures of The Brigham and Women’s Hospital, Inc. (BWH), The

General Hospital Corporation (MGH), The McLean Hospital Corporation (McLean), MGH Institute

of Health Professions (IHP), Spaulding Rehabilitation Hospital Corporation (SRH), Cooley

Dickinson Hospital (CDH), North Shore Medical Center, Inc. (NSMC), Newton Wellesley Hospital

(NWH), Brigham and Women’s Faulkner Hospital, Inc. (BWFH), Martha’s Vineyard Hospital (MVH),

Nantucket Cottage Hospital (NCH), and Partners Community Physicians Organization (PCPO).

These entities are all affiliates of Partners HealthCare.

3. Federal Student Loan Programs

The amounts reported in the Student Financial Aid Cluster of the Schedule represent the beginning

balance and newly issued loans in fiscal year 2016. As of September 30, 2016, IHP had loans

outstanding of $251,901 for loans issued as part of the Nurse Faculty Loan Program and ARRA -

Nurse Faculty Loan Program. The ARRA loans (CFDA number 93.408) were $20,201 and the

NonARRA loans (CFDA number 93.264) were $231,700.

4. Facilities and Administrative and Fringe Benefit Costs

Federal expenditures for Research and Development and Research and Development Training for

BWH, MGH, McLean, SRH and IHP include facilities and administrative cost recoveries and fringe

benefit cost recoveries in the amounts reported in the Schedule based on rates negotiated and

awarded with the DHHS Division of Cost Allocation. These rates are based on financial information

submitted utilizing the methods prescribed in Principles for Determining Costs Applicable to

Research and Development Under Grants and Contracts with Hospitals, contained in the Code of

Federal Regulation, Title 45, Part 74, Appendix E (OASC-3). The predetermined facilities and

administrative cost rates for IHP were based on financial information submitted utilizing the short

form methodology prescribed in OMB Circular A-21 Cost Principles for Educational Institutions.

Expenditures reported in Training and Other include the maximum facilities and administrative

recoveries approved by the sponsor. The 10% de-minimis rate is not utilized on Research and

Development or Research and Development Training by Partners HealthCare affiliates because

they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other

awards where allowed.

Part II Reports on Compliance and Internal Controls

Report of Independent Auditors on Internal Control Over Financial Reporting and on

Compliance and Other Matters Based on an Audit of Financial Statements Performed in

Accordance with Government Auditing Standards



We have audited, in accordance with the auditing standards generally accepted in the United States of

America and the standards applicable to financial audits contained in Government Auditing Standards

issued by the Comptroller General of the United States, the consolidated financial statements of Partners

HealthCare System, Inc. and Affiliates (Partners HealthCare) which comprise the consolidated balance

sheets as of September 30, 2016, and the related consolidated statements of operations, changes in net

assets and cash flows for the year then ended, and the related notes to the consolidated financial

statements, and have issued our report thereon dated December 9, 2016.

Internal Control Over Financial Reporting

In planning and performing our audit of the consolidated financial statements, we considered Partners

HealthCare’s internal control over financial reporting (“internal control”) to determine the audit procedures

that are appropriate in the circumstances for the purpose of expressing our opinion on the consolidated

financial statements, but not for the purpose of expressing an opinion on the effectiveness of Partners

HealthCare’s internal control. Accordingly, we do not express an opinion on the effectiveness of Partners

HealthCare’s internal control.

A deficiency in internal control exists when the design or operation of a control does not allow

management or employees, in the normal course of performing their assigned functions, to prevent, or

detect and correct, misstatements on a timely basis. A material weakness is a deficiency, or a

combination of deficiencies, in internal control such that there is a reasonable possibility that a material

misstatement of the entity’s consolidated financial statements will not be prevented, or detected and

corrected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in

internal control that is less severe than a material weakness, yet important enough to merit attention by

those charged with governance.

Our consideration of internal control was for the limited purpose described in the first paragraph of this

section and was not designed to identify all deficiencies in internal control that might be material

weaknesses or significant deficiencies. Given these limitations, during our audit we did not identify any

deficiencies in internal control that we consider to be material weaknesses. However, material

weaknesses may exist that have not been identified.


97

Compliance and Other Matters

As part of obtaining reasonable assurance about whether Partners HealthCare’s consolidated financial

statements are free from material misstatement, we performed tests of its compliance with certain

provisions of laws, regulations, contracts and grant agreements, noncompliance with which could have a

direct and material effect on the determination of consolidated financial statement amounts. However,

providing an opinion on compliance with those provisions was not an objective of our audit, and

accordingly, we do not express such an opinion. The results of our tests disclosed no instances of

noncompliance or other matters that are required to be reported under Government Auditing Standards.

Purpose of this Report

The purpose of this report is solely to describe the scope of our testing of internal control and compliance

and the results of that testing, and not to provide an opinion on the effectiveness of the entity’s internal

control or on compliance. This report is an integral part of an audit performed in accordance with

Government Auditing Standards in considering the entity’s internal control and compliance. Accordingly,

this communication is not suitable for any other purpose.

December 9, 2016

Report of Independent Auditors on Compliance with Requirements

That Could Have a Direct and Material Effect on Each Major Program and on Internal Control Over

Compliance in Accordance with the OMB Uniform Guidance



Report on Compliance for Each Major Federal Program

We have audited Partners HealthCare System, Inc. and Affiliates’ (Partners HealthCare) compliance with

the types of compliance requirements described in the OMB Compliance Supplement that could have a

direct and material effect on each of its major federal programs for the year ended September 30, 2016.

Partners HealthCare’s major federal programs are identified in the summary of auditor’s results section of

the accompanying schedule of findings and questioned costs.

Management’s Responsibility

Management is responsible for compliance with the requirements of laws, regulations, contracts, and

grants applicable to its federal programs.

Auditor’s Responsibility

Our responsibility is to express an opinion on compliance for each of Partners HealthCare’s major federal

programs based on our audit of the types of compliance requirements referred to above. We conducted

our audit of compliance in accordance with auditing standards generally accepted in the United States of

America; the standards applicable to financial audits contained in Government Auditing Standards, issued

by the Comptroller General of the United States; and the audit requirements of Title 2 U.S. Code of

Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit

Requirements for Federal Awards (Uniform Guidance). Those standards and the Uniform Guidance

require that we plan and perform the audit to obtain reasonable assurance about whether noncompliance

with the types of compliance requirements referred to above that could have a direct and material effect

on a major federal program occurred. An audit includes examining, on a test basis, evidence about

Partners HealthCare’s compliance with those requirements and performing such other procedures as we

considered necessary in the circumstances.

We believe that our audit provides a reasonable basis for our opinion on compliance for each major

federal program. However, our audit does not provide a legal determination of Partners HealthCare’s

compliance.

Opinion on Each Major Federal Program

In our opinion, Partners HealthCare complied, in all material respects, with the types of compliance

requirements referred to above that could have a direct and material effect on each of its major federal

programs for the year ended September 30, 2016.


99

Other Matters

The results of our auditing procedures disclosed instances of noncompliance, which are required to be

reported in accordance with OMB Uniform Guidance and which are described in the accompanying

schedule of findings and questioned costs as item 2016-001. Our opinion on each major federal program

is not modified with respect to this matter.

Partners HealthCare’s response to the noncompliance finding identified in our audit is described in the

accompanying “Management’s Views and Corrective Action Plan”. Partners HealthCare’s response was

not subjected to the auditing procedures applied in the audit of compliance and, accordingly, we express

no opinion on the response.

Report on Internal Control Over Compliance

Management of Partners HealthCare is responsible for establishing and maintaining effective internal

control over compliance with the types of compliance requirements referred to above. In planning and

performing our audit of compliance, we considered Partners HealthCare’s internal control over compliance

with the types of requirements that could have a direct and material effect on each major federal program

to determine the auditing procedures that are appropriate in the circumstances for the purpose of

expressing an opinion on compliance for each major federal program and to test and report on internal

control over compliance in accordance with the Uniform Guidance, but not for the purpose of expressing

an opinion on the effectiveness of internal control over compliance. Accordingly, we do not express an

opinion on the effectiveness of Partners HealthCare’s internal control over compliance.

A deficiency in internal control over compliance exists when the design or operation of a control over compliance does not allow management or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct, noncompliance with a type of compliance requirement of a federal program on a timely basis. A material weakness in internal control over compliance is a deficiency, or combination of deficiencies, in internal control over compliance, such that there is a reasonable possibility that material noncompliance with a type of compliance requirement of a federal program will not be prevented, or detected and corrected, on a timely basis. A significant deficiency in internal control over compliance is a deficiency, or a combination of deficiencies, in internal control over compliance with a type of compliance requirement of a federal program that is less severe than a material weakness in internal control over compliance, yet important enough to merit attention by those charged with governance.

Our consideration of internal control over compliance was for the limited purpose described in the first

paragraph of this section and was not designed to identify all deficiencies in internal control over

compliance that might be material weaknesses or significant deficiencies. We did not identify any

deficiencies in internal control over compliance that we consider to be material weaknesses. However,

material weaknesses may exist that have not been identified.

The purpose of this report on internal control over compliance is solely to describe the scope of our testing

of internal control over compliance and the results of that testing based on the requirements of the

Uniform Guidance. Accordingly, this report is not suitable for any other purpose

December 22, 2016

Part III Federal Award Findings and Questioned Costs

Partners HealthCare System, Inc. and Affiliates Schedule of Findings and Questioned Costs Year Ended September 30, 2016

100

1. Summary of Auditor’s Results

Financial Statements

Type of auditor’s report issued Unmodified

Internal control over financial reporting

Material weakness(es) identified? yes X no

Significant deficiency(ies) identified that are not

considered to be material weaknesses? yes X none reported

Noncompliance material to financial statements noted? yes X no

Federal Awards

Internal control over major programs

Material weakness(es) identified? yes X no

Significant deficiency(ies) identified that are not

considered to be material weaknesses? yes X none reported

Type of auditor’s report issued on compliance for

major programs Unmodified

Any audit findings disclosed that are required

to be reported in accordance with 2 CFR 200, 516(a)

X yes _ no

Identification of Major Programs Name of Federal Program or Cluster

Various CFDA numbers Research and Development,

Research Training

Dollar threshold used to distinguish between Type A

and Type B programs $3,000,000

Auditee qualified as low-risk auditee? X yes no

2. Financial Statement Findings

No findings to report.

Partners HealthCare System, Inc. and Affiliates Schedule of Findings and Questioned Costs Year Ended September 30, 2016

101

3. Federal Findings and Questioned Costs

2016-001 Unallowable Costs

Research and Development Cluster

Award Name: Cardiovascular Diseases Research

Sponsor Award Number: 3R01HL092577-06S1 and 5U01HL123339-02

Award Year: 2015 and 2016 CFDA: 93.837

Criteria

Partners HealthCare is subject to compliance requirements for travel within OASC-3 section III.43 and the National Institutes of Health policy statement Part IIA, section 7.9.1.

Condition

Of the 22 travel costs tested, we noted two instances where an employee on the grant upgraded their airfare from the standard accommodations offered by the commercial airline. The total upgrade costs charged to awards 3R01HL092577-06S1 and 5U01HL123339-02 was $70 and $30, respectively. In addition to the upgrade costs, an alcohol charge totaling $6.25 was included within the expense report selected under award 3R01HL092577-06S1.

Cause

The travel charges were submitted for reimbursement through the standard Partners HealthCare employee expense form, which are subject to independent review and approval. While itemized receipts were submitted with the expense reports, the unallowable costs were not identified and removed from the grants.

Effect

Unallowable costs were charged to two grants.

Questioned Costs

$106.25

Recommendation

Management should reinforce the importance of attention to detail in review of travel expense reimbursements affecting federal awards.

Management’s View and Corrective Action Plan

Following these findings are management’s views and corrective action plan.

Partners HealthCare System, Inc. and Affiliates Summary of Status of Prior Year Findings Fiscal Year Ended September 30, 2016

102

A. Summary of Status of Prior Year Findings

None to report.

Documents

Partners HealthCare System, Inc. and Affiliates · Partners HealthCare System, Inc. and Affiliates Report on Federal Awards in Accordance with OMB Uniform Guidance Index September